DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		1p36.13	1	16013277	HSPB7	SRARP - HSPB7	ENSG00000183888	ENSG00000173641		4470.0	751.0	rs1763604-C	rs1763604	0	1763604	downstream_gene_variant	1.0	0.42085	7e-09	8.154901959985743		0.0372	[0.025-0.05] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		1q21.3	1	155016057	ZBTB7B	ZBTB7B			ENSG00000160685			rs77548871-C	rs77548871	0	77548871	intron_variant	0.0	0.0472	5e-09	8.301029995663981		0.0991	[0.066-0.132] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		2p11.2	2	85573959	NR	VAMP8			ENSG00000118640			rs13007211-A	rs13007211	0	13007211	intron_variant	0.0	0.6935	1e-09	9.0		0.0432	[0.029-0.057] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		2q13	2	111138666	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs17041869-A	rs17041869	0	17041869	intron_variant	0.0	0.8804	2e-09	8.698970004336019		0.0571	[0.038-0.076] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		4q24	4	105137029	TET2	NA - TET2		ENSG00000168769			8846.0	rs57251748-CT	rs57251748	0	57251748	regulatory_region_variant	1.0	0.15	9e-12	11.045757490560677		0.0598	[0.043-0.077] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		7p15.1	7	27950149	JAZF1	JAZF1			ENSG00000153814			rs739704-A	rs739704	0	739704	intron_variant	0.0	0.2515	3e-14	13.522878745280336		0.0542	[0.04-0.068] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		7q35	7	144377836	ARHGEF5	ARHGEF5, ARHGEF5			ENSG00000050327, ENSG00000284933			rs720475-A	rs720475	0	720475	intron_variant	0.0	0.25455	7e-12	11.154901959985745		0.0495	[0.035-0.064] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		8q24.21	8	126990792	PCAT1/PCAT2	PCAT1			ENSG00000253438			rs17762342-A	rs17762342	0	17762342	intron_variant	0.0	0.7935	2e-15	14.69897000433602		0.061	[0.046-0.076] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		8q24.21	8	128187668	MIR1208/PVT1	PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		567.0	32836.0	rs3802173-T	rs3802173	0	3802173	intergenic_variant	1.0	0.2261	3e-11	10.522878745280336		0.0521	[0.037-0.068] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		9p21.3	9	21956231	CDKN2A/CDKN2B	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		18580.0	10698.0	rs9657608-T	rs9657608	0	9657608	intron_variant	1.0	0.0923	1e-10	10.0		0.0685	[0.048-0.089] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		10p12.31	10	22010574	DNAJC1	DNAJC1 - NA	ENSG00000136770			6805.0		rs7898685-A	rs7898685	0	7898685	regulatory_region_variant	1.0	0.2913	3e-10	9.522878745280336		0.0428	[0.029-0.056] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		10q25.3	10	113390512	HABP2	RNU7-165P - PPIAP39	ENSG00000238380	ENSG00000230018		37028.0	92104.0	rs568110-T	rs568110	0	568110	regulatory_region_variant	1.0	0.2057	5e-12	11.30102999566398		0.0523	[0.037-0.067] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		11q12.3	11	62126500	INCENP	INCENP			ENSG00000149503			rs7937840-T	rs7937840	0	7937840	intron_variant	0.0	0.26465	2e-09	8.698970004336019		0.0446	[0.03-0.059] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		11q13.2	11	66324772	NR	CD248 - RIN1	ENSG00000174807	ENSG00000174791		7728.0	5469.0	rs118151305-A	rs118151305	0	118151305	intergenic_variant	1.0	0.12004999999999999	6e-09	8.221848749616356		0.0672	[0.045-0.09] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		11q13.3	11	69138652	TPCN2	TPCN2 - SMIM38	ENSG00000162341	ENSG00000284713		2336.0	16826.0	rs72932523-A	rs72932523	0	72932523	intron_variant	1.0	0.10565	1e-09	9.0		0.0601	[0.041-0.08] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		14q32.11	14	91283251	CCDC88C	CCDC88C			ENSG00000015133			rs2277509-A	rs2277509	0	2277509	intron_variant	0.0	0.69865	9e-12	11.045757490560677		0.0466	[0.033-0.06] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		17q22	17	55135212	STXBP4	STXBP4			ENSG00000166263			rs2628317-A	rs2628317	0	2628317	intron_variant	0.0	0.72985	4e-16	15.397940008672036		0.0582	[0.044-0.072] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		19p13.11	19	19417997	GATAD2A	GATAD2A			ENSG00000167491			rs1469713-A	rs1469713	0	1469713	intron_variant	0.0	0.64405	1e-10	10.0		0.043	[0.03-0.056] unit decrease	Illumina [NR]	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		5q31.2	5	138428109	FAM53C, CDC25C, KDM3B	KDM3B			ENSG00000120733			rs17599026-T	rs17599026	0	17599026	intron_variant	0.0	0.08	4e-08	7.397940008672037		3.12	[2.08-4.69]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		12q13.13	12	53200654	intergenic	ITGB7			ENSG00000139626			rs11574532-T	rs11574532	0	11574532	intron_variant	0.0	0.07	2e-07	6.698970004336019		3.25	[2.08-5.07]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		4q22.1	4	87150076	intergenic	AFF1 - KLHL8	ENSG00000172493	ENSG00000145332		9037.0	10027.0	rs342442-?	rs342442	0	342442	regulatory_region_variant	1.0	0.62	4e-07	6.3979400086720375		1.9607843	[1.52-2.56]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		12p13.31	12	8514205	intergenic	CLEC4D			ENSG00000166527			rs4534636-A	rs4534636	0	4534636	intron_variant	0.0	0.20	2e-06	5.698970004336019		1.96	[1.49-2.59]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		18q21.1	18	45971047	intergenic	EPG5 - PSTPIP2	ENSG00000152223	ENSG00000152229		3718.0	12489.0	rs8098701-T	rs8098701	0	8098701	intergenic_variant	1.0	0.07	2e-06	5.698970004336019		2.41	[1.68-3.47]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		1q41	1	214606084	intergenic	ABHD17AP3, CENPF			ENSG00000250536, ENSG00000117724			rs7366282-C	rs7366282	0	7366282	splice_region_variant	0.0	0.06	2e-06	5.698970004336019		3.2	[1.98-5.16]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		2q36.1	2	221684477	intergenic	RPL23P5 - NA	ENSG00000230406			91616.0		rs10209697-A	rs10209697	0	10209697	intergenic_variant	1.0	0.07	2e-06	5.698970004336019		2.66	[1.77-3.99]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		6q14.1	6	82698067	intergenic							rs4997823-?	rs4997823	0	4997823	regulatory_region_variant	1.0	0.65	2e-06	5.698970004336019		2.0408163	[1.52-2.78]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		6p24.1	6	12217189	intergenic	HIVEP1 - EDN1	ENSG00000095951	ENSG00000078401		52190.0	73172.0	rs7356945-T	rs7356945	0	7356945	intergenic_variant	1.0	0.33	4e-06	5.3979400086720375		1.74	[1.38-2.21]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		22q11.23	22	23942638	intergenic	MIF-AS1 - GSTT2B	ENSG00000281335	ENSG00000133433		43708.0	14776.0	rs6003982-?	rs6003982	0	6003982	non_coding_transcript_exon_variant	1.0	0.56	4e-06	5.3979400086720375		1.9607843	[1.47-2.63]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals		8q24.3	8	141800605	intergenic	MIR1302-7 - NA	ENSG00000221768			14292.0		rs10101158-A	rs10101158	0	10101158	regulatory_region_variant	1.0	0.44	4e-06	5.3979400086720375		1.8	[1.40-2.31]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		5p15.2	5	13858219	DNAH5	DNAH5			ENSG00000039139			rs7720298-G	rs7720298	0	7720298	intron_variant	0.0	0.24	3e-08	7.522878745280337		2.71	[1.90-3.86]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		8p23.2	8	5689302	intergenic	RPL23AP54 - RN7SKP159	ENSG00000240486	ENSG00000222589		212336.0	221643.0	rs17362923-G	rs17362923	0	17362923	intergenic_variant	1.0	0.18	7e-07	6.154901959985743		2.7	[1.83-4.00]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		1q32.1	1	198705436	intergenic	PTPRC, PTPRC			ENSG00000262418, ENSG00000081237			rs76273496-C	rs76273496	0	76273496	intron_variant	0.0	0.07	3e-06	5.522878745280337		3.68	[2.13-6.33]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		Xq21.1	X	80753384	intergenic	BRWD3			ENSG00000165288			rs2203205-C	rs2203205	0	2203205	intron_variant	0.0	0.29	3e-06	5.522878745280337		1.74	[1.38-2.20]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		3q28	3	190286521	intergenic	NA - CLDN1		ENSG00000163347			19186.0	rs144596911-A	rs144596911	0	144596911	intergenic_variant	1.0	0.09	3e-06	5.522878745280337		3.6	[2.11-6.17]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		18p11.32	18	514471	intergenic	LINC01925			ENSG00000264265			rs62091368-A	rs62091368	0	62091368	intron_variant	0.0	0.07	4e-06	5.3979400086720375		4.36	[2.33-8.14]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		5q23.3	5	128745323	intergenic	SLC27A6			ENSG00000113396			rs141342719-T	rs141342719	0	141342719	intron_variant	0.0	0.12	4e-06	5.3979400086720375		3.5	[2.05-5.95]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	1,245 European ancestry individuals		18p11.32	18	2825420	intergenic	SMCHD1 - EMILIN2	ENSG00000101596	ENSG00000132205		20403.0	21586.0	rs673783-G	rs673783	0	673783	intron_variant	1.0	0.31	4e-06	5.3979400086720375		2.49	[1.69-3.67]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		11q12.2	11	60441351	Intergenic	MS4A5			ENSG00000166930			rs11230328-G	rs11230328	0	11230328	intron_variant	0.0	0.27	6e-10	9.221848749616356		0.31	[0.21-0.41] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		10p14	10	10074911	Intergenic	LINC02670 - ELOCP3	ENSG00000224788	ENSG00000229919		11409.0	99319.0	rs147596965-T	rs147596965	0	147596965	intergenic_variant	1.0	0.07	6e-08	7.221848749616356		0.67	[0.43-0.91] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		2q31.1	2	174729547	Intergenic	H3P6 - CHRNA1	ENSG00000235655	ENSG00000138435		9229.0	18045.0	rs77530448-G	rs77530448	0	77530448	intron_variant	1.0	0.09	7e-08	7.154901959985743		0.36	[0.23-0.49] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		15q12	15	25730061	Intergenic	ATP10A			ENSG00000206190			rs4906759-T	rs4906759	0	4906759	intron_variant	0.0	0.06	2e-07	6.698970004336019		0.55	[0.34-0.75] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		4p15.2	4	26002024	Intergenic	SMIM20 - LINC02357	ENSG00000250317	ENSG00000283314		72150.0	68730.0	rs71610881-A	rs71610881	0	71610881	intergenic_variant	1.0	0.06	5e-07	6.301029995663981		0.6	[0.36-0.83] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		19q13.2	19	40682173	Intergenic	NUMBL			ENSG00000105245			rs141799618-G	rs141799618	0	141799618	intron_variant	0.0	0.06	1e-06	6.0		0.44	[0.26-0.62] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		10q26.2	10	126642144	Intergenic	C10orf90			ENSG00000154493			rs2842169-C	rs2842169	0	2842169	intron_variant	0.0	0.1	1e-06	6.0		0.28	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		11q24.1	11	123204711	Intergenic	CLMP - U8	ENSG00000166250	ENSG00000239142		9463.0	96679.0	rs11219068-A	rs11219068	0	11219068	intron_variant	1.0	0.15	2e-06	5.698970004336019		0.28	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		17p13.2	17	6384826	Intergenic	BTF3P14 - AIPL1	ENSG00000262609	ENSG00000129221		61598.0	8867.0	rs8075565-T	rs8075565	0	8075565	intergenic_variant	1.0	0.13	2e-06	5.698970004336019		0.28	[0.16-0.39] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		4q28.3	4	134616564	Intergenic	LINC02462 - NA	ENSG00000251291			70916.0		rs6535028-T	rs6535028	0	6535028	intergenic_variant	1.0	0.1	3e-06	5.522878745280337		0.29	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		15q21.1	15	46564730	Intergenic	NA - RNU6-1014P		ENSG00000238456			95928.0	rs4775602-C	rs4775602	0	4775602	intron_variant	1.0	0.16	3e-06	5.522878745280337		0.23	[0.13-0.32] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		1p13.3	1	109165601	Intergenic	ELAPOR1			ENSG00000116299			rs60481745-A	rs60481745	0	60481745	intron_variant	0.0	0.1	4e-06	5.3979400086720375		0.37	[0.22-0.53] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		8p23.2	8	3289837	Intergenic	CSMD1			ENSG00000183117			rs7829759-A	rs7829759	0	7829759	intron_variant	0.0	0.11	4e-06	5.3979400086720375		0.33	[0.19-0.47] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		15q24.2	15	75637650	Intergenic	SNUPN - IMP3	ENSG00000169371	ENSG00000177971		11181.0	1435.0	rs79604958-C	rs79604958	0	79604958	intron_variant	1.0	0.07	4e-06	5.3979400086720375		0.47	[0.27-0.68] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		12p13.31	12	8552873	Intergenic	CLEC4E - Y_RNA	ENSG00000166523	ENSG00000264495		11968.0	39603.0	rs10770857-A	rs10770857	0	10770857	intron_variant	1.0	0.37	5e-06	5.301029995663981		0.17	[0.10-0.25] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals		15q25.1	15	79696844	Intergenic							rs12591436-G	rs12591436	0	12591436	intergenic_variant	1.0	0.34	6e-06	5.221848749616356		0.18	[0.10-0.26] unit increase	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals		8q21.13	8	79779234	intergenic	LINC01607			ENSG00000272138			rs6999859-G	rs6999859	0	6999859	intron_variant	0.0	0.28	3e-06	5.522878745280337		1.73	[1.37-2.17]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals		19p13.2	19	10457843	intergenic	PDE4A			ENSG00000065989			rs4804134-?	rs4804134	0	4804134	intron_variant	0.0	0.69	3e-06	5.522878745280337		1.6666665	[1.35-2.08]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals		1q42.12	1	225904035	intergenic	LEFTY1			ENSG00000243709			rs360071-T	rs360071	0	360071	intron_variant	0.0	0.49	4e-06	5.3979400086720375		1.61	[1.32-1.97]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals		3p12.3	3	76667643	intergenic	ROBO2			ENSG00000185008			rs12497518-?	rs12497518	0	12497518	intron_variant	0.0	0.53	1e-06	6.0		1.6666665	[1.35-2.08]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals		Xq23	X	115688155	intergenic	ASS1P5 - DANT2	ENSG00000227881	ENSG00000235244		22022.0	6725.0	rs141044160-C	rs141044160	0	141044160	intergenic_variant	1.0	0.05	2e-06	5.698970004336019		2.68	[1.78-4.04]	NR [~ 38000000] (imputed)	N
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals		3q26.1	3	162481716	intergenic	NA - TOMM22P6		ENSG00000241874			4825.0	rs7432328-A	rs7432328	0	7432328	intergenic_variant	1.0	0.06	3e-06	5.522878745280337		3.36	[2.05-5.59]	NR [~ 38000000] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		13q13.3	13	36861531	NR	SMAD9			ENSG00000120693			rs140971918-G	rs140971918	0	140971918	intron_variant	0.0	0.63	4e-06	5.3979400086720375		1.68	[1.34-2.09]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		13q34	13	112620498	NR	TUBGCP3 - ATP11AUN	ENSG00000126216	ENSG00000197595		32293.0	26546.0	rs7325069-G	rs7325069	0	7325069	intergenic_variant	1.0	0.62	3e-06	5.522878745280337		1.63	[1.33-1.99]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		14q32.2	14	97356528	NR	NA - LINC02325		ENSG00000246084			70543.0	rs234439-G	rs234439	0	234439	intergenic_variant	1.0	0.79	3e-06	5.522878745280337		1.78	[1.39-2.26]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		16p13.3	16	7552979	NR	RBFOX1			ENSG00000078328			rs112896149-G	rs112896149	0	112896149	intron_variant	0.0	0.8	5e-06	5.301029995663981		1.87	[1.43-2.45]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		18q21.1	18	49679976	NR	SMUG1P1 - NA	ENSG00000267444			28816.0		rs8093567-T	rs8093567	0	8093567	intergenic_variant	1.0	0.84	2e-06	5.698970004336019		2.01	[1.51-2.69]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		19q13.31	19	44371829	NR	ZNF112 - ZNF285	ENSG00000062370	ENSG00000267508		4612.0	10469.0	rs2571082-G	rs2571082	0	2571082	intron_variant	1.0	0.72	7e-06	5.154901959985743		1.76	[1.38-2.25]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		19q13.43	19	56687205	NR	ZIM2-AS1			ENSG00000269793			rs7258285-G	rs7258285	0	7258285	intron_variant	0.0	0.7	3e-06	5.522878745280337		1.66	[1.34-2.06]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		1p31.1	1	79987113	NR							rs1340678-T	rs1340678	0	1340678	intron_variant	1.0	0.51	4e-06	5.3979400086720375		1.56	[1.29-1.89]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		1p22.2	1	89431556	NR	GBP1P1 - LRRC8B	ENSG00000225492	ENSG00000197147		5313.0	93273.0	rs12095604-C	rs12095604	0	12095604	intron_variant	1.0	0.1	5e-06	5.301029995663981		2.1	[1.53-2.88]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		1q42.11	1	224217786	NR	DEGS1 - NVL	ENSG00000143753	ENSG00000143748		24345.0	9548.0	rs61005944-CT	rs61005944	0	61005944	regulatory_region_variant	1.0	0.22	1e-06	6.0		1.77	[1.41-2.23]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		2p22.1	2	41094221	NR	NA - HNRNPA1P57		ENSG00000237442			49559.0	rs148184576-A	rs148184576	0	148184576	intergenic_variant	1.0	0.94	3e-06	5.522878745280337		3.59	[2.09-6.16]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		2q11.2	2	97135631	NR	ANKRD36			ENSG00000135976			rs58488929-C	rs58488929	1	2443902	intron_variant	0.0	0.07	6e-06	5.221848749616356		2.28	[1.59-3.25]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		2q14.3	2	127104557	NR	BIN1			ENSG00000136717			rs6431219-C	rs6431219	0	6431219	intron_variant	0.0	0.51	8e-06	5.096910013008056		1.55	[1.28-1.88]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		3q27.1	3	184083406	NR	HTR3C2P			ENSG00000233576			rs5855014-GC	rs5855014	0	5855014	splice_region_variant	0.0	0.85	3e-06	5.522878745280337		2.12	[1.55-2.91]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls					NR							chr4:181412356-T	chr4:181412356	0			1.0	0.93	5e-06	5.301029995663981		3.04	[1.88-4.91]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		5q23.1	5	116942357	NR							rs76861935-C	rs76861935	0	76861935	intergenic_variant	1.0	0.86	9e-06	5.045757490560675		2.02	[1.48-2.75]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		5q34	5	162565392	NR	RNU6-164P - NA	ENSG00000201474			87399.0		rs17060512-T	rs17060512	0	17060512	intron_variant	1.0	0.89	7e-06	5.154901959985743		2.32	[1.61-3.35]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		6p25.1	6	4905041	NR	CDYL			ENSG00000153046			rs79774606-G	rs79774606	0	79774606	intron_variant	0.0	0.81	9e-06	5.045757490560675		1.93	[1.44-2.57]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		7p14.3	7	29103463	NR	CPVL			ENSG00000106066			rs6979813-C	rs6979813	0	6979813	intron_variant	0.0	0.72	6e-06	5.221848749616356		1.7	[1.35-2.14]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		8q24.21	8	127062570	NR	PCAT1			ENSG00000253438			rs72725854-T	rs72725854	0	72725854	intron_variant	0.0	0.06	2e-11	10.69897000433602		3.37	[2.36-4.82]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		8q24.21	8	127164718	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs76784613-G	rs76784613	0	76784613	intron_variant	0.0	0.04	1e-06	6.0		2.86	[1.87-4.37]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		9p23	9	11130398	NR							rs2151715-G	rs2151715	0	2151715	intergenic_variant	1.0	0.7	3e-06	5.522878745280337		1.74	[1.38-2.18]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		9p23	9	12079333	NR							rs4741206-G	rs4741206	0	4741206	intergenic_variant	1.0	0.78	9e-06	5.045757490560675		1.78	[1.38-2.30]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		9p23	9	12184024	NR							rs73408421-A	rs73408421	0	73408421	intergenic_variant	1.0	0.76	1e-06	6.0		1.81	[1.42-2.30]	Illumina [17125421] (imputed)	N
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls		10q21.1	10	53578095	NR							rs11003686-A	rs11003686	0	11003686	intergenic_variant	1.0	0.1	9e-06	5.045757490560675		2.06	[1.50-2.84]	Illumina [17125421] (imputed)	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		16q22.1	16	70741552	VAC14	VAC14			ENSG00000103043			rs875858-?	rs875858	0	875858	intron_variant	0.0	NR	2e-08	7.698970004336019		3.6	[2.21-5.84]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		10q26.3	10	130032376	Intergenic	C10orf143			ENSG00000237489			rs11017056-?	rs11017056	0	11017056	intron_variant	0.0	NR	4e-07	6.3979400086720375		2.61	[1.77-3.84]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		13q12.13	13	25800908	ATP8A2	ATP8A2			ENSG00000132932			rs1326116-?	rs1326116	0	1326116	intron_variant	0.0	NR	2e-06	5.698970004336019		2.77	[1.79-4.27]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		18p11.31	18	4772808	Intergenic							rs8089250-?	rs8089250	0	8089250	intergenic_variant	1.0	NR	2e-06	5.698970004336019		2.72	[1.78-4.17]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		2q36.3	2	225488082	KIAA1486	NYAP2			ENSG00000144460			rs6436559-?	rs6436559	0	6436559	intron_variant	0.0	NR	3e-06	5.522878745280337		3.34	[1.95-5.71]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		5p15.33	5	3727065	Intergenic							rs1566691-?	rs1566691	0	1566691	intergenic_variant	1.0	NR	4e-06	5.3979400086720375		3.64	[2.03-6.52]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		11q25	11	132887775	OPCML	OPCML			ENSG00000183715			rs1027796-?	rs1027796	0	1027796	intron_variant	0.0	NR	4e-06	5.3979400086720375		2.38	[1.62-3.48]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		9q33.1	9	115509305	Intergenic							rs2213920-?	rs2213920	0	2213920	intron_variant	1.0	NR	5e-06	5.301029995663981		2.63	[1.70-4.06]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		2q36.3	2	228150003	SPHKAP	SPHKAP			ENSG00000153820			rs4438470-?	rs4438470	0	4438470	intron_variant	0.0	NR	5e-06	5.301029995663981		2.71	[1.73-4.25]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		2p25.2	2	6637697	Intergenic	MIR7515HG			ENSG00000236172			rs17815605-?	rs17815605	0	17815605	non_coding_transcript_exon_variant	0.0	NR	6e-06	5.221848749616356		2.886	[NR]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		5q31.1	5	136245971	TRPC7	TRPC7			ENSG00000069018			rs11740657-?	rs11740657	0	11740657	intron_variant	0.0	NR	9e-06	5.045757490560675		2.776	[NR]	Illumina [498081]	N
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy		10q21.3	10	66659088	CTNNA3	CTNNA3			ENSG00000183230			rs10997287-?	rs10997287	0	10997287	intron_variant	0.0	NR	9e-06	5.045757490560675		4.0816326	[NR]	Illumina [498081]	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	19q13.33	19	50858501	KLK3	KLK3			ENSG00000142515			rs17632542-T	rs17632542	0	17632542	missense_variant	0.0	0.92	1e-07	7.0		1.85	[1.61-2.09]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11p15.5	11	2207722	TH	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		34584.0	60776.0	rs7126629-C	rs7126629	0	7126629	intergenic_variant	1.0	0.21	2e-08	7.698970004336019		1.44	[1.31-1.57]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11p15.5	11	2212344	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206.0	56154.0	rs7127900-A	rs7127900	0	7127900	intergenic_variant	1.0	NR	1e-07	7.0		1.4	[NR]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11q13.3	11	69227030	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67278.0	67121.0	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1.0	NR	1e-06	6.0		1.3	[NR]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	17q12	17	37736310	TCF2	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs2005705-G	rs2005705	0	2005705	intron_variant	0.0	0.56	1e-06	6.0		1.35	[1.23-1.47]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	NR	1e-08	8.0		1.36	[NR]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.42	2e-07	6.698970004336019		1.32	[1.21-1.43]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	8q24.21	8	127395198	MYC	POU5F1B, PCAT1, CASC8			ENSG00000212993, ENSG00000253438, ENSG00000246228			rs10505477-A	rs10505477	0	10505477	intron_variant	0.0	0.49	9e-09	8.045757490560675		1.39	[1.28-1.50]	Illumina [2639562] (imputed)	N
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11q13.3	11	69241647	MYEOV	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		81895.0	52504.0	rs11228583-T	rs11228583	0	11228583	regulatory_region_variant	1.0	0.52	2e-07	6.698970004336019		1.33	[1.22-1.44]	Illumina [2639562] (imputed)	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	5p15.33	5	1895715	NR	CTD-2194D22.4			ENSG00000249326			rs12653946-T	rs12653946	0	12653946	intron_variant	0.0	0.43	3e-07	6.522878745280337	(Japanese)	1.39	[1.22-1.57]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-T	rs1512268	0	1512268	intergenic_variant	1.0	0.36	5e-06	5.301029995663981	(Japanese)	1.35	[1.19-1.53]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127094635	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs6983561-C	rs6983561	0	6983561	intron_variant	0.0	0.18	4e-13	12.397940008672036	(Japanese)	1.87	[1.58-2.22]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127519892	NR	CASC8 - NA	ENSG00000246228			37753.0		rs10090154-T	rs10090154	0	10090154	intergenic_variant	1.0	0.08	3e-06	5.522878745280337	(Latin American)	1.68	[1.35-2.09]	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127112950	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs10505483-T	rs10505483	0	10505483	intron_variant	0.0	NR	7e-15	14.154901959985745	(Japanese and Latin American)	1.73	NR	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	3p12.1	3	87085650	NR	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		32912.0	3479.0	rs17023900-G	rs17023900	0	17023900	intergenic_variant	1.0	NR	6e-08	7.221848749616356	(Japanese and Latin American)	1.41	NR	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8p21.2	8	23676505	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		40998.0	2192.0	rs10503733-T	rs10503733	0	10503733	intergenic_variant	1.0	NR	8e-08	7.096910013008056	(Japanese and Latin American)	1.29	NR	Illumina [528023]	N
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127092098	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs13254738-C	rs13254738	0	13254738	non_coding_transcript_exon_variant	0.0	0.54	4e-10	9.397940008672036	(Japanese)	1.59	[1.38-1.84]	Illumina [528023]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	2q37.1	2	233759924	UGT1A8	UGT1A4, UGT1A7, UGT1A10, UGT1A6, UGT1A3, UGT1A9, UGT1A5, UGT1A8			ENSG00000244474, ENSG00000244122, ENSG00000242515, ENSG00000167165, ENSG00000288702, ENSG00000241119, ENSG00000288705, ENSG00000242366			rs887829-T	rs887829	0	887829	intron_variant	0.0	NR	8.999999999999998e-25	24.045757490560675	(Bilirubin)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	12p12.1	12	21229685	SLCO1B1	SLCO1B1			ENSG00000134538			rs11045879-C	rs11045879	0	11045879	intron_variant	0.0	NR	5e-15	14.30102999566398	(Glycochenodeoxycholic acid 3-glucuronide)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	10q24.2	10	98387303	PYROXD2	PYROXD2			ENSG00000119943			rs4345897-G	rs4345897	0	4345897	missense_variant	0.0	NR	1.9999999999999998e-91	90.69897000433602	(Caprolactam)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	11q12.2	11	61803910	FADS1	FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs174549-G	rs174549	0	174549	5_prime_UTR_variant	0.0	NR	1.9999999999999998e-30	29.69897000433602	(Glycerolphosphocholine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	2q34	2	210210185	ACADL	ACADL			ENSG00000115361			rs3764913-T	rs3764913	0	3764913	non_coding_transcript_exon_variant	0.0	NR	4.0000000000000003e-29	28.39794000867204	(2,6 dimethylheptanoyl carnitine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	19p13.12	19	15879621	CYP4F2	CYP4F2			ENSG00000186115			rs2108622-T	rs2108622	0	2108622	missense_variant	0.0	NR	9e-24	23.045757490560675	(Glycerolphosphocholine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	7q21.3	7	95308945	PON1	PON1			ENSG00000005421			rs2057681-G	rs2057681	0	2057681	intron_variant	0.0	NR	7e-15	14.154901959985745	(C9H14Ona)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	15q21.3	15	58438954	LIPC	LIPC-AS1, ALDH1A2, LIPC			ENSG00000259293, ENSG00000128918, ENSG00000166035			rs261342-C	rs261342	0	261342	intron_variant	0.0	NR	9e-13	12.045757490560677	(Glycerophospho-N-Palmitoyl Ethanolamine)			Affymetrix [333722]	N
2013-03-22	23281178	Hong MG	2013-03-01	Hum Mutat	www.ncbi.nlm.nih.gov/pubmed/23281178	A genome-wide assessment of variability in human serum metabolism.	Metabolite levels	214 European ancestry prostate cancer cases, 188 European ancestry controls	489 European ancestry prostate cancer cases	17q23.3	17	63492371	ACE	ACE			ENSG00000159640			rs4351-A	rs4351	0	4351	intron_variant	0.0	NR	9e-13	12.045757490560677	(Unknown)			Affymetrix [333722]	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	16q22.2	16	71997071	PKD1L3	PKD1L3			ENSG00000277481			rs12597458-G	rs12597458	0	12597458	intron_variant	0.0	0.56	1e-07	7.0		1.11	[1.06‐1.15]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	6p22.3	6	21330062	CDKAL1	CDKAL1 - LINC00581	ENSG00000145996	ENSG00000280989		97658.0	155834.0	rs12198220-T	rs12198220	0	12198220	intergenic_variant	1.0	0.74	2e-07	6.698970004336019		1.12	[1.07‐1.17]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127505328	LOC727677, CASC8	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		23189.0	181015.0	rs4242382-A	rs4242382	0	4242382	intergenic_variant	1.0	0.1	1.0000000000000001e-34	34.0		1.45	[1.35-1.54]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	17q12	17	37741595	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs8064454-C	rs8064454	0	8064454	intron_variant	0.0	0.52	8.000000000000001e-29	28.096910013008056		1.24	[1.19‐1.29]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	17q24.3	17	71110733	BC039327, CASC17	CASC17			ENSG00000260785			rs17765344-A	rs17765344	0	17765344	intron_variant	0.0	0.48	4e-21	20.39794000867204		1.19	[1.15-1.23]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	22q13.2	22	43104206	BIK	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	0.5	1e-16	16.0		1.18	[1.12-1.22]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	10q11.22	10	46046326	PARG, TIMM23, MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.39	1e-15	15.0		1.16	[1.12-1.20]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	3q26.2	3	170281428	PRKCI	PRKCI			ENSG00000163558			rs71277158-T	rs71277158	0	71277158	non_coding_transcript_exon_variant	0.0	0.82	8e-14	13.096910013008056		1.22	[1.15-1.28]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	11q13.3	11	69218116	LOC338694, MYEOV	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		58364.0	76035.0	rs7929962-T	rs7929962	0	7929962	regulatory_region_variant	1.0	0.51	2e-13	12.69897000433602		1.15	[1.11‐1.19]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	6q25.3	6	160419220	SLC22A3	SLC22A3			ENSG00000146477			rs7758229-T	rs7758229	0	7758229	intron_variant	0.0	0.31	4e-12	11.397940008672036		1.15	[1.10‐1.20]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	2p15	2	62950976	EHBP1	EHBP1			ENSG00000115504			rs2430386-T	rs2430386	0	2430386	intron_variant	0.0	0.5	9e-12	11.045757490560677		1.14	[1.10‐1.18]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	3p12.1	3	87085650	LINC00506, BC050344	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		32912.0	3479.0	rs17023900-G	rs17023900	0	17023900	intergenic_variant	1.0	0.07	1e-11	11.0		1.26	[1.18‐1.34]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	5p15.33	5	1282299	TERT, hTERT	TERT			ENSG00000164362			rs7725218-G	rs7725218	0	7725218	intron_variant	0.0	0.64	3e-11	10.522878745280336		1.15	[1.10-1.19]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	12q24.21	12	114228397	TBX5	GLULP5 - LINC02459	ENSG00000257915	ENSG00000257476		122466.0	10573.0	rs10774740-G	rs10774740	0	10774740	intergenic_variant	1.0	0.6	3e-10	9.522878745280336		1.14	[1.09-1.18]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	4q24	4	105140377	TET2	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-C	rs7679673	0	7679673	intron_variant	1.0	0.58	4e-09	8.397940008672037		1.12	[1.08-1.16]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	Xp11.22	X	52867918	NR	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0.0	0.161	4e-06	5.3979400086720375		1.15	[1.09-1.22]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.499	4e-10	9.397940008672036		1.23	[1.15-1.32]	Illumina [1531807] (imputed)	N
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127112671	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0.0	0.029	5e-09	8.301029995663981		1.65	[1.39-1.95]	Illumina [1531807] (imputed)	N
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	5q14.3	5	87315172	RASA1, CCNH	RASA1			ENSG00000145715			rs35148638-C	rs35148638	0	35148638	intron_variant	0.0	0.255	6e-09	8.221848749616356		0.088	[0.059-0.117] unit increase	Illumina [1531807] (imputed)	N
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	3q26.31	3	175534948	NAALADL2	NAALADL2			ENSG00000177694			rs78943174-C	rs78943174	0	78943174	intron_variant	0.0	0.987	4e-08	7.397940008672037		0.289	[0.19-0.39] unit increase	Illumina [1531807] (imputed)	N
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	19q13.33	19	50857584	KLK3	KLK3			ENSG00000142515			rs62113212-T	rs62113212	0	62113212	non_coding_transcript_exon_variant	0.0	0.061	6e-09	8.221848749616356		0.138	[0.091-0.185] unit increase	Illumina [1531807] (imputed)	N
2014-12-17	24974847	Fachal L	2014-06-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24974847	A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.	Response to radiotherapy in prostate cancer (toxicity)	Up to 652 European ancestry cases	849 European ancestry cases	2q24.2	2	159042977	TANC1, BTF3L4P2, GSTM3P2	TANC1			ENSG00000115183			rs7582141-T	rs7582141	0	7582141	intron_variant	0.0	0.04	5e-11	10.30102999566398	(late toxicity)	0.37	[NR] unit increase	Affymetrix [552597]	N
2009-02-26	19117981	Sun J	2009-01-01	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19117981	Sequence variants at 22q13 are associated with prostate cancer risk.	Prostate cancer	1,235 European ancestry aggressive cases, 1,599 European ancestry controls	1,215 European ancestry aggressive cases, 2,213 European ancestry non-aggressive cases, 1,208 European ancestry controls, 1,034 aggressive cases, 921 non-aggressive cases, 2,231 controls	22q13.1	22	40056115	TNRC6B	TNRC6B			ENSG00000100354			rs9623117-C	rs9623117	0	9623117	intron_variant	0.0	0.21	5e-07	6.301029995663981		1.18	[1.11-1.26]	Affymetrix, Illumina [~ 2000000] (imputed)	N
2013-11-15	23719583	Kerns SL	2013-05-26	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/23719583	Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.	Adverse response to radiation therapy	79 European, African, Asian, and Hispanic ancestry cases, 241 European, African, Asian, and Hispanic ancestry controls	107 European, African, Asian, and Hispanic ancestry cases, 671 European, African, Asian, and Hispanic ancestry controls	7q21.3	7	97388483	ACN9, TAC1	NA - AP1S2P1		ENSG00000226046			49035.0	rs10255878-?	rs10255878	0	10255878	intergenic_variant	1.0	0.14	4e-06	5.3979400086720375		5.2	[1.9-14.5]	Affymetrix [614453]	N
2013-11-15	23719583	Kerns SL	2013-05-26	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/23719583	Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.	Adverse response to radiation therapy	79 European, African, Asian, and Hispanic ancestry cases, 241 European, African, Asian, and Hispanic ancestry controls	107 European, African, Asian, and Hispanic ancestry cases, 671 European, African, Asian, and Hispanic ancestry controls	11q21	11	93058934	MTNR1B, SLC36A4	RPL26P31 - SLC36A4	ENSG00000242807	ENSG00000180773		6107.0	85240.0	rs7120482-?	rs7120482	0	7120482	intergenic_variant	1.0	0.29	5e-08	7.301029995663981		3.1	[1.7-5.6]	Affymetrix [614453]	N
2013-11-15	23719583	Kerns SL	2013-05-26	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/23719583	Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.	Adverse response to radiation therapy	79 European, African, Asian, and Hispanic ancestry cases, 241 European, African, Asian, and Hispanic ancestry controls	107 European, African, Asian, and Hispanic ancestry cases, 671 European, African, Asian, and Hispanic ancestry controls	4q28.3	4	137213427	LOC646316, PCDH18	LINC02511 - SERF1AP1	ENSG00000248869	ENSG00000250813		628.0	87574.0	rs10519410-?	rs10519410	0	10519410	intergenic_variant	1.0	0.20	1e-06	6.0		1.5	[1.0-2.3]	Affymetrix [614453]	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	3q26.2	3	170412314	CLDN11, SKIL	SKIL - CLDN11	ENSG00000136603	ENSG00000013297		15479.0	6554.0	rs10936632-A	rs10936632	0	10936632	intron_variant	1.0	0.52	7e-22	21.154901959985743		1.11	[1.08-1.14]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	5p15.33	5	1279913	TERT	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	0.81	3e-24	23.522878745280337		1.15	[1.11-1.19]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	Xq12	X	67801708	AR	BMI1P1 - NA	ENSG00000234201			8813.0		rs5919432-A	rs5919432	0	5919432	intergenic_variant	1.0	0.81	1e-08	8.0		1.06	[1.02-1.12]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	2p11.2	2	85567174	GGCX, VAMP8, VAMP5, RNF181	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0.0	0.59	3e-15	14.522878745280336		1.09	[1.06-1.12]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	2q37.3	2	237478585	intergenic	COL6A3 - MLPH	ENSG00000163359	ENSG00000115648		64257.0	6843.0	rs7584330-C	rs7584330	0	7584330	intergenic_variant	1.0	0.22	3e-09	8.522878745280337		1.06	[1.02-1.09]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	3q23	3	141383991	ZBTB38	ZBTB38			ENSG00000177311			rs6763931-T	rs6763931	0	6763931	intron_variant	0.0	0.45	2e-08	7.698970004336019		1.04	[1.01-1.07]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	5p12	5	44365443	FGF10	FGF10			ENSG00000070193			rs2121875-G	rs2121875	0	2121875	intron_variant	0.0	0.34	4e-08	7.397940008672037		1.05	[1.02-1.08]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	6p21.33	6	31150734	CCHCR1	CCHCR1, CCHCR1, CCHCR1, CCHCR1, CCHCR1, CCHCR1			ENSG00000204536, ENSG00000223533, ENSG00000206457, ENSG00000206355, ENSG00000224180, ENSG00000234114			rs130067-G	rs130067	0	130067	missense_variant	0.0	0.21	3e-08	7.522878745280337		1.05	[1.02-1.09]	NR [2600000] (imputed)	N
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	12q13.12	12	49282227	PRPH	TUBA1C - TROAP-AS1	ENSG00000167553	ENSG00000258334		7627.0	10404.0	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1.0	0.31	7e-12	11.154901959985745		1.07	[1.04-1.10]	NR [2600000] (imputed)	N
2015-05-15	23104005	Gudmundsson J	2012-10-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23104005	A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.	Prostate cancer	5,141 European ancestry cases, 54,444 European ancestry controls	Up to 5,470 European ancestry cases, up to 7,583 European ancestry controls	8q24.21	8	127179427	HOXB13	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs188140481-A	rs188140481	0	188140481	non_coding_transcript_exon_variant	0.0	0.054	6e-34	33.22184874961636		2.9	[2.44-3.44]	Illumina [~ 32500000] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	1q32.1	1	205673662	SLC45A3	SLC45A3			ENSG00000158715			rs2153904-C	rs2153904	0	2153904	intron_variant	0.0	0.5	1e-13	13.0		0.13	[0.091-0.169] unit decrease	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	1q32.1	1	205787356	SLC41A1	RAB29 - SLC41A1	ENSG00000117280	ENSG00000133065		11874.0	1738.0	rs6679073-C	rs6679073	0	6679073	regulatory_region_variant	1.0	0.5	4e-15	14.397940008672036		0.15	[0.11-0.19] unit decrease	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	10q11.22	10	46052478	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		4298.0	10772.0	rs4631830-C	rs4631830	0	4631830	TF_binding_site_variant	1.0	0.45	7e-11	10.154901959985745		0.12	[0.081-0.159] unit increase	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	19q13.33	19	50842312	KLK3, KLK15	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		5099.0	12603.0	rs2659051-G	rs2659051	0	2659051	intron_variant	1.0	0.66	9e-21	20.045757490560675		0.2	[0.16-0.24] unit decrease	Affymetrix [2163106] (imputed)	N
2015-07-10	25434496	Kim S	2014-11-27	Gene	www.ncbi.nlm.nih.gov/pubmed/25434496	Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.	Prostate-specific antigen levels	554 Korean ancestry individuals	1,575 Korean ancestry individuals	1q32.1	1	205756218	NUCKS1, RAB7L1	NUCKS1 - RAB29	ENSG00000069275	ENSG00000117280		6036.0	11768.0	rs823123-G	rs823123	0	823123	intergenic_variant	1.0	0.16	5e-13	12.30102999566398		0.19	[0.13-0.25] unit increase	Affymetrix [2163106] (imputed)	N
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	8q24.21	8	127091692	intergenic	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0.0	NR	1e-12	12.0				Illumina [587294]	N
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	9q31.2	9	107394019	KLF4, RAD23B	RAD23B - LINC01509	ENSG00000119318	ENSG00000226825		61827.0	26172.0	rs817826-C	rs817826	0	817826	intergenic_variant	1.0	0.084	5e-14	13.30102999566398		1.41	[1.29-1.54]	Illumina [587294]	N
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	19q13.42	19	54293995	LILRA3	MIR4752 - LILRA5	ENSG00000264703	ENSG00000187116		11815.0	13075.0	rs103294-C	rs103294	0	103294	3_prime_UTR_variant	1.0	0.238	5e-16	15.30102999566398		1.28	[1.21-1.36]	Illumina [587294]	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		2p16.1	2	60535367		BCL11A			ENSG00000119866			rs2556378-T	rs2556378	0	2556378	3_prime_UTR_variant	0.0	0.154	3e-12	11.522878745280336		1.12	[1.08-1.16]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		13q14.3	13	50514220		DLEU1			ENSG00000176124			rs1638703-C	rs1638703	0	1638703	intron_variant	0.0	0.256	1e-14	14.0		1.11	[1.08-1.14]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		10q26.12	10	120870067		WDR11			ENSG00000120008			rs4548546-T	rs4548546	0	4548546	intron_variant	0.0	0.31	2e-16	15.69897000433602		1.11	[1.08-1.14]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		6p22.1	6	27800570		RSL24D1P1 - H4C10P	ENSG00000218069	ENSG00000217862		19459.0	6505.0	rs200476-A	rs200476	0	200476	intergenic_variant	1.0	0.838	4e-15	14.397940008672036		1.1363636	[1.1-1.18]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		19q12	19	31614073		LINC02841 - RNA5SP471	ENSG00000267407	ENSG00000252780		59270.0	41283.0	rs11084596-T	rs11084596	0	11084596	regulatory_region_variant	1.0	0.644	4.0000000000000004e-24	23.39794000867204		1.1363636	[1.11-1.16]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		20q13.33	20	62475466		GATA5			ENSG00000130700			rs200383755-G	rs200383755	0	200383755	missense_variant	0.0	0.9909	1e-09	9.0		1.5625	[1.35-1.82]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		10p12.31	10	22138360		NA - ADIPOR1P1		ENSG00000232497			24632.0	rs148678804-A	rs148678804	0	148678804	intergenic_variant	1.0	0.035	2e-18	17.69897000433602		1.31	[1.23-1.39]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		10q26.12	10	121285698		LINC01153 - NA	ENSG00000227143			99732.0		rs11199879-C	rs11199879	0	11199879	regulatory_region_variant	1.0	0.252	6e-18	17.221848749616356		1.13	[1.10-1.16]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		5p15.33	5	1287079		TERT			ENSG00000164362			rs2853677-G	rs2853677	0	2853677	3_prime_UTR_variant	0.0	0.421	4e-20	19.39794000867204		1.12	[1.09-1.14]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		18q11.2	18	22324181		NA - CTAGE1		ENSG00000282841			89418.0	rs9958656-T	rs9958656	0	9958656	intergenic_variant	1.0	0.43	4e-17	16.397940008672037		1.11	[1.08-1.13]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		10p12.31	10	22021369		DNAJC1 - NA	ENSG00000136770			17600.0		rs7906649-G	rs7906649	0	7906649	intergenic_variant	1.0	0.286	5e-13	12.30102999566398		1.1	[1.07-1.13]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		12q24.21	12	114671102		TBX3			ENSG00000135111			rs8853-C	rs8853	0	8853	3_prime_UTR_variant	0.0	0.494	1e-09	9.0		1.08	[1.05-1.10]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		18q11.2	18	22454054		ATP7BP1 - NA	ENSG00000270855			34760.0		rs17670370-G	rs17670370	0	17670370	intergenic_variant	1.0	0.262	5e-06	5.301029995663981		1.06	[1.04,1.09]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		17q12	17	37742390		HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651052-G	rs11651052	0	11651052	intron_variant	0.0	0.53	8e-06	5.096910013008056		1.0526316	[1.03-1.08]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		10q26.13	10	121586602		FGFR2			ENSG00000066468			rs2981575-A	rs2981575	0	2981575	intron_variant	0.0	0.573	5e-07	6.301029995663981		1.0638298	[1.04-1.09]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		13q14.3	13	50904782		DLEU1, RNASEH2B-AS1			ENSG00000176124, ENSG00000233672			rs6561599-G	rs6561599	0	6561599	non_coding_transcript_exon_variant	0.0	0.629	6e-09	8.221848749616356		1.0752687	[1.05-1.1]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		12q24.21	12	114230813		NA - LINC02459		ENSG00000257476			8157.0	rs2555019-C	rs2555019	0	2555019	intergenic_variant	1.0	0.544	3e-12	11.522878745280336		1.0869565	[1.06-1.11]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		20q13.33	20	62466597		GATA5			ENSG00000130700			rs6061244-G	rs6061244	0	6061244	intron_variant	0.0	0.614	3e-10	9.522878745280336		1.0869565	[1.05-1.11]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls												rs10054105-T	rs10054105	0	10054105	intron_variant	1.0	0.787	2e-11	10.69897000433602		1.1111112	[1.08-1.14]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		5p15.33	5	1322353		CLPTM1L			ENSG00000049656			rs381949-G	rs381949	0	381949	intron_variant	0.0	0.585	6e-25	24.22184874961636		1.1363636	[1.11-1.16]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		5q31.1	5	135271869		C5orf66						rs677394-C	rs677394	0	677394	intron_variant	0.0	0.877	1e-10	10.0		1.1363636	[1.09-1.18]	Affymetrix, Illumina [42907111] (imputed)	N
2019-04-04	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)	18,138 European ancestry cases, 277,213 European ancestry controls		11p15.5	11	199492		ODF3, BET1L			ENSG00000177947, ENSG00000177951			rs72878024-G	rs72878024	0	72878024	missense_variant	0.0	0.92	6e-12	11.221848749616356		1.1764705	[1.12-1.22]	Affymetrix, Illumina [42907111] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	15q22.31	15	66649755	intergenic	LINC01169			ENSG00000259471			rs8023793-A	rs8023793	0	8023793	intron_variant	0.0	0.569	3e-11	10.522878745280336		1.114	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	12p13.1	12	12737692	CDKN1B, APOLD1	APOLD1			ENSG00000178878			rs11055034-C	rs11055034	0	11055034	intron_variant	0.0	0.58	6e-12	11.221848749616356		1.119	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	2p21	2	43326810	THADA	THADA			ENSG00000115970			rs1465618-T	rs1465618	0	1465618	intron_variant	0.0	0.647	1e-06	6.0		1.137	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	10q22.3	10	78484866	ZMIZ1-AS	LINC00856						rs4554825-C	rs4554825	0	4554825	intron_variant	0.0	0.766	8e-12	11.096910013008056		1.142	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	12q21.33	12	89762600	intergenic	RNU6-148P - NA	ENSG00000252823			8448.0		rs4842687-A	rs4842687	0	4842687	intron_variant	1.0	0.756	6e-12	11.221848749616356		1.143	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	5p15.33	5	1279913	TERT	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	0.756	8e-06	5.096910013008056		1.146	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	17q12	17	37714971	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0.0	0.703	6e-07	6.221848749616356		1.147	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	10q26.12	10	121085195	FGFR2, WDR11	NA - RPL19P16		ENSG00000236762			47895.0	rs2252004-C	rs2252004	0	2252004	regulatory_region_variant	1.0	0.785	8e-06	5.096910013008056		1.151	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	19q13.33	19	50851341	KLK3	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		14128.0	3574.0	rs2659124-T	rs2659124	0	2659124	intergenic_variant	1.0	0.605	2e-08	7.698970004336019		1.156	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	19q13.33	19	50861367	KLK3, KLK2	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603.0	201.0	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1.0	0.6	3e-09	8.522878745280337		1.163	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	126869707	intergenic	PCAT1			ENSG00000253438			rs16901814-G	rs16901814	0	16901814	intron_variant	0.0	0.838	6e-12	11.221848749616356		1.167	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	2q31.1	2	172446825	ITGA6	ITGA6			ENSG00000091409			rs12621278-A	rs12621278	0	12621278	intron_variant	0.0	0.777	3e-08	7.522878745280337		1.182	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	2p15	2	63561915	WDPCP	WDPCP			ENSG00000143951			rs114780236-G	rs114780236	1	72806027	intron_variant	0.0	0.829	2e-14	13.69897000433602		1.187	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	22q13.1	22	38742327	SUN2	SUN2			ENSG00000100242			rs138708-G	rs138708	0	138708	missense_variant	0.0	0.834	1e-15	15.0		1.198	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	6q22.1	6	116888889	RFX6	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0.0	0.631	9e-15	14.045757490560677		1.222	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	126999692	intergenic	PCAT1			ENSG00000253438			rs10086908-T	rs10086908	0	10086908	intron_variant	0.0	0.797	7e-14	13.154901959985745		1.269	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	17q12	17	37738049	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0.0	0.648	5e-27	26.30102999566398		1.365	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	3p11.2	3	87418182	FOU1F1	KRT8P25 - NA	ENSG00000239829			93459.0		rs2055109-C	rs2055109	0	2055109	intergenic_variant	1.0	0.107	9e-06	5.045757490560675		1.1947432	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	3p12.1	3	87061524	VGLL3	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786.0	27605.0	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1.0	0.259	1e-09	9.0		1.1778563	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	5p15.33	5	1895715	IRX4	CTD-2194D22.4			ENSG00000249326			rs12653946-T	rs12653946	0	12653946	intron_variant	0.0	0.445	1e-16	16.0		1.2254902	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	6p21.1	6	41568689	FOXP4	FOXP4			ENSG00000137166			rs1983891-T	rs1983891	0	1983891	intron_variant	0.0	0.419	5e-08	7.301029995663981		1.1454753	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	7p15.1	7	27936944	JAZF1	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.099	6e-06	5.221848749616356		1.1947432	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	127527115	intergenic	CASC8 - NA	ENSG00000246228			44976.0		rs7837688-T	rs7837688	0	7837688	intergenic_variant	1.0	0.158	2e-58	57.69897000433602		1.7271158	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	127472793	CASC6	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	0.179	3.9999999999999995e-42	41.39794000867204		1.5060241	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	127112671	PRNCR1	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0.0	0.188	3e-34	33.52287874528034		1.4285715	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8p21.2	8	23668950	NKX3.1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-T	rs1512268	0	1512268	intergenic_variant	1.0	0.37	3e-24	23.522878745280337		1.2886598	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	127401060	intergenic	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.334	1e-08	8.0		1.1560693	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.455	5e-10	9.30102999566398		1.1641443	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	13q22.1	13	73154002	KLF5	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		40984.0	37526.0	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1.0	0.386	7e-08	7.154901959985743		1.1428571	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	20q13.33	20	63731211	ZGPAT	ZGPAT			ENSG00000197114			rs6062509-T	rs6062509	0	6062509	intron_variant	0.0	0.389	4e-06	5.3979400086720375		1.1223345	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	1p36.31	1	5683136	intergenic							rs7542260-T	rs7542260	0	7542260	intergenic_variant	1.0	0.902	4e-11	10.397940008672036		1.1862396	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	2p15	2	62525840	TMEM17	TMEM17 - RPL21P37	ENSG00000186889	ENSG00000229503		13946.0	6743.0	rs11125927-G	rs11125927	0	11125927	regulatory_region_variant	1.0	0.772	4e-16	15.397940008672036		1.1627907	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	3q21.3	3	128498656	GATA2	GATA2-AS1			ENSG00000244300			rs73862213-G	rs73862213	0	73862213	intron_variant	0.0	0.923	6e-23	22.22184874961636		1.3140606	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	8q24.21	8	126783938	intergenic	PCAT1			ENSG00000253438			rs75777376-C	rs75777376	0	75777376	intron_variant	0.0	0.923	1e-20	20.0		1.32626	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	10q22.3	10	79067076	ZMIZ1	ZMIZ1-AS1			ENSG00000224596			rs77911174-G	rs77911174	0	77911174	intron_variant	0.0	0.634	5e-20	19.30102999566398		1.1641443	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls				SLC52A3, FAM110A							rs6117562-A	rs6117562	0	6117562	intron_variant	1.0	0.512	3e-08	7.522878745280337		1.0928961	NR	Illumina [7742602] (imputed)	N
2019-10-17	31562322	Takata R	2019-09-27	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31562322	12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.	Prostate cancer	5,088 Japanese ancestry cases, 10,682 Japanese ancestry controls	4,818 Japanese ancestry cases, 73,261 Japanese ancestry controls	Xp11.22	X	54427973	FGD1, GNL3L, TSR2	WNK3 - TSR2	ENSG00000196632	ENSG00000158526		69331.0	12431.0	rs4826594-A	rs4826594	0	4826594	regulatory_region_variant	1.0	0.508	7e-09	8.154901959985743		1.0695187	NR	Illumina [7742602] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	ENSG00000107404	ENSG00000162576		2257.0	1014.0	rs186507655-A	rs186507655	0	186507655	regulatory_region_variant	1.0	NR	5e-10	9.30102999566398	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q22	1	155212373	MTX1	MTX1			ENSG00000173171			rs2075570-T	rs2075570	0	2075570	intron_variant	0.0	NR	5e-06	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		3p24.1	3	27285723	NEK10	NEK10			ENSG00000163491			rs481519-T	rs481519	0	481519	intron_variant	0.0	NR	2e-09	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		4q24	4	105140377	Intergenic	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-A	rs7679673	0	7679673	intron_variant	1.0	NR	1e-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		5p15.33	5	1282299	TERT	TERT			ENSG00000164362			rs7725218-A	rs7725218	0	7725218	intron_variant	0.0	NR	2e-10	9.69897000433602	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		5q11.2	5	56737113	Intergenic	NA - MAP3K1		ENSG00000095015			78436.0	rs1862626-T	rs1862626	0	1862626	intergenic_variant	1.0	NR	4e-12	11.397940008672036	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p22.1	6	29785031	Intergenic	IFITM4P - HLA-V	ENSG00000233023	ENSG00000223606		33883.0	5923.0	rs147680653-G	rs147680653	1	9258375	intergenic_variant	1.0	NR	1e-06	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696.0	39739.0	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1.0	NR	5e-07	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.33	6	31347004	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		45362.0	6868.0	rs115392158-G	rs115392158	1	2507997	intron_variant	1.0	NR	3e-07	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313.0	6428.0	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1.0	NR	6e-08	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0.0	NR	5e-06	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		10q26.13	10	121575416	FGFR2	FGFR2			ENSG00000066468			rs11200014-A	rs11200014	0	11200014	intron_variant	0.0	NR	8e-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		11q13.3	11	69227030	Intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67278.0	67121.0	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1.0	NR	4e-14	13.397940008672036	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		11q22.3	11	103813371	Intergenic	NA - MIR4693		ENSG00000264200			36535.0	rs148883465-G	rs148883465	0	148883465	intron_variant	1.0	NR	3e-08	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q13.12	12	49251457	TUBA1C	TUBA1C			ENSG00000167553			rs11168936-C	rs11168936	0	11168936	intron_variant	0.0	NR	9e-07	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q13.13	12	52918828	KRT8	KRT8			ENSG00000170421			rs73110464-T	rs73110464	0	73110464	intron_variant	0.0	NR	2e-15	14.69897000433602	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q24.12	12	111446804	SH2B3	ATXN2, SH2B3			ENSG00000204842, ENSG00000111252			rs3184504-C	rs3184504	0	3184504	missense_variant	0.0	NR	1e-06	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32394673	BRCA2	BRCA2			ENSG00000139618			rs11571818-C	rs11571818	0	11571818	intron_variant	0.0	NR	5e-10	9.30102999566398	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		14q24.1	14	68559662	RAD51B	RAD51B			ENSG00000182185			rs11844632-A	rs11844632	0	11844632	intron_variant	0.0	NR	3e-10	9.522878745280336	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0.0	NR	7e-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		19p13.11	19	17279482	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0.0	NR	2e-09	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701.0	62578.0	rs11907546-T	rs11907546	0	11907546	intergenic_variant	1.0	NR	3e-06	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		11q22.3	11	103745837	Intergenic							rs141752671-G	rs141752671	0	141752671	intron_variant	1.0	NR	1e-07	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q24.12	12	111621753	Intergenic	ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497.0	20393.0	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1.0	NR	5e-06	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-C	rs2300206	0	2300206	intron_variant	0.0	NR	6e-06	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32295727	FRY	FRY			ENSG00000073910			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0.0	NR	4e-09	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q22	1	155216951	GBAP1	GBAP1			ENSG00000160766			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0.0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q22	1	155212052	MTX1	MTX1			ENSG00000173171			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0.0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q32.2	1	210816167	KCNH1	KCNH1			ENSG00000143473			rs11119608-T	rs11119608	0	11119608	intron_variant	0.0	NR	1e-07	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		3q26.2	3	169043635	Intergenic	LINC01997 - MECOM	ENSG00000241383	ENSG00000085276		5219.0	39864.0	rs75316749-G	rs75316749	0	75316749	intergenic_variant	1.0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696.0	39739.0	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1.0	NR	2e-06	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.33	6	31347004	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		45362.0	6868.0	rs115392158-G	rs115392158	1	2507997	intron_variant	1.0	NR	9e-06	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313.0	6428.0	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1.0	NR	5e-07	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6q14.1	6	80398959	Intergenic	RPL17P25 - RPSAP72	ENSG00000219547	ENSG00000219361		24390.0	71112.0	rs4604234-C	rs4604234	0	4604234	intergenic_variant	1.0	NR	6e-06	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		9p21.3	9	21951903	Intergenic	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		14252.0	15026.0	rs12349081-A	rs12349081	0	12349081	intron_variant	1.0	NR	6e-06	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0.0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q24.12	12	111446804	SH2B3	ATXN2, SH2B3			ENSG00000204842, ENSG00000111252			rs3184504-C	rs3184504	0	3184504	missense_variant	0.0	NR	2e-06	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32398489	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0.0	NR	8e-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0.0	NR	1e-09	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		19p13.11	19	17279482	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075	intron_variant	0.0	NR	4e-07	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701.0	62578.0	rs11907546-C	rs11907546	0	11907546	intergenic_variant	1.0	NR	3e-09	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32265853	FRY	FRY			ENSG00000073910			rs56404467-A	rs56404467	0	56404467	intron_variant	0.0	NR	1e-07	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-G	rs2300206	0	2300206	intron_variant	0.0	NR	2e-08	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85578945	NR	VAMP8			ENSG00000118640			rs3731827-T	rs3731827	0	3731827	intron_variant	0.0	0.584	1e-09	9.0		1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127119564	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs116041037-A	rs116041037	0	116041037	intron_variant	0.0	1.0E-4	6e-10	9.221848749616356	(African American)	2.67	[1.96-3.64]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23649749	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		14242.0	28948.0	rs142463603-A	rs142463603	1	13279749	intergenic_variant	1.0	0.417	4e-16	15.397940008672036		1.18	[1.13-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37305.0	166899.0	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1.0	0.099	4.0000000000000006e-45	44.39794000867204		1.54	[1.45-1.63]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.401	7e-21	20.154901959985743		1.21	[1.16-1.25]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69244226	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		84474.0	49925.0	rs376592364-T	rs376592364	0	376592364	intergenic_variant	1.0	0.52	6e-20	19.22184874961636		1.2	[1.16-1.25]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls				NR							12:49672714-G	12:49672714	0			1.0	0.254	8e-09	8.096910013008056		1.14	[1.09-1.19]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls				NR							12:53309584-A	12:53309584	0			1.0	0.122	2e-14	13.69897000433602		1.25	[1.18-1.33]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37743574	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263763-A	rs11263763	0	11263763	intron_variant	0.0	0.519	5e-24	23.30102999566398		1.22	[1.18-1.28]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71111532	NR	CASC17			ENSG00000260785			rs8071558-C	rs8071558	0	8071558	intron_variant	0.0	0.483	7e-11	10.154901959985745		1.14	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	0.505	2e-09	8.698970004336019		1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.77	3e-09	8.522878745280337	(European)	1.17	[1.11-1.23]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-A	rs1512268	0	1512268	intergenic_variant	1.0	0.43	2e-12	11.69897000433602	(European)	1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0.0	0.6	4e-15	14.397940008672036		1.17	[1.13-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127081052	NR	PRNCR1, PCAT1, CASC19			ENSG00000282961, ENSG00000253438, ENSG00000254166			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0.0	0.21	5e-21	20.30102999566398	(European)	1.28	[1.21-1.34]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127094635	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs6983561-C	rs6983561	0	6983561	intron_variant	0.0	0.035	5e-19	18.30102999566398	(European)	1.61	[1.45-1.78]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.77	3e-11	10.522878745280336		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.51	3e-24	23.522878745280337	(European)	1.25	[1.20-1.31]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127328663	NR	CASC8, POU5F1B, PCAT1			ENSG00000246228, ENSG00000212993, ENSG00000253438			rs16902104-T	rs16902104	0	16902104	intron_variant	0.0	0.14	1e-09	9.0		1.18	[1.12-1.25]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69227200	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67448.0	66951.0	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1.0	0.52	8e-18	17.096910013008056	(European)	1.21	[1.16-1.26]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028.0	5309.0	rs902774-A	rs902774	0	902774	regulatory_region_variant	1.0	0.15	1e-07	7.0	(European)	1.17	[1.11-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	4q24	4	105140377	NR	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-C	rs7679673	0	7679673	intron_variant	1.0	0.59	5e-08	7.301029995663981		1.12	[1.07-1.16]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	0.48	8e-09	8.096910013008056	(European)	1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127081052	NR	PRNCR1, PCAT1, CASC19			ENSG00000282961, ENSG00000253438, ENSG00000254166			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0.0	0.21	6e-21	20.22184874961636		1.25	[1.19-1.30]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.4	3e-18	17.522878745280337	(European)	1.21	[1.16-1.26]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0.0	0.81	1e-06	6.0	(European)	1.15	[1.09-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50851341	KLK3	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		14128.0	3574.0	rs2659124-T	rs2659124	0	2659124	intergenic_variant	1.0	0.854	1e-13	13.0		1.18	[1.13-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27937744	NR	JAZF1			ENSG00000153814			rs7808935-T	rs7808935	0	7808935	intron_variant	0.0	0.766	3e-11	10.522878745280336		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127064901	NR	PCAT1			ENSG00000253438			rs77541621-A	rs77541621	0	77541621	non_coding_transcript_exon_variant	0.0	0.022	1.9999999999999998e-26	25.69897000433602	(conditioned, EA)	2.0408163	[1.79-2.33]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127091724	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0.0	0.667	3e-08	7.522878745280337	(conditioned, East Asian)	1.92	[1.54-2.44]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37305.0	166899.0	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1.0	0.14	9e-07	6.045757490560675	(East Asian)	1.83	[1.44-2.33]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q22.1	6	116888889	NR	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0.0	0.71	1e-06	6.0	(European)	1.13	[1.07-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.12	12	49282227	NR	TUBA1C - TROAP-AS1	ENSG00000167553	ENSG00000258334		7627.0	10404.0	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1.0	0.29	2e-06	5.698970004336019	(European)	1.12	[1.07-1.18]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603.0	201.0	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1.0	0.85	2e-08	7.698970004336019	(European)	1.2	[1.13-1.28]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0.0	0.21	1e-06	6.0	(European)	1.14	[1.08-1.20]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0.0	0.58	5e-06	5.301029995663981	(European)	1.11	[1.06-1.16]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69227200	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67448.0	66951.0	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1.0	0.52	5e-19	18.30102999566398		1.2	[1.15-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028.0	5309.0	rs902774-A	rs902774	0	902774	regulatory_region_variant	1.0	0.15	9e-08	7.045757490560675		1.16	[1.10-1.23]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	126999692	NR	PCAT1			ENSG00000253438			rs10086908-T	rs10086908	0	10086908	intron_variant	0.0	0.71	2e-10	9.69897000433602	(European)	1.17	[1.12-1.23]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	0.48	2e-09	8.698970004336019		1.13	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q22.1	6	116888889	NR	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0.0	0.71	6e-07	6.221848749616356		1.12	[1.07-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127328663	NR	CASC8, POU5F1B, PCAT1			ENSG00000246228, ENSG00000212993, ENSG00000253438			rs16902104-T	rs16902104	0	16902104	intron_variant	0.0	0.14	5e-10	9.30102999566398	(European)	1.21	[1.14-1.28]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-A	rs1512268	0	1512268	intergenic_variant	1.0	0.43	4e-15	14.397940008672036		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37305.0	166899.0	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1.0	0.099	2e-40	39.69897000433602	(European)	1.56	[1.46-1.67]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0.0	0.21	9e-06	5.045757490560675		1.12	[1.06-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0.0	0.58	3e-09	8.522878745280337		1.13	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0.0	0.6	1e-14	14.0	(European)	1.19	[1.14-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	126999692	NR	PCAT1			ENSG00000253438			rs10086908-T	rs10086908	0	10086908	intron_variant	0.0	0.71	2e-12	11.69897000433602		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	0.51	5e-09	8.301029995663981	(European)	1.14	[1.09-1.19]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127082911	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs13252298-A	rs13252298	0	13252298	non_coding_transcript_exon_variant	0.0	0.71	2e-06	5.698970004336019		1.11	[1.06-1.16]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127094635	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs6983561-C	rs6983561	0	6983561	intron_variant	0.0	0.035	6e-22	21.22184874961636		1.45	[1.34-1.56]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.51	3e-27	26.522878745280337		1.25	[1.20-1.30]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.12	12	49282227	NR	TUBA1C - TROAP-AS1	ENSG00000167553	ENSG00000258334		7627.0	10404.0	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1.0	0.29	7e-08	7.154901959985743		1.12	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0.0	0.81	6e-07	6.221848749616356		1.14	[1.08-1.20]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603.0	201.0	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1.0	0.85	6e-09	8.221848749616356		1.17	[1.11-1.24]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q25.3	6	160160512	SLC22A2, SLC22A1	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1794.0	10549.0	rs4646284-TG	rs4646284	0	4646284	downstream_gene_variant	1.0	0.298	1e-19	19.0		1.18	[1.14-1.22]	Affymetrix [up to 19977088] (imputed)	N
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q25.3	6	160412632	SLC22A3	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0.0	0.279	6e-12	11.221848749616356		1.14	[1.10-1.18]	Affymetrix [up to 19977088] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			ENSG00000078114			rs12243039-?	rs12243039	0	12243039	intron_variant	0.0	0.01	6e-06	5.221848749616356	(All samples, overall toxicity, multivariable analysis)	3.39		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	1p13.2	1	111873741	KCND3	KCND3			ENSG00000171385			rs2788612-?	rs2788612	0	2788612	intron_variant	0.0	0.05	6e-16	15.221848749616356	(Prostate cancer, rectal incontinence, univariable analysis)	0.18	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10q24.31	10	100170652	ERLIN1	ERLIN1			ENSG00000107566			rs11595238-?	rs11595238	0	11595238	intron_variant	0.0	0.04	2e-06	5.698970004336019	(Prostate cancer, rectal incontinence, multivariable analysis)	6.61		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	15q21.1	15	46737708	SEMA6D	RN7SKP101 - NA	ENSG00000223308			17196.0		rs16958536-?	rs16958536	0	16958536	intron_variant	1.0	0.22	4e-06	5.3979400086720375	(Breast cancer, telangiectasia, multivariable analysis)	1.66		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			ENSG00000078114			rs12243039-?	rs12243039	0	12243039	intron_variant	0.0	0.01	8e-06	5.096910013008056	(Breast cancer, overall toxicity, multivariable analysis)	3.28		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	17q12	17	35565049	SLFN14	SLFN14 - SNHG30	ENSG00000236320	ENSG00000267321		4230.0	3027.0	rs2840044-?	rs2840044	0	2840044	intergenic_variant	1.0	0.33	8e-06	5.096910013008056	(Breast cancer, overal toxicity, multivariable analysis)	1.56		Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	3p24.1	3	29287529	RBMS3	RBMS3-AS3, RBMS3			ENSG00000235904, ENSG00000144642			rs9832625-?	rs9832625	0	9832625	intron_variant	0.0	0.08	3e-06	5.522878745280337	(Prostate cancer, rectal incontinence, univariable analysis)	0.07	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	21q21.1	21	16396204	CNTNAP2	MIR99AHG			ENSG00000215386			rs2823779-?	rs2823779	0	2823779	intron_variant	0.0	0.09	7e-06	5.154901959985743	(Prostate cancer, urine incontinence, univariable analysis)	0.1	[NR] unit increase	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	5q21.1	5	101043689	ST8SIA4							rs575018-?	rs575018	0	575018	intergenic_variant	1.0	0.34	7e-07	6.154901959985743	(Breast cancer, overall toxicity, univariable analysis)	0.13	[NR] unit decrease	Illumina [2417493] (imputed)	N
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	6p25.1	6	6550516	LY86-AS1	LY86-AS1			ENSG00000216863			rs17142289-?	rs17142289	0	17142289	intron_variant	0.0	0.02	4e-06	5.3979400086720375	(Breast cancer, overall toxicity, univariable analysis)	0.35	[NR] unit increase	Illumina [2417493] (imputed)	N
2011-06-03	21602798	Haiman CA	2011-05-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21602798	Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.	Prostate cancer	3,425 African American cases, 3,290 African American controls	1,500 African American/Afro-Caribbean cases, 1,908 African American/Afro-Caribbean controls, 344 Sub-Saharan African ancestry cases, 1,361 Sub-Saharan African ancestry controls	17q21.33	17	49359387	ZNF652	ZNF652			ENSG00000198740			rs7210100-?	rs7210100	0	7210100	intron_variant	0.0	0.05	3e-13	12.522878745280336		1.51	[1.35-1.69]	Illumina [10471986]	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127401060	SRRM1P1, POU5F1B	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	NR	4e-15	14.397940008672036		0.29	[0.22-0.36] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	NR	3e-26	25.522878745280337		0.4	[0.33-0.47] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	17q24.3	17	71122495	SOX9, CALM2P1	CASC17			ENSG00000260785			rs4793529-T	rs4793529	0	4793529	intron_variant	0.0	NR	2e-13	12.69897000433602		0.28	[0.20-0.35] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	19q13.33	19	50858501	KLK3	KLK3			ENSG00000142515			rs17632542-T	rs17632542	0	17632542	missense_variant	0.0	NR	2.0000000000000002e-28	27.69897000433602		0.73	[0.60-0.86] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127094539	SRRM1P1, POU5F1B	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs12682344-G	rs12682344	0	12682344	intron_variant	0.0	NR	5e-12	11.30102999566398		0.67	[0.48-0.86] unit increase	Illumina [514432] (imputed)	N
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127472793	MYC	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	NR	6e-18	17.221848749616356		0.51	[0.40-0.63] unit increase	Illumina [514432] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	1q32.1	1	205667206	SLC45A3	SLC45A3			ENSG00000158715			rs4951018-C	rs4951018	0	4951018	intron_variant	0.0	0.22	1e-08	8.0		0.0394282	[0.027-0.052] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19	50858501	KLK3	KLK3			ENSG00000142515			rs17632542-T	rs17632542	0	17632542	missense_variant	0.0	0.92	0.0	339.69897000433605		0.435333	[0.41-0.46] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	4q32.1	4	156613097	PDGFC	NA - LINC02272		ENSG00000251283			21397.0	rs10023685-G	rs10023685	0	10023685	intergenic_variant	1.0	0.37	2e-09	8.698970004336019		0.0346789	[0.023-0.046] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	Xp11.21	X	55910389	RRAGB	NA - GOT2P6		ENSG00000214745			50819.0	rs10855058-A	rs10855058	0	10855058	intron_variant	1.0	0.3	1e-08	8.0		0.0254562	[0.017-0.034] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	4q31.22	4	145953076	ZNF827	ZNF827 - Y_RNA	ENSG00000151612	ENSG00000264495		14253.0	5052.0	rs56935123-AT	rs56935123	0	56935123	intergenic_variant	1.0	0.45	4e-09	8.397940008672037		0.0351137	[0.023-0.047] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	7p15.1	7	27936944	JAZF1	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.76	4e-19	18.39794000867204		0.0575792	[0.045-0.07] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	9q33.2	9	120881149	PHF19	PHF19			ENSG00000119403			rs59482735-T	rs59482735	0	59482735	intron_variant	0.0	0.32	4e-09	8.397940008672037		0.0363711	[0.024-0.048] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12	10	121289750	FGFR2	LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		103784.0	121166.0	rs10886902-C	rs10886902	0	10886902	regulatory_region_variant	1.0	0.24	2e-53	52.69897000433602		0.100774	[0.088-0.114] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	13q14.3	13	50513307	DLEU1	DLEU1			ENSG00000176124			rs202346-A	rs202346	0	202346	intron_variant	0.0	0.25	3e-22	21.522878745280337		0.061691	[0.049-0.074] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10p12.31	10	22292652	COMMD3, BMI1, SPAG6	RPL31P45 - COMMD3	ENSG00000233318	ENSG00000148444		25306.0	23734.0	rs116940348-A	rs116940348	0	116940348	intergenic_variant	1.0	0.03	1e-14	14.0		0.144017	[0.11-0.18] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	1p22.3	1	87724354	LMO4	PKN2-AS1			ENSG00000237505			rs6662386-C	rs6662386	0	6662386	intron_variant	0.0	0.44	7e-20	19.154901959985743		0.051711	[0.041-0.063] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	11p13	11	34761870	EHF, APIP	EHF - APIP	ENSG00000135373	ENSG00000149089		98582.0	91224.0	rs4378355-C	rs4378355	0	4378355	intergenic_variant	1.0	0.39	2e-10	9.69897000433602		0.0368406	[0.025-0.048] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	11q22.2	11	102525876	MMP7	MMP7			ENSG00000137673			rs12285347-C	rs12285347	0	12285347	intron_variant	0.0	0.46	8e-12	11.096910013008056		0.038463	[0.027-0.049] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12, 10q26.13	10;10;10	120915337;121425789;121289750	FGFR2, WDR11, 7SK	WDR11 - RPL19P16; RN7SKP167 - FGFR2; LINC01153 - RN7SKP167						rs200367988-A; rs10749415-A; rs10886902-T	rs200367988; rs10749415; rs10886902	0		intergenic_variant; intergenic_variant; regulatory_region_variant		0.148	4e-18	17.397940008672037		0.091	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	14q32.13	14	94631219	SERPINA3	SERPINA3 - ADIPOR1P2	ENSG00000196136	ENSG00000258805		7164.0	644.0	rs8023057-A	rs8023057	0	8023057	upstream_gene_variant	1.0	0.82	2e-15	14.69897000433602		0.06069	[0.046-0.076] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12, 10q26.13	10;10;10	120915337;121425789;121289750	FGFR2, WDR11, 7SK	WDR11 - RPL19P16; RN7SKP167 - FGFR2; LINC01153 - RN7SKP167						rs200367988-A; rs10749415-A; rs10886902-C	rs200367988; rs10749415; rs10886902	0		intergenic_variant; intergenic_variant; regulatory_region_variant		0.078	4e-43	42.39794000867204		0.206	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10q26.13	10	121425789	WDR11, FGFR2	RN7SKP167 - FGFR2	ENSG00000222979	ENSG00000066468		14589.0	52543.0	rs10749415-?	rs10749415	0	10749415	intergenic_variant	1.0	0.95	8.999999999999998e-25	24.045757490560675	(conditional on Round 3 SNPs)	0.117	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-A; rs266849-T; rs11665748-G; rs17632542-G; rs266868-A; rs6070-T; rs2739472-C	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.204	2e-111	110.69897000433602		0.211	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	13q14.3	13	50871978	intergenic	RNASEH2B-AS1, DLEU1			ENSG00000233672, ENSG00000176124			rs12429206-?	rs12429206	0	12429206	intron_variant	0.0	0.343	7e-08	7.154901959985743	(conditional on Round 3 SNPs)	0.031	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	11q24.3	11	129444288	intergenic	BARX2			ENSG00000043039			rs147520802-?	rs147520802	0	147520802	intron_variant	0.0	0.017	3e-06	5.522878745280337	(conditional on Round 4 SNPs)	0.109	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	8q24.21	8	127330621	MYC	PCAT1, CASC8, POU5F1B			ENSG00000253438, ENSG00000246228, ENSG00000212993			rs17464492-?	rs17464492	0	17464492	intron_variant	0.0	0.71	2e-10	9.69897000433602	(conditional on Round 1 SNPs)	0.04	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	3q23	3	141414608	ZBTB38	ZBTB38			ENSG00000177311			rs1991431-?	rs1991431	0	1991431	intron_variant	0.0	0.43	3e-11	10.522878745280336	(conditional on Round 1 SNPs)	0.037	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-A; rs266849-T; rs11665748-A; rs17632542-A; rs266868-A; rs6070-T; rs2739472-C	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.024	1e-07	7.0		0.124	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10p12.1	10	27805490	ARMC4	ODAD2			ENSG00000169126			rs2492906-?	rs2492906	0	2492906	intron_variant	0.0	0.79	1e-08	8.0	(conditional on Round 1 SNPs)	0.037	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-G; rs266849-T; rs11665748-G; rs17632542-G; rs266868-G; rs6070-A; rs2739472-T	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.02	3e-11	10.522878745280336		0.201	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-G; rs266849-C; rs11665748-G; rs17632542-G; rs266868-A; rs6070-T; rs2739472-C	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.011	2.0000000000000003e-45	44.69897000433602		0.494	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q12	19	31614073	THEG5	LINC02841 - RNA5SP471	ENSG00000267407	ENSG00000252780		59270.0	41283.0	rs11084596-T	rs11084596	0	11084596	regulatory_region_variant	1.0	0.61	1e-15	15.0		0.0475551	[0.036-0.059] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	2p16.1	2	60532612	BCL11A	BCL11A			ENSG00000119866			rs2556375-G	rs2556375	0	2556375	intron_variant	0.0	0.17	6e-19	18.22184874961636		0.0652336	[0.051-0.08] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	Xp22.13	X	17802225	RAI2	RAI2			ENSG00000131831			rs16980679-G	rs16980679	0	16980679	intron_variant	0.0	0.95	3e-15	14.522878745280336		0.0765243	[0.058-0.096] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	5p15.33	5	1356569	TERT, CLPTM1L	LINC01511			ENSG00000250584			rs37004-C	rs37004	0	37004	intron_variant	0.0	0.79	9e-13	12.045757490560677		0.0604747	[0.044-0.077] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	6p21.1	6	43742611	VEGFA	MRPS18A - VEGFA	ENSG00000096080	ENSG00000112715		54820.0	27573.0	rs6920449-T	rs6920449	0	6920449	regulatory_region_variant	1.0	0.16	6e-12	11.221848749616356		0.0529541	[0.038-0.068] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	8p21.2	8	23670998	NKX3-1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		35491.0	7699.0	rs13272392-T	rs13272392	0	13272392	intergenic_variant	1.0	0.43	4.0000000000000006e-34	33.39794000867204		0.0685113	[0.057-0.08] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	8q24.21	8	127395198	MYC	POU5F1B, PCAT1, CASC8			ENSG00000212993, ENSG00000253438, ENSG00000246228			rs10505477-A	rs10505477	0	10505477	intron_variant	0.0	0.49	7e-21	20.154901959985743		0.0525797	[0.042-0.064] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	9q33.1	9	117970471	TLR4							rs6478343-C	rs6478343	0	6478343	intron_variant	1.0	0.82	2e-08	7.698970004336019		0.0415085	[0.027-0.056] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	17q12	17	37737784	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263761-A	rs11263761	0	11263761	intron_variant	0.0	0.51	6e-20	19.22184874961636		0.0515111	[0.04-0.063] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.39	9.999999999999999e-51	50.0		0.0843414	[0.073-0.095] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	Xp22.11	X	24041058	EIF2S3, KLHL15	KLHL15 - EIF2S3	ENSG00000174010	ENSG00000130741		13872.0	13888.0	rs6627995-T	rs6627995	0	6627995	intergenic_variant	1.0	0.33	1e-13	13.0		0.0343829	[0.025-0.043] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12, 10q26.13	10;10;10	120915337;121425789;121289750	FGFR2, WDR11, 7SK	WDR11 - RPL19P16; RN7SKP167 - FGFR2; LINC01153 - RN7SKP167						rs200367988-G; rs10749415-G; rs10886902-T	rs200367988; rs10749415; rs10886902	0		intergenic_variant; intergenic_variant; regulatory_region_variant		0.025	3e-11	10.522878745280336		0.168	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	12q24.21	12	114656455	TBX3	OSTF1P1 - Y_RNA	ENSG00000258244	ENSG00000264495		67653.0	1494.0	rs11067228-A	rs11067228	0	11067228	TF_binding_site_variant	1.0	0.54	1e-14	14.0		0.0439143	[0.033-0.055] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	10q26.12, 10q26.13	10;10;10	120915337;121425789;121289750	FGFR2, WDR11, 7SK	WDR11 - RPL19P16; RN7SKP167 - FGFR2; LINC01153 - RN7SKP167						rs200367988-G; rs10749415-A; rs10886902-T	rs200367988; rs10749415; rs10886902	0		intergenic_variant; intergenic_variant; regulatory_region_variant		0.491	1e-35	35.0		0.089	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	16p13.3	16	4299110	GLIS2, TFAP4	TFAP4 - GLIS2	ENSG00000090447	ENSG00000126603		26035.0	15651.0	rs9921192-C	rs9921192	0	9921192	TF_binding_site_variant	1.0	0.5	1e-09	9.0		0.0350975	[0.024-0.046] unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-G; rs266849-C; rs11665748-G; rs17632542-G; rs266868-G; rs6070-T; rs2739472-T	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.042	9e-186	185.04575749056067		0.506	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50851141	KLK3	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		13928.0	3774.0	rs11665748-?	rs11665748	0	11665748	upstream_gene_variant	1.0	0.65	2.9999999999999995e-54	53.52287874528034	(conditional on Round 1 SNPs)	0.09	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-A; rs266849-T; rs11665748-G; rs17632542-G; rs266868-A; rs6070-A; rs2739472-C	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.107	8e-17	16.096910013008056		0.109	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-G; rs266849-C; rs11665748-G; rs17632542-G; rs266868-G; rs6070-A; rs2739472-T	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.01	1e-85	85.0		0.856	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-A; rs266849-T; rs11665748-A; rs17632542-G; rs266868-A; rs6070-T; rs2739472-C	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.059	4e-09	8.397940008672037		0.1	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10q26.12	10	120915337	WDR11, FGFR2	WDR11 - RPL19P16	ENSG00000120008	ENSG00000236762		5813.0	217753.0	rs200367988-?	rs200367988	0	200367988	intergenic_variant	1.0	0.33	5e-18	17.30102999566398	(conditional on Round 1 SNPs)	0.051	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer), 5,603 European ancestry individuals	19q13.33	19;19;19;19;19;19;19	50858126;50845834;50851141;50858501;50849681;50876854;50870023	KLK3, KLK2	KLK3; KLK15 - KLK3; KLK15 - KLK3; KLK3; KLK15 - KLK3; KLK2; KLK2						rs61752561-G; rs266849-T; rs11665748-G; rs17632542-G; rs266868-G; rs6070-T; rs2739472-T	rs61752561; rs266849; rs11665748; rs17632542; rs266868; rs6070; rs2739472	0		missense_variant; intron_variant; upstream_gene_variant; missense_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.029	8e-10	9.096910013008056		0.153	unit decrease	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50845834	KLK3	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		8621.0	9081.0	rs266849-A	rs266849	0	266849	intron_variant	1.0	0.79	4e-17	16.397940008672037	(conditional on Round 4 SNPs)	0.057	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50849681	KLK3	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		12468.0	5234.0	rs266868-?	rs266868	0	266868	intron_variant	1.0	0.71	1e-14	14.0	(conditional on Round 3 SNPs)	0.046	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50870023	KLK2	KLK2			ENSG00000167751			rs2739472-?	rs2739472	0	2739472	intron_variant	0.0	0.56	8e-10	9.096910013008056	(conditional on Round 6 SNPs)	0.034	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	8p21.2	8	23609471	SLC25A37	RNU4-71P - SINHCAFP3	ENSG00000252067	ENSG00000253488		9333.0	25405.0	rs4614003-?	rs4614003	0	4614003	intergenic_variant	1.0	0.296	1e-15	15.0	(conditional on Round 1 SNPs)	0.05	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	10q26.13	10	121572176	intergenic	FGFR2			ENSG00000066468			rs4752569-?	rs4752569	0	4752569	intron_variant	0.0	0.503	1e-11	11.0	(conditional on Round 2 SNPs)	0.038	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	8q24.21	8	127461280	intergenic	CASC8			ENSG00000246228			rs4871796-?	rs4871796	0	4871796	intron_variant	0.0	0.073	4e-06	5.3979400086720375	(conditional on Round 2 SNPs)	0.048	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	2p15	2	63050708	intergenic	OTX1			ENSG00000115507			rs58235267-?	rs58235267	0	58235267	intron_variant	0.0	0.471	6e-07	6.221848749616356	(conditional on Round 2 SNPs)	0.027	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	Xp22.2	X	16812550	TXLNG	TXLNG			ENSG00000086712			rs5969745-?	rs5969745	0	5969745	intron_variant	0.0	0.6	3e-13	12.522878745280336	(conditional on Round 1 SNPs)	0.03	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50876854	KLK2	KLK2			ENSG00000167751			rs6070-?	rs6070	0	6070	non_coding_transcript_exon_variant	0.0	0.65	4e-16	15.397940008672036	(conditional on Round5 SNPs	0.048	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	19q13.33	19	50858126	KLK3	KLK3			ENSG00000142515			rs61752561-?	rs61752561	0	61752561	missense_variant	0.0	0.97	1.9999999999999998e-25	24.69897000433602	(conditional on Round 2 SNPs)	0.172	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	16q23.2	16	79821935	intergenic	LINC01228			ENSG00000261082			rs66624999-?	rs66624999	0	66624999	intron_variant	0.0	0.864	2e-07	6.698970004336019	(conditional on Round 2 SNPs)	0.04	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	13q14.11	13	41321130	intergenic	NAA16			ENSG00000172766			rs74922337-?	rs74922337	0	74922337	intron_variant	0.0	0.917	2e-07	6.698970004336019	(conditional on Round 1 SNPs)	0.055	unit increase	Affymetrix [10109774] (imputed)	N
2017-05-25	28139693	Hoffmann TJ	2017-01-31	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/28139693	Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.	Prostate-specific antigen levels (conditioned on lead SNPs)	28,503 European ancestry individuals	2,716 Latino individuals, 2,518 East Asian ancestry individuals, 1,585 African American individuals, 6,193 European ancestry individuals (later diagnosed with prostate cancer)	13q14.3	13	50507855	intergenic	DLEU1			ENSG00000176124			rs9596300-?	rs9596300	0	9596300	intron_variant	0.0	0.853	1e-08	8.0	(conditional on Round 1 SNPs)	0.045	unit increase	Affymetrix [10109774] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	3p14.1	3	67392218	NR	SUCLG2			ENSG00000172340			rs76010824-A	rs76010824	0	76010824	intron_variant	0.0	0.07	1e-07	7.0		1.26	[1.16-1.38]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	Xp11.22	X	50451939	NR	DGKK			ENSG00000274588			rs140659849-A	rs140659849	0	140659849	intron_variant	0.0	0.01	1e-07	7.0		2.61	[1.83-3.73]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	2p23.1	2	30399958	NR	LINC01936 - LCLAT1	ENSG00000235997	ENSG00000172954		38948.0	47268.0	rs114997855-A	rs114997855	0	114997855	intergenic_variant	1.0	0.02	1e-07	7.0		1.67	[1.38-2.03]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	Xq25	X	127519376	NR							rs723557-G	rs723557	0	723557	intergenic_variant	1.0	0.08	6e-07	6.221848749616356		1.15	[1.09-1.22]	Affymetrix, Illumina [up to 9536409] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls					NR							kgp1923988-C	kgp1923988	0			1.0	0.192	3e-08	7.522878745280337		1.41	[1.25-1.59]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		6q25.3	6	160421505	SLC22A3	SLC22A3			ENSG00000146477			rs3123636-C	rs3123636	0	3123636	intron_variant	0.0	0.356	3e-09	8.522878745280337		1.37	[1.23-1.51]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls					NR							kgp9645322-A	kgp9645322	0			1.0	0.044	8e-10	9.096910013008056		2.39	[1.81-3.16]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		10q11.22	10	46057653	TIMM23	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		9473.0	5597.0	rs10763567-A	rs10763567	0	10763567	regulatory_region_variant	1.0	0.489	6e-10	9.221848749616356		1.31	[1.19-1.44]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		11q13.3	11	69244777	MYEOV	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		85025.0	49374.0	rs12270641-T	rs12270641	0	12270641	intergenic_variant	1.0	0.45	1e-11	11.0		1.4	[1.27-1.55]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		17q12	17	37742390	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651052-A	rs11651052	0	11651052	intron_variant	0.0	0.435	3e-10	9.522878745280336		1.37	[1.24-1.51]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		8q24.21	8	127101181	PRNCR1	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs56005245-T	rs56005245	0	56005245	intron_variant	0.0	0.225	1e-08	8.0		1.41	[1.25-1.59]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		8q24.21	8	127196124	CASC19	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs138042437-G	rs138042437	0	138042437	intron_variant	0.0	0.015	2e-08	7.698970004336019		13.25	[5.37-32.69]	Illumina [~ 9400000] (imputed)	N
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls		8q24.21	8	127311646	CASC8, CASC21	PCAT1, CASC8			ENSG00000253438, ENSG00000246228			rs4506170-C	rs4506170	0	4506170	non_coding_transcript_exon_variant	0.0	0.166	2e-09	8.698970004336019		1.51	[1.32-1.73]	Illumina [~ 9400000] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	10p14	10	9602837	intergenic							rs4749884-C	rs4749884	0	4749884	intergenic_variant	1.0	0.533	7e-06	5.154901959985743		1.12	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	11p15.4	11	7535346	PPFIBP2	PPFIBP2			ENSG00000166387			rs12791447-C	rs12791447	0	12791447	intron_variant	0.0	0.136	4e-08	7.397940008672037		1.23	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	12q23.1	12	97483128	RMST	RMST			ENSG00000255794			rs75718479-C	rs75718479	0	75718479	intron_variant	0.0	0.877	1e-06	6.0		1.22	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	14q23.2	14	64227194	ESR2	ESR2			ENSG00000140009			rs58262369-T	rs58262369	0	58262369	3_prime_UTR_variant	0.0	0.072	6e-10	9.221848749616356		1.28	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	2p24.1	2	20688505	C2orf43	LDAH			ENSG00000118961			rs13385191-G	rs13385191	0	13385191	intron_variant	0.0	NR	5e-06	5.301029995663981		1.17	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	3p12.1	3	87061524	VGLL3	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786.0	27605.0	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1.0	NR	6e-06	5.221848749616356		1.1904762	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	5p15.33	5	1895715	IRX4	CTD-2194D22.4			ENSG00000249326			rs12653946-A	rs12653946	0	12653946	intron_variant	0.0	NR	2e-12	11.69897000433602		1.2820514	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	6q22.1	6	116888889	RFX6	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0.0	NR	4e-11	10.397940008672036		1.2820514	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8p21.2	8	23668950	NKX3-1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-T	rs1512268	0	1512268	intergenic_variant	1.0	NR	1e-13	13.0		1.3157895	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8q24.21	8	127112671	POU5F1B	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0.0	NR	1e-16	16.0		1.3888888	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8q24.21	8	127472793	LOC727677, POU5F1B	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	NR	4.0000000000000004e-23	22.39794000867204		1.5384616	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	NR	4e-08	7.397940008672037		1.2048193	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	13q22.1	13	73154002	KLF5	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		40984.0	37526.0	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1.0	NR	1e-06	6.0		1.1904762	[NR]	Illumina [4550396] (imputed)	N
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	17q12	17	37738049	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0.0	NR	6e-08	7.221848749616356		1.2345679	[NR]	Illumina [4550396] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		20q13.2	20	53838666	BCAS1	NA - SUMO1P1		ENSG00000241721			36586.0	rs6091758-G	rs6091758	0	6091758	intergenic_variant	1.0	NR	6e-06	5.221848749616356		1.1	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		16q23.3	16	82145289	RP11-510J16.5	MTCYBP28 - MPHOSPH6	ENSG00000260161	ENSG00000135698		23520.0	2509.0	rs201158093-TAA	rs201158093	1	199737822	intergenic_variant	1.0	NR	6e-07	6.221848749616356		1.11	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		9q34.11	9	129813781	TOR1A	TOR1A			ENSG00000136827			rs1182-A	rs1182	0	1182	3_prime_UTR_variant	0.0	NR	1e-07	7.0		1.13	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		12q24.33	12	132491403	FBRSL1	FBRSL1			ENSG00000112787			rs7295014-G	rs7295014	0	7295014	intron_variant	0.0	NR	6e-08	7.221848749616356		1.12	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6q25.2	6	153119944	NR	RGS17			ENSG00000091844			rs1933488-A	rs1933488	0	1933488	intron_variant	0.0	0.58	4e-21	20.39794000867204		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6q25.3	6	160412632	NR	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0.0	0.28	5e-33	32.30102999566398		1.11	[1.09-1.13]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7p15.3	7	20954872	NR	LINC01162			ENSG00000232790			rs12155172-A	rs12155172	0	12155172	intron_variant	0.0	0.22	9.000000000000001e-23	22.045757490560675		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.76	2.0000000000000003e-45	44.69897000433602		1.14	[1.12-1.16]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7p12.3	7	47397647	NR	TNS3			ENSG00000136205			rs56232506-A	rs56232506	0	56232506	intron_variant	0.0	0.45	1e-11	11.0		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7q21.3	7	98187015	NR	LMTK2			ENSG00000164715			rs6465657-C	rs6465657	0	6465657	intron_variant	0.0	0.46	7e-37	36.15490195998574		1.11	[1.09-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		8p21.2	8	23581462	NR	SLC25A37 - RNU4-71P	ENSG00000147454	ENSG00000252067		5999.0	18564.0	rs2928679-A	rs2928679	0	2928679	intergenic_variant	1.0	0.44	2e-11	10.69897000433602		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		8p21.2	8	26034626	NR	EBF2			ENSG00000221818			rs11135910-T	rs11135910	0	11135910	intron_variant	0.0	0.15	9e-13	12.045757490560677		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		8q24.21	8	127091872	NR	PRNCR1, CASC19, PCAT1			ENSG00000282961, ENSG00000254166, ENSG00000253438			rs183373024-G	rs183373024	0	183373024	non_coding_transcript_exon_variant	0.0	0.01	4e-160	159.39794000867204		2.91	[2.69-3.14]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		8q24.21	8	127472793	NR	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	0.11	1e-179	179.0		1.41	[1.38-1.45]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		9p21.3	9	22041999	NR	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0.0	0.14	2e-10	9.69897000433602		1.08	[1.05-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10q11.22	10	45587537	NR	MARCHF8, MARCHF8			ENSG00000165406, ENSG00000278545			rs76934034-T	rs76934034	0	76934034	intron_variant	0.0	0.92	2e-14	13.69897000433602		1.12	[1.09-1.16]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.38	2e-147	146.69897000433602		1.23	[1.21-1.25]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10q24.32	10	102654464	NR	TRIM8			ENSG00000171206			rs3850699-A	rs3850699	0	3850699	non_coding_transcript_exon_variant	0.0	0.7	6e-16	15.221848749616356		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10q26.13	10	125008303	NR	CTBP2			ENSG00000175029			rs4962416-C	rs4962416	0	4962416	intron_variant	0.0	0.27	2e-11	10.69897000433602		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11p15.5	11	2212344	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206.0	56154.0	rs7127900-A	rs7127900	0	7127900	intergenic_variant	1.0	0.2	5.0000000000000005e-68	67.30102999566398		1.19	[1.16-1.21]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q13.3	11	69227030	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67278.0	67121.0	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1.0	0.5	9.999999999999999e-87	86.0		1.17	[1.15-1.19]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q22.2	11	102530930	NR	MMP7 - MMP20	ENSG00000137673	ENSG00000137674		180.0	45902.0	rs11568818-T	rs11568818	0	11568818	upstream_gene_variant	1.0	0.55	2e-19	18.69897000433602		1.08	[1.06-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q23.2	11	113936459	NR	HTR3B			ENSG00000149305			rs11214775-G	rs11214775	0	11214775	intron_variant	0.0	0.71	4e-15	14.397940008672036		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q13.11	12	48025835	NR	COL2A1 - SENP1	ENSG00000139219	ENSG00000079387		21281.0	17062.0	rs80130819-A	rs80130819	0	80130819	regulatory_region_variant	1.0	0.91	2e-11	10.69897000433602		1.1	[1.07-1.13]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q13.12	12	49282227	NR	TUBA1C - TROAP-AS1	ENSG00000167553	ENSG00000258334		7627.0	10404.0	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1.0	0.29	2e-15	14.69897000433602		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		10p15.3	10	808752	LARP4B	LARP4B			ENSG00000107929			rs141536087-GCGCA	rs141536087	0	141536087	intron_variant	0.0	NR	5e-06	5.301029995663981		1.09	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		7p22.3	7	1904901	MAD1L1	MAD1L1			ENSG00000002822			rs527510716-C	rs527510716	0	527510716	intron_variant	0.0	NR	3e-07	6.522878745280337		1.1	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		11p15.4	11	7526356	PPFIBP2	PPFIBP2			ENSG00000166387			rs61890184-A	rs61890184	0	61890184	intron_variant	0.0	NR	1e-07	7.0		1.11	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		Xp22.2	X	11464514	ARHGAP6	ARHGAP6			ENSG00000047648			rs17321482-C	rs17321482	0	17321482	intron_variant	0.0	NR	1e-08	8.0		1.1	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		12p13.1	12	14263984	RNU6-491P	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758.0	92858.0	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1.0	NR	9e-07	6.045757490560675		1.07	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		6p21.31	6	34825347	UHRF1BP1	UHRF1BP1			ENSG00000065060			rs9469899-A	rs9469899	0	9469899	intron_variant	0.0	NR	2e-06	5.698970004336019		1.07	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		19q13.2	19	42196795	POU2F2	POU2F2 - DEDD2	ENSG00000028277	ENSG00000160570		210.0	1803.0	rs61088131-T	rs61088131	0	61088131	intergenic_variant	1.0	NR	4e-06	5.3979400086720375		1.09	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		20q13.2	20	53838666	BCAS1	NA - SUMO1P1		ENSG00000241721			36586.0	rs6091758-G	rs6091758	0	6091758	intergenic_variant	1.0	NR	2e-07	6.698970004336019		1.08	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		18q21.2	18	55563628	TCF4	TCF4			ENSG00000196628			rs28607662-C	rs28607662	0	28607662	intron_variant	0.0	NR	5e-06	5.301029995663981		1.11	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		16q21	16	57620664	GPR56	ADGRG1			ENSG00000205336			rs11863709-C	rs11863709	0	11863709	intron_variant	0.0	NR	7e-07	6.154901959985743		1.21	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		12q21.33	12	89766754	RNU6-148P	RNU6-148P - NA	ENSG00000252823			12602.0		rs5799921-GA	rs5799921	0	5799921	intron_variant	1.0	NR	1e-06	6.0		1.08	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		2q13	2	111135519	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs11691517-T	rs11691517	0	11691517	intron_variant	0.0	NR	7e-07	6.154901959985743		1.08	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		9q34.11	9	129813781	TOR1A	TOR1A			ENSG00000136827			rs1182-A	rs1182	0	1182	3_prime_UTR_variant	0.0	NR	1e-07	7.0		1.09	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		5q31.1	5	134500518	RNU6-456P	RNU6-456P - LINC01843	ENSG00000207222	ENSG00000251169		234.0	6034.0	rs10793821-T	rs10793821	0	10793821	upstream_gene_variant	1.0	NR	9e-07	6.045757490560675		1.07	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		1q21.3	1	153927425	DENND4B	GATAD2B - DENND4B	ENSG00000143614	ENSG00000198837		4065.0	2076.0	rs34579442-C	rs34579442	0	34579442	intron_variant	1.0	NR	8e-07	6.096910013008056		1.08	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		16q21	16	57619621	intergenic	ADGRG1			ENSG00000205336			rs11859370-T	rs11859370	0	11859370	intron_variant	0.0	NR	2e-08	7.698970004336019		1.21	[1.13-1.29]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		Xp22.2	X	11321091	intergenic	ARHGAP6			ENSG00000047648			rs2788524-G	rs2788524	0	2788524	intron_variant	0.0	NR	4e-10	9.397940008672036		1.1	[1.07-1.13]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls		2q13	2	111146954	intergenic	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs56366063-C	rs56366063	0	56366063	intron_variant	0.0	NR	1e-08	8.0		1.14	[1.09-1.19]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		6q27	6	170160655	LOC154449	NA - RPL12P23		ENSG00000218716			39114.0	rs138004030-G	rs138004030	0	138004030	non_coding_transcript_exon_variant	1.0	0.91	3e-08	7.522878745280337		1.27	[1.17-1.38]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		12q24.33	12	132563775	Intergenic	FBRSL1			ENSG00000112787			rs111599055-C	rs111599055	0	111599055	intron_variant	0.0	0.69	1e-08	8.0		1.13	[1.08-1.18]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		6p22.3	6	19628196	Intergenic	LNC-LBCS			ENSG00000228412			rs77777548-G	rs77777548	0	77777548	intron_variant	0.0	0.02	3e-08	7.522878745280337		2.94	[2.01-4.29]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		10p15.3	10	808752	LARP4B	LARP4B			ENSG00000107929			rs141536087-GCGCA	rs141536087	0	141536087	intron_variant	0.0	NR	4e-06	5.3979400086720375		1.13	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		12p13.1	12	14263984	RNU6-491P	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758.0	92858.0	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1.0	NR	7e-08	7.154901959985743		1.11	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		19p13.11	19	17103263	MYO9B	MYO9B			ENSG00000099331			rs11666569-C	rs11666569	0	11666569	non_coding_transcript_exon_variant	0.0	NR	3e-06	5.522878745280337		1.11	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls		9p22.1	9	19055967	HAUS6	HAUS6			ENSG00000147874			rs1048169-C	rs1048169	0	1048169	3_prime_UTR_variant	0.0	NR	8e-07	6.096910013008056		1.1	[NR]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17q12	17	37738049	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0.0	0.53	1e-132	132.0		1.22	[1.20-1.24]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	0.48	9.999999999999999e-92	91.0		1.17	[1.16-1.19]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		19q13.2	19	41479679	NR	PCAT19			ENSG00000267107			rs11672691-G	rs11672691	0	11672691	non_coding_transcript_exon_variant	0.0	0.74	2.0000000000000002e-23	22.69897000433602		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		20q13.33	20	63731211	NR	ZGPAT			ENSG00000197114			rs6062509-T	rs6062509	0	6062509	intron_variant	0.0	0.7	3e-18	17.522878745280337		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xp22.2	X	9846095	NR	SHROOM2			ENSG00000146950			rs2405942-A	rs2405942	0	2405942	intron_variant	0.0	0.78	2e-12	11.69897000433602		1.05	[1.04-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		1p36.22	1	10496040	NR	PEX14			ENSG00000142655			rs636291-A	rs636291	0	636291	intron_variant	0.0	0.68	6e-07	6.221848749616356		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0.0	0.22	1e-11	11.0		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		1q32.1	1	204549714	NR	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0.0	0.74	3e-24	23.522878745280337		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p25.1	2	9977740	NR	GRHL1			ENSG00000134317			rs11902236-T	rs11902236	0	11902236	intron_variant	0.0	0.27	5e-07	6.301029995663981		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p25.1	2	10570604	NR	NA - NOL10		ENSG00000115761			150.0	rs9287719-C	rs9287719	0	9287719	intergenic_variant	1.0	0.47	6e-17	16.221848749616356		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p24.1	2	20678393	NR	GDF7			ENSG00000143869			rs9306895-C	rs9306895	0	9306895	3_prime_UTR_variant	0.0	0.36	3e-21	20.522878745280337		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p21	2	43326810	NR	THADA			ENSG00000115970			rs1465618-T	rs1465618	0	1465618	intron_variant	0.0	0.21	2e-18	17.69897000433602		1.09	[1.07-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p15	2	62904596	NR	EHBP1			ENSG00000115504			rs721048-A	rs721048	0	721048	intron_variant	0.0	0.18	5e-22	21.30102999566398		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-T	rs10187424	0	10187424	intron_variant	0.0	0.57	1e-20	20.0		1.08	[1.06-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q31.1	2	172446825	NR	ITGA6			ENSG00000091409			rs12621278-A	rs12621278	0	12621278	intron_variant	0.0	0.94	1.9999999999999998e-42	41.69897000433602		1.27	[1.23-1.32]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q37.3	2	237534583	NR	MLPH			ENSG00000115648			rs2292884-G	rs2292884	0	2292884	missense_variant	0.0	0.24	4e-11	10.397940008672036		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q37.3	2	241443449	NR	FARP2			ENSG00000006607			rs3771570-T	rs3771570	0	3771570	3_prime_UTR_variant	0.0	0.15	1e-14	14.0		1.09	[1.06-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		5p15.33	5	1279913	NR	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	0.79	4e-52	51.39794000867204		1.17	[1.15-1.20]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		5q35.3	5	178541914	COL23A1	COL23A1			ENSG00000050767			rs4976790-T	rs4976790	0	4976790	intron_variant	0.0	0.11	7e-09	8.154901959985743		1.08	[1.05-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.33	6	30633455	ATAT1	ATAT1, ATAT1, ATAT1, ATAT1, ATAT1			ENSG00000223752, ENSG00000234549, ENSG00000235658, ENSG00000206488, ENSG00000137343			rs12665339-G	rs12665339	0	12665339	intron_variant	0.0	0.17	6e-09	8.221848749616356		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.32	6	33020918	HLA-DOA	HLA-DOA - HLA-DPA1	ENSG00000230141	ENSG00000236177		11327.0	43651.0	rs9296068-T	rs9296068	0	9296068	intergenic_variant	1.0	0.65	1e-08	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.31	6	34825347	UHRF1BP1	UHRF1BP1			ENSG00000065060			rs9469899-A	rs9469899	0	9469899	intron_variant	0.0	0.36	5e-09	8.301029995663981		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.1	6	43726861	RP1-261G23.5	MRPS18A - VEGFA	ENSG00000096080	ENSG00000112715		39070.0	43323.0	rs4711748-T	rs4711748	0	4711748	intron_variant	1.0	0.23	3e-08	7.522878745280337		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7p22.3	7	1904901	MAD1L1	MAD1L1			ENSG00000002822			rs527510716-C	rs527510716	0	527510716	intron_variant	0.0	0.24	5e-08	7.301029995663981		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7p21.1	7	20374488	ITGB8	ITGB8			ENSG00000105855			rs11452686-T	rs11452686	0	11452686	intron_variant	0.0	0.56	8e-09	8.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		7p14.1	7	40835593	SUGCT	SUGCT			ENSG00000175600			rs17621345-A	rs17621345	0	17621345	intron_variant	0.0	0.74	7e-14	13.154901959985745		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		9p22.1	9	19055967	HAUS6	HAUS6			ENSG00000147874			rs1048169-C	rs1048169	0	1048169	3_prime_UTR_variant	0.0	0.38	7e-14	13.154901959985745		1.06	[1.05-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		9p13.3	9	34049781	RN7SKP114	UBAP2 - RN7SKP114	ENSG00000137073	ENSG00000222259		393.0	185.0	rs10122495-T	rs10122495	0	10122495	TF_binding_site_variant	1.0	0.31	1e-08	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		9q34.11	9	129813781	TOR1A	TOR1A			ENSG00000136827			rs1182-A	rs1182	0	1182	3_prime_UTR_variant	0.0	0.22	1e-09	9.0		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10p15.3	10	808752	LARP4B	LARP4B			ENSG00000107929			rs141536087-GCGCA	rs141536087	0	141536087	intron_variant	0.0	0.15	9e-13	12.045757490560677		1.08	[1.06-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10q23.31	10	88435392	RNLS	RNLS			ENSG00000184719			rs1935581-C	rs1935581	0	1935581	intron_variant	0.0	0.63	7e-09	8.154901959985743		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		10q25.2	10	112952395	TCF7L2	TCF7L2			ENSG00000148737			rs7094871-G	rs7094871	0	7094871	intron_variant	0.0	0.54	5e-08	7.301029995663981		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11p15.5	11	1486282	MOB2	MOB2			ENSG00000182208			rs1881502-T	rs1881502	0	1881502	intron_variant	0.0	0.19	7e-09	8.154901959985743		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls					PPFIBP2							rs61890184-A	rs61890184d	0	61890184d		1.0	0.12	7e-09	8.154901959985743		1.07	[1.05-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11p11.2	11	47400412	RP11-750H9.5	SPI1 - MIR4487	ENSG00000066336	ENSG00000264583		21865.0	558.0	rs547171081-CGG	rs547171081	1	531832175	intron_variant	1.0	0.47	3e-08	7.522878745280337		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q12.3	11	62140968	INCENP	INCENP			ENSG00000149503			rs2277283-C	rs2277283	0	2277283	missense_variant	0.0	0.31	3e-10	9.522878745280336		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q13.2	11	67184494	KDM2A	KDM2A			ENSG00000173120			rs12785905-C	rs12785905	0	12785905	intron_variant	0.0	0.05	8e-09	8.096910013008056		1.12	[1.08-1.17]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q13.5	11	76549500	C11orf30	EMSY			ENSG00000158636			rs11290954-AC	rs11290954	0	11290954	intron_variant	0.0	0.68	7e-13	12.154901959985745		1.06	[1.05-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q22.3	11	108272729	ATM	ATM			ENSG00000149311			rs1800057-G	rs1800057	0	1800057	missense_variant	0.0	0.02	8e-09	8.096910013008056		1.16	[1.10-1.22]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q24.2	11	125184897	PKNOX2	PKNOX2			ENSG00000165495			rs138466039-T	rs138466039	0	138466039	intron_variant	0.0	0.01	2e-11	10.69897000433602		1.32	[1.22-1.44]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		11q25	11	134396478	B3GAT1	B3GAT1			ENSG00000109956			rs878987-G	rs878987	0	878987	intron_variant	0.0	0.15	5e-08	7.301029995663981		1.07	[1.04-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12p13.1	12	12718165	CDKN1B	CDKN1B			ENSG00000111276			rs2066827-T	rs2066827	0	2066827	missense_variant	0.0	0.76	2e-09	8.698970004336019		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12p13.1	12	14263984	RNU6-491P	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758.0	92858.0	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1.0	0.55	1e-12	12.0		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q14.2	12	64619044	RASSF3	RASSF3			ENSG00000153179			rs7968403-T	rs7968403	0	7968403	intron_variant	0.0	0.64	3e-12	11.522878745280336		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q21.33	12	89766754	RNU6-148P	RNU6-148P - NA	ENSG00000252823			12602.0		rs5799921-GA	rs5799921	0	5799921	intron_variant	1.0	0.68	7e-12	11.154901959985745		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q24.33	12	132491403	FBRSL1	FBRSL1			ENSG00000112787			rs7295014-G	rs7295014	0	7295014	intron_variant	0.0	0.35	1e-09	9.0		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		14q11.2	14	22836440	MMP14	MRPL52 - MMP14	ENSG00000172590	ENSG00000157227		1403.0	120.0	rs1004030-T	rs1004030	0	1004030	upstream_gene_variant	1.0	0.58	2e-08	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		14q13.3	14	36669089	PAX9	PAX9			ENSG00000198807			rs11629412-C	rs11629412	0	11629412	intron_variant	0.0	0.58	2e-12	11.69897000433602		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		15q15.1	15	40630717	CASC5	KNL1			ENSG00000137812			rs4924487-C	rs4924487	0	4924487	intron_variant	0.0	0.81	1e-08	8.0		1.06	[1.04-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		15q21.3	15	56093670	RFX7	RFX7			ENSG00000181827			rs33984059-A	rs33984059	0	33984059	missense_variant	0.0	0.98	1e-08	8.0		1.19	[1.12-1.27]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		15q22.31	15	66472304	MAP2K1	MAP2K1			ENSG00000169032			rs112293876-C	rs112293876	1	60289963	intron_variant	0.0	0.29	4e-10	9.397940008672036		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		16q21	16	57620664	GPR56	ADGRG1			ENSG00000205336			rs11863709-C	rs11863709	0	11863709	intron_variant	0.0	0.96	2e-11	10.69897000433602		1.16	[1.11-1.21]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		16q23.3	16	82145289	RP11-510J16.5	MTCYBP28 - MPHOSPH6	ENSG00000260161	ENSG00000135698		23520.0	2509.0	rs201158093-TAA	rs201158093	1	199737822	intergenic_variant	1.0	0.44	9e-09	8.045757490560675		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17p13.1	17	7899800	CHD3	CHD3			ENSG00000170004			rs28441558-C	rs28441558	0	28441558	intron_variant	0.0	0.05	1e-16	16.0		1.16	[1.12-1.20]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17q11.2	17	31771730	RP11-805L22.3	GPR160P2 - COPRS	ENSG00000265863	ENSG00000172301		10345.0	80141.0	rs142444269-C	rs142444269	0	142444269	intergenic_variant	1.0	0.78	3e-10	9.522878745280336		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17q22	17	58378759	RNF43	TSPOAP1-AS1, RNF43			ENSG00000265148, ENSG00000108375			rs2680708-G	rs2680708	0	2680708	intron_variant	0.0	0.61	2e-08	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		18q21.2	18	54246103	MBD2	MBD2 - POLI	ENSG00000134046	ENSG00000101751		21434.0	23414.0	rs8093601-C	rs8093601	0	8093601	intergenic_variant	1.0	0.44	2e-08	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		18q21.2	18	55563628	TCF4	TCF4			ENSG00000196628			rs28607662-C	rs28607662	0	28607662	intron_variant	0.0	0.1	3e-08	7.522878745280337		1.08	[1.05-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		18q21.32	18	59079083	OACYLP	OACYLP - SEC11C	ENSG00000224367	ENSG00000166562		9745.0	60783.0	rs12956892-T	rs12956892	0	12956892	intergenic_variant	1.0	0.3	8e-09	8.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		18q21.33	18	63293961	BCL2	BCL2			ENSG00000171791			rs533722308-CT	rs533722308	1	397698226	intron_variant	0.0	0.42	1e-08	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		18q22.3	18	75324210	TSHZ1	TSHZ1 - SMIM21	ENSG00000179981	ENSG00000206026		34260.0	85266.0	rs10460109-T	rs10460109	0	10460109	intergenic_variant	1.0	0.42	4e-08	7.397940008672037		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		19p13.11	19	17103263	MYO9B	MYO9B			ENSG00000099331			rs11666569-C	rs11666569	0	11666569	non_coding_transcript_exon_variant	0.0	0.71	8e-09	8.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		19q12	19	31676897	THEG5	RNA5SP471 - IRF2BP1	ENSG00000252780	ENSG00000170604		21436.0	14206711.0	rs118005503-G	rs118005503	0	118005503	intergenic_variant	1.0	0.91	7e-09	8.154901959985743		1.09	[1.06-1.13]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		19q13.2	19	42196795	POU2F2	POU2F2 - DEDD2	ENSG00000028277	ENSG00000160570		210.0	1803.0	rs61088131-T	rs61088131	0	61088131	intergenic_variant	1.0	0.82	9e-09	8.045757490560675		1.06	[1.04-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		20q11.21	20	32759707	DNMT3B	COMMD7 - DNMT3B	ENSG00000149600	ENSG00000088305		16240.0	2678.0	rs11480453-C	rs11480453	0	11480453	intergenic_variant	1.0	0.6	3e-08	7.522878745280337		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		20q13.2	20	53838666	BCAS1	NA - SUMO1P1		ENSG00000241721			36586.0	rs6091758-G	rs6091758	0	6091758	intergenic_variant	1.0	0.47	6e-18	17.221848749616356		1.07	[1.06-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		22q12.1	22	28492951	TTC28	TTC28			ENSG00000100154			rs9625483-A	rs9625483	0	9625483	intron_variant	0.0	0.03	2e-08	7.698970004336019		1.14	[1.09-1.20]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xp22.2	X	11464514	ARHGAP6	ARHGAP6			ENSG00000047648			rs17321482-C	rs17321482	0	17321482	intron_variant	0.0	0.87	2e-13	12.69897000433602		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		5q35.1	5	169745129	DOCK2	DOCK2			ENSG00000134516			rs76551843-A	rs76551843	0	76551843	intron_variant	0.0	0.99	2e-08	7.698970004336019		1.31	[1.19-1.44]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p22.1	6	30105999	NR	TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1			ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130, ENSG00000238027, ENSG00000225038, ENSG00000225732, ENSG00000235722, ENSG00000231226, ENSG00000232510, ENSG00000237050, ENSG00000229223			rs7767188-A	rs7767188	0	7767188	intron_variant	0.0	0.21	2e-08	7.698970004336019		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.33	6	31150734	NR	CCHCR1, CCHCR1, CCHCR1, CCHCR1, CCHCR1, CCHCR1			ENSG00000204536, ENSG00000223533, ENSG00000206457, ENSG00000206355, ENSG00000224180, ENSG00000234114			rs130067-G	rs130067	0	130067	missense_variant	0.0	0.2	2e-07	6.698970004336019		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.32	6	32224554	NR	NOTCH4 - TSBP1-AS1	ENSG00000238196	ENSG00000225914		487.0	30086.0	rs3096702-A	rs3096702	0	3096702	intergenic_variant	1.0	0.38	1e-11	11.0		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p21.32	6	32433162	NR	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25399.0	6716.0	rs3129859-G	rs3129859	0	3129859	intergenic_variant	1.0	0.67	1e-12	12.0		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6q21	6	108963986	NR	ARMC2			ENSG00000118690			rs2273669-G	rs2273669	0	2273669	intron_variant	0.0	0.15	3e-10	9.522878745280336		1.07	[1.05-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q26.2	3	169375312	MECOM	MECOM			ENSG00000085276			rs142436749-G	rs142436749	0	142436749	intron_variant	0.0	0.01	5e-09	8.301029995663981		1.25	[1.16-1.34]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		5q31.1	5	134500518	RNU6-456P	RNU6-456P - LINC01843	ENSG00000207222	ENSG00000251169		234.0	6034.0	rs10793821-T	rs10793821	0	10793821	upstream_gene_variant	1.0	0.57	5e-11	10.30102999566398		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xq12	X	67801708	NR	BMI1P1 - NA	ENSG00000234201			8813.0		rs5919432-T	rs5919432	0	5919432	intergenic_variant	1.0	0.8	1e-09	9.0		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xq13.1	X	71188133	NR	NLGN3 - GJB1	ENSG00000196338	ENSG00000169562		16932.0	24678.0	rs4844289-G	rs4844289	0	4844289	intron_variant	1.0	0.38	3e-12	11.522878745280336		1.04	[1.03-1.05]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q24.33	12	132563775	NR	FBRSL1			ENSG00000112787			rs111599055-C	rs111599055	0	111599055	intron_variant	0.0	0.69	8e-08	7.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3p12.1	3	87061524	NR	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786.0	27605.0	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1.0	0.1	6e-21	20.22184874961636		1.13	[1.10-1.16]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q13.2	3	113556777	NR	SIDT1			ENSG00000072858			rs7611694-A	rs7611694	0	7611694	intron_variant	0.0	0.58	5e-25	24.30102999566398		1.09	[1.07-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q21.3	3	128319530	NR	EEFSEC			ENSG00000132394			rs10934853-A	rs10934853	0	10934853	intron_variant	0.0	0.28	1.0000000000000001e-29	29.0		1.1	[1.09-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q23	3	141383991	NR	ZBTB38			ENSG00000177311			rs6763931-A	rs6763931	0	6763931	intron_variant	0.0	0.44	7e-08	7.154901959985743		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q26.2	3	170412314	NR	SKIL - CLDN11	ENSG00000136603	ENSG00000013297		15479.0	6554.0	rs10936632-A	rs10936632	0	10936632	intron_variant	1.0	0.51	3e-34	33.52287874528034		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		4q13.3	4	72989536	NR	RNU4ATAC9P - RNU6ATAC5P	ENSG00000252955	ENSG00000210839		24233.0	37212.0	rs10009409-T	rs10009409	0	10009409	intergenic_variant	1.0	0.31	4e-10	9.397940008672036		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		4q13.3	4	73483441	NR	AFM			ENSG00000079557			rs1894292-G	rs1894292	0	1894292	intron_variant	0.0	0.52	5e-15	14.30102999566398		1.06	[1.05-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		4q22.3	4	94641726	NR	PDLIM5			ENSG00000163110			rs17021918-C	rs17021918	0	17021918	intron_variant	0.0	0.65	1.0000000000000001e-24	24.0		1.09	[1.07-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		4q24	4	105140377	NR	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-C	rs7679673	0	7679673	intron_variant	1.0	0.59	1.0000000000000001e-49	49.0		1.13	[1.11-1.15]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		16q21	16	57619621	NR	ADGRG1			ENSG00000205336			rs11859370-T	rs11859370	0	11859370	intron_variant	0.0	0.95	2e-10	9.69897000433602		1.13	[1.09-1.17]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xp22.2	X	11321091	NR	ARHGAP6			ENSG00000047648			rs2788524-G	rs2788524	0	2788524	intron_variant	0.0	0.15	9e-11	10.045757490560677		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q13	2	111146954	NR	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs56366063-C	rs56366063	0	56366063	intron_variant	0.0	0.11	2e-08	7.698970004336019		1.08	[1.05-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		1q21.3	1	154861707	NR	KCNN3			ENSG00000143603			rs1218582-G	rs1218582	0	1218582	intron_variant	0.0	0.45	1e-08	8.0		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028.0	5309.0	rs902774-A	rs902774	0	902774	regulatory_region_variant	1.0	0.15	2e-31	30.69897000433602		1.13	[1.11-1.16]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		14q24.1	14	68660027	NR	RAD51B			ENSG00000182185			rs7141529-C	rs7141529	0	7141529	intron_variant	0.0	0.5	2e-10	9.69897000433602		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		12q24.21	12	114247766	NR	LINC02459 - NA	ENSG00000257476			5996.0		rs1270884-A	rs1270884	0	1270884	intergenic_variant	1.0	0.48	1e-18	18.0		1.07	[1.06-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		14q22.1	14	52905612	NR	FERMT2			ENSG00000073712			rs8008270-C	rs8008270	0	8008270	intron_variant	0.0	0.81	6e-16	15.221848749616356		1.09	[1.07-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		14q24.2	14	70625539	NR	RN7SL77P - TTC9	ENSG00000240837	ENSG00000133985		15160.0	16377.0	rs8014671-G	rs8014671	0	8014671	intron_variant	1.0	0.58	2e-08	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17p13.3	17	715725	NR	VPS53, VPS53			ENSG00000141252, ENSG00000283883			rs684232-C	rs684232	0	684232	intron_variant	0.0	0.35	4.0000000000000004e-24	23.39794000867204		1.09	[1.07-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17q21.32	17	48728343	NR	HOXB13			ENSG00000159184			rs138213197-T	rs138213197	0	138213197	missense_variant	0.0	0.002	9e-63	62.04575749056068		3.85	[3.29-4.51]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		17q21.32	17	49267824	NR	FLJ40194			ENSG00000177369			rs11650494-A	rs11650494	0	11650494	intron_variant	0.0	0.08	9e-12	11.045757490560677		1.1	[1.07-1.14]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		18q23	18	79013973	NR	SALL3 - ATP9B	ENSG00000263310	ENSG00000166377		11296.0	55312.0	rs7241993-C	rs7241993	0	7241993	intergenic_variant	1.0	0.69	2e-18	17.69897000433602		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		19q13.2	19	38244973	NR	SPINT2			ENSG00000167642			rs8102476-C	rs8102476	0	8102476	intron_variant	0.0	0.54	9e-30	29.045757490560675		1.09	[1.08-1.11]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603.0	201.0	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1.0	0.85	2.9999999999999997e-47	46.52287874528034		1.18	[1.15-1.21]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		20q13.33	20	62440555	NR	RBBP8NL - GATA5	ENSG00000130701	ENSG00000130700		13016.0	22942.0	rs2427345-C	rs2427345	0	2427345	intron_variant	1.0	0.62	3e-08	7.522878745280337		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		22q13.1	22	40075184	NR	TNRC6B			ENSG00000100354			rs58133635-T	rs58133635	0	58133635	intron_variant	0.0	0.2	5e-12	11.30102999566398		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	0.5	5.9999999999999995e-71	70.22184874961636		1.15	[1.14-1.17]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xp11.22	X	51498820	NR	LINC01496			ENSG00000234766			rs5945619-C	rs5945619	0	5945619	non_coding_transcript_exon_variant	0.0	0.36	1e-73	73.0		1.11	[1.10-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		Xp11.22	X	52867918	NR	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0.0	0.18	8e-16	15.096910013008056		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		1p22.3	1	87745033	RP11-60A14.1	PKN2-AS1			ENSG00000237505			rs56391074-AT	rs56391074	0	56391074	intron_variant	0.0	0.38	2e-08	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		1q21.3	1	153927425	DENND4B	GATAD2B - DENND4B	ENSG00000143614	ENSG00000198837		4065.0	2076.0	rs34579442-C	rs34579442	0	34579442	intron_variant	1.0	0.34	5e-14	13.30102999566398		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p25.1	2	8456993	AC011747.3	LINC00299			ENSG00000236790			rs62106670-T	rs62106670	0	62106670	intron_variant	0.0	0.38	7e-09	8.154901959985743		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2p14	2	66425753	MEIS1-AS3	LINC01873 - MEIS1-AS3	ENSG00000232164	ENSG00000226819		33303.0	982.0	rs74702681-T	rs74702681	0	74702681	intergenic_variant	1.0	0.02	2e-09	8.698970004336019		1.17	[1.11-1.23]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q13	2	111135519	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs11691517-T	rs11691517	0	11691517	intron_variant	0.0	0.74	4e-12	11.397940008672036		1.07	[1.05-1.08]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q31.1	2	173369819	CDCA7	CDCA7 - JPT1P1	ENSG00000144354	ENSG00000213148		822.0	61530.0	rs34925593-C	rs34925593	0	34925593	intergenic_variant	1.0	0.48	3e-08	7.522878745280337		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		2q33.1	2	201258757	CASP8	CASP8			ENSG00000064012			rs59308963-T	rs59308963	0	59308963	intron_variant	0.0	0.73	2e-08	7.698970004336019		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q13.12	3	107243674	DUBR	DUBR			ENSG00000243701			rs1283104-G	rs1283104	0	1283104	intron_variant	0.0	0.38	9e-09	8.045757490560675		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		3q25.1	3	152286413	MBNL1	MBNL1			ENSG00000152601			rs182314334-T	rs182314334	0	182314334	intron_variant	0.0	0.9	4e-11	10.397940008672036		1.09	[1.06-1.12]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		5p12	5	44365443	NR	FGF10			ENSG00000070193			rs2121875-C	rs2121875	0	2121875	intron_variant	0.0	0.33	1e-08	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls		6p24.2	6	11218797	NR	NEDD9			ENSG00000111859			rs4713266-C	rs4713266	0	4713266	intron_variant	0.0	0.52	1e-10	10.0		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	2,463 African American or Afro-Caribbean cases, 2,306 African American or Afro-Caribbean controls		8q24.21	8	127091724	LINC01245	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs72725879-?	rs72725879	0	72725879	non_coding_transcript_exon_variant	0.0	NR	4e-12	11.397940008672036		0.297	unit increase	Illumina [15394464] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	2,463 African American or Afro-Caribbean cases, 2,306 African American or Afro-Caribbean controls		8q24.21	8	127075584	LINC01245	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs76595456-T	rs76595456	0	76595456	intron_variant	0.0	NR	1e-15	15.0		0.55	unit increase	Illumina [15394464] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	1,106 Japanese American cases, 1,093 Japanese American controls		8q24.21	8	127091692	LINC01245	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0.0	NR	1e-13	13.0		0.5	unit decrease	Illumina [4623264] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	1,106 Japanese American cases, 1,093 Japanese American controls		8q24.21	8	127527115	NR	CASC8 - NA	ENSG00000246228			44976.0		rs7837688-?	rs7837688	0	7837688	intergenic_variant	1.0	NR	3e-09	8.522878745280337		0.48	unit increase	Illumina [4623264] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	1,106 Japanese American cases, 1,093 Japanese American controls		8p21.2	8	23676505	NKX3-1, SINHCAFP3	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		40998.0	2192.0	rs10503733-?	rs10503733	0	10503733	intergenic_variant	1.0	NR	3e-06	5.522878745280337		1.3426423		Illumina [4623264] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	1,106 Japanese American cases, 1,093 Japanese American controls		8q24.21	8	127096171	NR	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs4871009-?	rs4871009	0	4871009	intron_variant	0.0	NR	3e-12	11.522878745280336		0.52	unit increase	Illumina [4623264] (imputed)	N
2020-10-16	32986714	Fiorica PN	2020-09-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/32986714	Multi-ethnic transcriptome-wide association study of prostate cancer.	Prostate cancer	1,081 Hispanic or Latin American cases, 1,066 Hispanic or Latin American controls					NR							chr13:106685795-?	chr13:106685795	0			1.0	NR	4e-07	6.3979400086720375				Illumina [7010834] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		11q12.1	11	57158067	NR	NA - LRRC55		ENSG00000183908			23680.0	rs72915971-?	rs72915971	0	72915971	intergenic_variant	1.0	0.02	5e-07	6.301029995663981		2.16	[1.60-2.91]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals					NR							chr12:102080173-?	chr12:102080173	0			1.0	0.03	1e-09	9.0		3.57	[2.37-5.39]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		15q12	15	27501193	NR	GABRG3			ENSG00000182256			rs192744896-?	rs192744896	0	192744896	intron_variant	0.0	0.03	4e-07	6.3979400086720375		3.72	[2.23-6.18]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		3p24.1	3	26507456	NR							rs149927798-?	rs149927798	0	149927798	intergenic_variant	1.0	0.02	2e-07	6.698970004336019		3.98	[2.36-6.71]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		8p23.3	8	755922	NR	DLGAP2, DLGAP2			ENSG00000198010, ENSG00000282318			rs139288166-?	rs139288166	0	139288166	intron_variant	0.0	0.03	7e-08	7.154901959985743		4.3	[2.53-7.31]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		8q24.23	8	137307143	NR							rs73712257-?	rs73712257	0	73712257	intergenic_variant	1.0	0.03	2e-07	6.698970004336019		4.72	[2.62-8.50]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		8p23.3	8	612963	NR	TDRP - ERICH1	ENSG00000180190	ENSG00000104714		67182.0	1783.0	rs148048756-?	rs148048756	0	148048756	intergenic_variant	1.0	0.03	4e-08	7.397940008672037		4.83	[2.75-8.47]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		7q31.1	7	107992726	NR	LAMB1			ENSG00000091136			rs2237706-?	rs2237706	0	2237706	intron_variant	0.0	0.09	5e-07	6.301029995663981		1.94	[1.50-2.52]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		5q33.3	5	157976402	NR	SSBP2 - RNU2-48P	ENSG00000145687	ENSG00000222626		76224605.0	364.0	rs17055178-G	rs17055178	0	17055178	regulatory_region_variant	1.0	0.09	6e-10	9.221848749616356		1.95	[1.58-2.40]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		10q26.12	10	120534056	NR	PLPP4			ENSG00000203805			rs61871726-?	rs61871726	0	61871726	intron_variant	0.0	0.07	5e-07	6.301029995663981		1.98	[1.52-2.59]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		8q24.23	8	136150901	NR	LINC02055			ENSG00000254101			rs9644474-?	rs9644474	0	9644474	intron_variant	0.0	0.95	8e-08	7.096910013008056		2.15	[1.64-2.81]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		10p11.23	10	30391095	NR	NIFKP1 - CCND3P1	ENSG00000214434	ENSG00000224473		10033.0	12102.0	rs2031925-?	rs2031925	0	2031925	intergenic_variant	1.0	0.05	2e-07	6.698970004336019		2.43	[1.73-3.40]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		3q24	3	145512282	NR	NA - LARP7P4		ENSG00000244024			11256.0	rs74346764-?	rs74346764	0	74346764	intergenic_variant	1.0	0.05	3e-07	6.522878745280337		2.52	[1.77-3.58]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)	3,379 European ancestry individuals		8p12	8	30701718	NR	GSR			ENSG00000104687			rs149176864-?	rs149176864	0	149176864	intron_variant	0.0	0.02	1e-07	7.0		2.99	[1.99-4.49]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	14q13.3	14	36589404	NR	NKX2-8 - RN7SKP257	ENSG00000136327	ENSG00000201395		6790.0	4435.0	rs11624322-?	rs11624322	0	11624322	intron_variant	1.0	0.37	4e-07	6.3979400086720375		1.51	[1.29-1.77]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	7p21.2	7	15370687	NR	AGMO			ENSG00000187546			rs60424486-?	rs60424486	0	60424486	intron_variant	0.0	0.08	4e-07	6.3979400086720375		1.84	[1.45-2.33]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	9p21.1	9	30866810	NR	RPS26P2 - FTLP4	ENSG00000233278	ENSG00000214020		34585.0	68675.0	rs10969913-G	rs10969913	0	10969913	intergenic_variant	1.0	0.05	3e-10	9.522878745280336		3.92	[2.57-6.00]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	2q22.1	2	140972483	NR	LRP1B			ENSG00000168702			rs75988504-?	rs75988504	0	75988504	intron_variant	0.0	0.04	5e-08	7.301029995663981		2.01	[1.56-2.58]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	3p24.3	3	21718112	NR	ZNF385D			ENSG00000151789			rs73046248-?	rs73046248	0	73046248	intron_variant	0.0	0.04	4e-07	6.3979400086720375		2.4	[1.71-3.36]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	4p16.3	4	3535970	NR	LRPAP1 - LINC00955	ENSG00000163956	ENSG00000216560		3524.0	40899.0	rs113370662-?	rs113370662	0	113370662	regulatory_region_variant	1.0	0.04	5e-07	6.301029995663981		2.78	[1.87-4.15]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	19p13.3	19	5200642	NR	PTPRS			ENSG00000105426			rs78166464-?	rs78166464	0	78166464	intron_variant	0.0	0.01	3e-07	6.522878745280337		2.83	[1.90-4.21]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	2q37.3	2	237171408	NR	COPS8 - NA	ENSG00000198612			70934.0		rs11687040-?	rs11687040	0	11687040	regulatory_region_variant	1.0	0.01	4e-07	6.3979400086720375		3.37	[2.11-5.40]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	3p14.2	3	59918603	NR	FHIT			ENSG00000189283			rs139239158-?	rs139239158	0	139239158	intron_variant	0.0	0.02	3e-08	7.522878745280337		3.69	[2.32-5.87]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	1p36.23	1	7498192	NR	CAMTA1			ENSG00000171735			rs112193369-?	rs112193369	0	112193369	intron_variant	0.0	0.02	1e-07	7.0		4.09	[2.43-6.90]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	19p13.2	19	10823418	NR	DNM2			ENSG00000079805			rs77581414-?	rs77581414	0	77581414	non_coding_transcript_exon_variant	0.0	0.04	3e-07	6.522878745280337		6.07	[3.04-12.1]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)	3,470 European ancestry individuals	NR	19p13.3	19	1543772	NR	PLK5 - MEX3D	ENSG00000185988	ENSG00000181588		7726.0	10900.0	rs180958289-?	rs180958289	0	180958289	intergenic_variant	1.0	0.02	5e-09	8.301029995663981		7.78	[3.92-15.5]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	1q42.2	1	230701434	NR	AGT			ENSG00000135744			rs11122573-T	rs11122573	0	11122573	intron_variant	0.0	0.06	2e-08	7.698970004336019	(EA)	1.92	[1.53-2.42]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	19p13.3	19	6573500	NR	Y_RNA - CD70	ENSG00000264495	ENSG00000125726		443.0	9683.0	rs72993079-?	rs72993079	0	72993079	intergenic_variant	1.0	0.05	4e-07	6.3979400086720375	(EA)	2.14	[1.60-2.87]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	5q32	5	145379637	NR	NA - PRELID2		ENSG00000186314			92162.0	rs76661052-?	rs76661052	0	76661052	intron_variant	1.0	0.03	3e-07	6.522878745280337	(EA)	2.33	[1.68-3.22]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	2p16.1	2	56629125	NR							rs17190422-?	rs17190422	0	17190422	intergenic_variant	1.0	0.06	3e-07	6.522878745280337	(EA)	2.57	[1.79-3.68]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	2p14	2	68397478	NR	PLEK - WDR4P2	ENSG00000115956	ENSG00000229462		25.0	48232.0	rs144214859-?	rs144214859	0	144214859	intergenic_variant	1.0	0.02	3e-07	6.522878745280337	(EA)	2.58	[1.80-3.70]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	6q21	6	112023534	NR	NA - CCN6		ENSG00000112761			30541.0	rs73539559-?	rs73539559	0	73539559	intergenic_variant	1.0	0.02	2e-07	6.698970004336019	(EA)	2.86	[1.93-4.26]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	6q21	6	113907536	NR	LINC02880			ENSG00000175967			rs490393-?	rs490393	0	490393	intron_variant	0.0	0.03	2e-07	6.698970004336019	(EA)	2.96	[1.96-4.47]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	3p14.1	3	64003780	NR	ATXN7 - PSMD6-AS2	ENSG00000163635	ENSG00000239653		318.0	242.0	rs4688181-?	rs4688181	0	4688181	intergenic_variant	1.0	0.04	1e-07	7.0	(EA)	3.22	[2.09-4.98]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	2q37.3	2	241004033	NR	SNED1			ENSG00000162804			rs13403657-?	rs13403657	0	13403657	intron_variant	0.0	0.03	1e-08	8.0	(EA)	3.26	[2.17-4.90]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	9p24.1	9	4600633	NR	SPATA6L			ENSG00000106686			rs3739643-?	rs3739643	0	3739643	3_prime_UTR_variant	0.0	0.04	2e-07	6.698970004336019	(EA)	3.44	[2.17-5.47]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	3q22.1	3	133982979	NR	SLCO2A1			ENSG00000174640			rs9832989-?	rs9832989	0	9832989	intron_variant	0.0	0.06	4e-07	6.3979400086720375	(EA)	4.45	[2.50-7.92]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	3p14.3	3	54695885	NR	CACNA2D3			ENSG00000157445			rs139882217-?	rs139882217	0	139882217	intron_variant	0.0	0.04	7e-08	7.154901959985743	(EA)	4.78	[2.71-8.44]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	9q21.31	9	80614113	NR	MTND2P9 - NA	ENSG00000225901			48151.0		rs138731641-?	rs138731641	0	138731641	intergenic_variant	1.0	0.04	5e-07	6.301029995663981	(EA)	5.46	[2.82-10.6]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	9q21.32	9	83585894	NR	FRMD3 - RNU4-15P	ENSG00000172159	ENSG00000199483		47348.0	10550.0	rs190601686-?	rs190601686	0	190601686	intergenic_variant	1.0	0.01	2e-07	6.698970004336019	(EA)	9.13	[3.95-21.1]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals				NR							chr12:31100664-?	chr12:31100664	0			1.0	0.02	1e-07	7.0	(EA)	9.22	[4.06-20.9]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)	3,619 European ancestry individuals	538 Japanese ancestry individuals	1q42.13	1	230316103	NR	PGBD5			ENSG00000177614			rs147121532-?	rs147121532	0	147121532	3_prime_UTR_variant	0.0	NR	4e-06	5.3979400086720375	(EA)	4.43	[2.35-8.33]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Response to radiotherapy in prostate cancer (overall toxicity)	3,871 European ancestry individuals					NR							chr18:57916552-?	chr18:57916552	0			1.0	0.26	2e-07	6.698970004336019		0.07	[0.04-0.10] unit increase	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Response to radiotherapy in prostate cancer (overall toxicity)	3,871 European ancestry individuals					NR							chr12:33380941-?	chr12:33380941	0			1.0	0.04	1e-07	7.0		0.17	[0.11-0.23] unit increase	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Response to radiotherapy in prostate cancer (overall toxicity)	3,871 European ancestry individuals		Xp11.4	X	38291789	NR	RPGR			ENSG00000156313			rs75759941-?	rs75759941	0	75759941	intron_variant	0.0	0.05	9e-08	7.045757490560675		0.25	[0.16-0.34] unit increase	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	3,782 European ancestry individuals		3q26.32	3	177401529	NR	LINC00501 - LINC00578	ENSG00000203645	ENSG00000228221		78111.0	40381.0	rs6791846-?	rs6791846	0	6791846	regulatory_region_variant	1.0	0.45	5e-07	6.301029995663981		1.47	[1.26-1.71]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	3,782 European ancestry individuals		11q23.3	11	116574969	NR	LINC02151 - LINC02702	ENSG00000236437	ENSG00000237937		74339.0	64453.0	rs368141164-?	rs368141164	0	368141164	intergenic_variant	1.0	0.06	2e-07	6.698970004336019		1.87	[1.48-2.36]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	3,782 European ancestry individuals		4q28.1	4	122999342	NR	SPATA5			ENSG00000145375			rs186353960-?	rs186353960	0	186353960	intron_variant	0.0	0.04	3e-07	6.522878745280337		2.44	[1.73-3.44]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	3,782 European ancestry individuals		3p22.3	3	36203204	NR	RFC3P1 - NA	ENSG00000236158			32756.0		rs141203061-?	rs141203061	0	141203061	intergenic_variant	1.0	0.03	4e-07	6.3979400086720375		2.71	[1.84-4.00]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	3,782 European ancestry individuals		4q35.1	4	183770411	NR	TRAPPC11 - STOX2	ENSG00000168538	ENSG00000173320		56817.0	27281.0	rs191705561-?	rs191705561	0	191705561	intergenic_variant	1.0	0.01	4e-08	7.397940008672037		3.05	[2.05-4.53]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2019-08-07	31095341	Kerns SL	2019-05-16	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/31095341	Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy.	Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)	3,782 European ancestry individuals		11p15.1	11	17399294	NR	ABCC8			ENSG00000006071			rs61415111-?	rs61415111	0	61415111	intron_variant	0.0	0.02	3e-07	6.522878745280337		4.6	[2.57-8.24]	Affymetrix, Illumina [~ 6000000] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q26.2	3	169764547	NR	TERC			ENSG00000270141			rs2293607-T	rs2293607	0	2293607	non_coding_transcript_exon_variant	0.0	NR	2e-13	12.69897000433602		1.06	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q26.2	3	170356729	NR	PRKCI - SKIL	ENSG00000163558	ENSG00000136603		50752.0	949.0	rs78416326-G	rs78416326	0	78416326	upstream_gene_variant	1.0	NR	5.0000000000000005e-99	98.30102999566398		1.206	[1.18-1.23]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q26.2	3	170365753	NR	SKIL			ENSG00000136603			rs577952184-C	rs577952184	1	59222162	intron_variant	0.0	NR	5e-18	17.30102999566398		1.1	[1.08-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q26.31	3	172663987	NR	NCEH1			ENSG00000144959			rs11717887-C	rs11717887	0	11717887	intron_variant	0.0	NR	3e-08	7.522878745280337		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q13.3	4	73576632	NR	RASSF6			ENSG00000169435			rs17804499-G	rs17804499	0	17804499	missense_variant	0.0	NR	3.9999999999999996e-26	25.39794000867204		1.214	[1.17-1.26]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q13.3	4	73611418	NR	RASSF6			ENSG00000169435			rs13142786-T	rs13142786	0	13142786	intron_variant	0.0	NR	9e-24	23.045757490560675		1.071	[1.06-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q22.3	4	94623567	NR	PDLIM5			ENSG00000163110			rs6853490-G	rs6853490	0	6853490	intron_variant	0.0	NR	5.0000000000000004e-29	28.30102999566398		1.077	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q24	4	105140377	NR	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-C	rs7679673	0	7679673	intron_variant	1.0	NR	3e-35	34.52287874528034		1.1	[1.08-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q24	4	105143597	NR	NA - TET2		ENSG00000168769			2278.0	rs17035310-C	rs17035310	0	17035310	intergenic_variant	1.0	NR	3e-09	8.522878745280337		1.069	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q31.1	4	140027681	NR	MAML3			ENSG00000196782			rs77821238-C	rs77821238	0	77821238	intron_variant	0.0	NR	4e-08	7.397940008672037		1.054	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q31.22	4	145958085	NR	ZNF827 - Y_RNA	ENSG00000151612	ENSG00000264495		19262.0	43.0	rs72725734-G	rs72725734	0	72725734	intergenic_variant	1.0	NR	1e-08	8.0		1.052	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		4q31.3	4	151109188	NR	SH3D19			ENSG00000109686			rs147762399-T	rs147762399	0	147762399	intron_variant	0.0	NR	4e-09	8.397940008672037		1.084	[1.06-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p15.33	5	1279913	NR	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	NR	8e-55	54.096910013008056		1.144	[1.12-1.16]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p15.33	5	1292003	NR	TERT			ENSG00000164362			rs71595003-A	rs71595003	0	71595003	intron_variant	0.0	NR	3e-14	13.522878745280336		1.188	[1.14-1.24]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p12.1	3	87094867	NR	LINC00506			ENSG00000281392			rs143745027-G	rs143745027	0	143745027	non_coding_transcript_exon_variant	0.0	NR	3e-38	37.52287874528034		1.169	[1.14-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p11.2	3	87126834	NR	LINC00506			ENSG00000281392			rs7628934-C	rs7628934	0	7628934	intron_variant	0.0	NR	2e-41	40.69897000433602		1.098	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p11.2	3	87350212	NR	KRT8P25 - NA	ENSG00000239829			25489.0		rs114810266-A	rs114810266	0	114810266	intergenic_variant	1.0	NR	8e-11	10.096910013008056		1.165	[1.11-1.22]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q13.12	3	107243674	NR	DUBR			ENSG00000243701			rs1283104-G	rs1283104	0	1283104	intron_variant	0.0	NR	3e-11	10.522878745280336		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q13.12	3	107474490	NR	LINC01990 - BBX	ENSG00000273125	ENSG00000114439		10578.0	48446.0	rs151038334-C	rs151038334	0	151038334	intergenic_variant	1.0	NR	2e-08	7.698970004336019		1.079	[1.05-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q13.2	3	113581336	NR	SIDT1			ENSG00000072858			rs2271494-A	rs2271494	0	2271494	intron_variant	0.0	NR	2e-31	30.69897000433602		1.081	[1.07-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q21.3	3	128179658	NR	EEFSEC			ENSG00000132394			rs2811476-C	rs2811476	0	2811476	intron_variant	0.0	NR	4.0000000000000004e-39	38.39794000867204		1.102	[1.09-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q21.3	3	128495151	NR	GATA2-AS1			ENSG00000244300			rs35006112-G	rs35006112	0	35006112	intron_variant	0.0	NR	4e-21	20.39794000867204		1.083	[1.06-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q22.3	3	137843981	NR	LINC01210 - HSPA8P9	ENSG00000239513	ENSG00000241478		63099.0	36314.0	rs1457063-A	rs1457063	0	1457063	intergenic_variant	1.0	NR	1e-09	9.0		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q23	3	141428572	NR	ZBTB38			ENSG00000177311			rs7650602-C	rs7650602	0	7650602	intron_variant	0.0	NR	5e-13	12.30102999566398		1.049	[1.04-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3q25.1	3	152293957	NR	MBNL1			ENSG00000152601			rs145053401-C	rs145053401	0	145053401	intron_variant	0.0	NR	9e-13	12.045757490560677		1.087	[1.06-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q22.3	10	79076241	NR	ZMIZ1			ENSG00000108175			rs12412705-C	rs12412705	0	12412705	intron_variant	0.0	NR	7e-12	11.154901959985745		1.068	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q23.31	10	88435392	NR	RNLS			ENSG00000184719			rs1935581-C	rs1935581	0	1935581	intron_variant	0.0	NR	8e-11	10.096910013008056		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q24.32	10	102668959	NR	TRIM8 - ARL3	ENSG00000171206	ENSG00000138175		10641.0	4772.0	rs12262998-C	rs12262998	0	12262998	intergenic_variant	1.0	NR	5e-22	21.30102999566398		1.073	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q25.2	10	112951996	NR	TCF7L2			ENSG00000148737			rs10885396-T	rs10885396	0	10885396	intron_variant	0.0	NR	2e-10	9.69897000433602		1.043	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q26.12	10	121035413	NR	NA - RPL19P16		ENSG00000236762			97677.0	rs4558107-A	rs4558107	0	4558107	intergenic_variant	1.0	NR	2e-16	15.69897000433602		1.06	[1.05-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q26.12	10	121074969	NR	NA - RPL19P16		ENSG00000236762			58121.0	rs140783917-C	rs140783917	0	140783917	intergenic_variant	1.0	NR	1e-14	14.0		1.209	[1.15-1.27]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q26.12	10	121294504	NR							rs10788167-T	rs10788167	0	10788167	intergenic_variant	1.0	NR	1e-15	15.0		1.063	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q26.13	10	121425789	NR	RN7SKP167 - FGFR2	ENSG00000222979	ENSG00000066468		14589.0	52543.0	rs10749415-A	rs10749415	0	10749415	intergenic_variant	1.0	NR	3e-17	16.522878745280337		1.116	[1.09-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q26.13	10	125008925	NR	CTBP2			ENSG00000175029			rs12769682-C	rs12769682	0	12769682	intron_variant	0.0	NR	5e-13	12.30102999566398		1.059	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11p15.5	11	1486282	NR	MOB2			ENSG00000182208			rs1881502-T	rs1881502	0	1881502	intron_variant	0.0	NR	8e-09	8.096910013008056		1.053	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11p15.5	11	2212863	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39725.0	55635.0	rs11043143-T	rs11043143	0	11043143	intergenic_variant	1.0	NR	2e-73	72.69897000433602		1.161	[1.14-1.18]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11p15.4	11	7526356	NR	PPFIBP2			ENSG00000166387			rs61890184-A	rs61890184	0	61890184	intron_variant	0.0	NR	5e-16	15.30102999566398		1.082	[1.06-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11p11.2	11	47406659	NR	MIR4487 - SLC39A13	ENSG00000264583	ENSG00000165915		5617.0	473.0	rs68010938-T	rs68010938	0	68010938	intron_variant	1.0	NR	3e-08	7.522878745280337		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q12.1	11	59135206	NR	FAM111A-DT			ENSG00000245571			rs1048374-G	rs1048374	0	1048374	non_coding_transcript_exon_variant	0.0	NR	1e-11	11.0		1.134	[1.09-1.18]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q12.3	11	62140968	NR	INCENP			ENSG00000149503			rs2277283-C	rs2277283	0	2277283	missense_variant	0.0	NR	8e-12	11.096910013008056		1.054	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q13.2	11	67184494	NR	KDM2A			ENSG00000173120			rs12785905-C	rs12785905	0	12785905	intron_variant	0.0	NR	2e-10	9.69897000433602		1.123	[1.08-1.16]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q13.3	11	69115458	NR	TPCN2			ENSG00000162341			rs3018690-T	rs3018690	0	3018690	intron_variant	0.0	NR	8e-11	10.096910013008056		1.046	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q13.3	11	69213321	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		53569.0	80830.0	rs11825796-A	rs11825796	0	11825796	intergenic_variant	1.0	NR	5e-27	26.30102999566398		1.094	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q13.3	11	69234875	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		75123.0	59276.0	rs11228580-C	rs11228580	0	11228580	intergenic_variant	1.0	NR	5.000000000000001e-125	124.30102999566398		1.27	[1.25-1.29]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q13.3	11	69648505	NR	CCND1			ENSG00000110092			rs3918298-A	rs3918298	0	3918298	intron_variant	0.0	NR	1e-18	18.0		1.135	[1.10-1.17]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q13.5	11	76556287	NR	EMSY - LINC02757	ENSG00000158636	ENSG00000255363		3262.0	51566.0	rs56159348-T	rs56159348	0	56159348	intergenic_variant	1.0	NR	4e-14	13.397940008672036		1.057	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q22.2	11	102530930	NR	MMP7 - MMP20	ENSG00000137673	ENSG00000137674		180.0	45902.0	rs11568818-T	rs11568818	0	11568818	upstream_gene_variant	1.0	NR	3.9999999999999996e-26	25.39794000867204		1.076	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q22.3	11	108486410	NR	POGLUT3			ENSG00000178202			rs74911261-A	rs74911261	0	74911261	missense_variant	0.0	NR	8e-09	8.096910013008056		1.153	[1.10-1.21]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q23.2	11	113829825	NR	USP28			ENSG00000048028			rs5794883-C	rs5794883	0	5794883	intron_variant	0.0	NR	3e-18	17.522878745280337		1.069	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q24.2	11	125184897	NR	PKNOX2			ENSG00000165495			rs138466039-T	rs138466039	0	138466039	intron_variant	0.0	NR	2e-11	10.69897000433602		1.324	[1.22-1.44]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127062570	NR	PCAT1			ENSG00000253438			rs72725854-T	rs72725854	0	72725854	intron_variant	0.0	NR	4.0000000000000004e-82	81.39794000867204		2.087	[1.94-2.25]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127064901	NR	PCAT1			ENSG00000253438			rs77541621-A	rs77541621	0	77541621	non_coding_transcript_exon_variant	0.0	NR	5e-147	146.30102999566398		1.892	[1.80-1.99]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127091724	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0.0	NR	1e-90	90.0		1.295	[1.26-1.33]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127091872	NR	PRNCR1, CASC19, PCAT1			ENSG00000282961, ENSG00000254166, ENSG00000253438			rs183373024-G	rs183373024	0	183373024	non_coding_transcript_exon_variant	0.0	NR	1e-80	80.0		2.269	[2.09-2.47]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127091973	NR	PRNCR1, CASC19, PCAT1			ENSG00000282961, ENSG00000254166, ENSG00000253438			rs78809737-G	rs78809737	0	78809737	non_coding_transcript_exon_variant	0.0	NR	3e-09	8.522878745280337		1.084	[1.06-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127330621	NR	PCAT1, CASC8, POU5F1B			ENSG00000253438, ENSG00000246228, ENSG00000212993			rs17464492-A	rs17464492	0	17464492	intron_variant	0.0	NR	4e-48	47.39794000867204		1.118	[1.10-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	NR	1e-113	113.0		1.171	[1.16-1.19]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127519892	NR	CASC8 - NA	ENSG00000246228			37753.0		rs10090154-T	rs10090154	0	10090154	intergenic_variant	1.0	NR	3e-15	14.522878745280336		1.347	[1.25-1.45]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127523298	NR	CASC8 - NA	ENSG00000246228			41159.0		rs34265760-T	rs34265760	0	34265760	intergenic_variant	1.0	NR	3e-10	9.522878745280336		1.117	[1.08-1.16]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127528531	NR	CASC8 - NA	ENSG00000246228			46392.0		rs12549761-C	rs12549761	0	12549761	intergenic_variant	1.0	NR	2.0000000000000003e-49	48.69897000433602		1.176	[1.15-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9p22.1	9	18554775	NR	ADAMTSL1			ENSG00000178031			rs34540271-C	rs34540271	0	34540271	intron_variant	0.0	NR	5e-11	10.30102999566398		1.051	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9p22.1	9	19072248	NR	HAUS6			ENSG00000147874			rs10122990-C	rs10122990	0	10122990	intron_variant	0.0	NR	5e-15	14.30102999566398		1.055	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9p21.3	9	22041999	NR	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0.0	NR	1e-12	12.0		1.074	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9p13.3	9	34049781	NR	UBAP2 - RN7SKP114	ENSG00000137073	ENSG00000222259		393.0	185.0	rs10122495-T	rs10122495	0	10122495	TF_binding_site_variant	1.0	NR	3e-11	10.522878745280336		1.051	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9q21.31	9	79475809	NR	CHCHD2P9 - LNCARSR	ENSG00000186940	ENSG00000233086		84050.0	29995.0	rs142727307-T	rs142727307	0	142727307	intergenic_variant	1.0	NR	1e-12	12.0		1.076	[1.05-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9q31.2	9	106770453	NR	LINC01505 - RNA5SP292	ENSG00000234323	ENSG00000212276		29578.0	73296.0	rs4451364-A	rs4451364	0	4451364	intergenic_variant	1.0	NR	3e-10	9.522878745280336		1.052	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9q31.2	9	107382606	NR	RAD23B - LINC01509	ENSG00000119318	ENSG00000226825		50414.0	37585.0	rs817872-C	rs817872	0	817872	intergenic_variant	1.0	NR	5e-22	21.30102999566398		1.071	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9q31.2	9	107527936	NR	KLF4 - PPIAP88	ENSG00000136826	ENSG00000227350		37454.0	15215.0	rs143655302-G	rs143655302	0	143655302	intergenic_variant	1.0	NR	4e-19	18.39794000867204		1.304	[1.23-1.38]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9q34.11	9	127667837	NR	STXBP1			ENSG00000136854			rs2241167-A	rs2241167	0	2241167	intron_variant	0.0	NR	1e-08	8.0		1.038	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		9q34.11	9	129811257	NR	TOR1B			ENSG00000136816			rs12634-T	rs12634	0	12634	3_prime_UTR_variant	0.0	NR	4e-14	13.397940008672036		1.058	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10p15.3	10	792696	NR	NA - LARP4B		ENSG00000107929			14218.0	rs12781100-T	rs12781100	0	12781100	intergenic_variant	1.0	NR	3e-14	13.522878745280336		1.079	[1.06-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q11.22	10	45609495	NR	MARCHF8 - ZFAND4	ENSG00000278545	ENSG00000172671		14589.0	6005.0	rs7075427-A	rs7075427	0	7075427	intergenic_variant	1.0	NR	2e-16	15.69897000433602		1.12	[1.09-1.15]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q11.22	10	46227793	NR	AGAP7P - ANTXRLP1	ENSG00000264204	ENSG00000263482		96435.0	6092.0	rs11599847-T	rs11599847	0	11599847	intergenic_variant	1.0	NR	2e-08	7.698970004336019		1.115	[1.07-1.16]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	NR	8.999999999999999e-192	191.04575749056067		1.212	[1.20-1.23]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		10q22.3	10	78477242	NR	LINC00856						rs11817544-C	rs11817544	0	11817544	intron_variant	0.0	NR	5e-15	14.30102999566398		1.09	[1.07-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	9q31.2	9	107527936	NR	KLF4 - PPIAP88	ENSG00000136826	ENSG00000227350		37454.0	15215.0	rs143655302-G	rs143655302	0	143655302	intergenic_variant	1.0	0.980677359	5e-06	5.301029995663981		1.3767446	[1.20-1.58]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.392245792	4e-40	39.39794000867204		1.2533711	[1.21-1.30]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	10q26.13	10	125008925	NR	CTBP2			ENSG00000175029			rs12769682-C	rs12769682	0	12769682	intron_variant	0.0	0.288620584	4e-06	5.3979400086720375		1.0890925	[1.05-1.13]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	11p15.5	11	2212863	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39725.0	55635.0	rs11043143-T	rs11043143	0	11043143	intergenic_variant	1.0	0.187987013	3e-22	21.522878745280337		1.2215796	[1.17-1.27]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	11q13.3	11	69234875	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		75123.0	59276.0	rs11228580-C	rs11228580	0	11228580	intergenic_variant	1.0	0.171570634	1.9999999999999998e-25	24.69897000433602		1.2797145	[1.22-1.34]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	11q13.3	11	69648505	NR	CCND1			ENSG00000110092			rs3918298-A	rs3918298	0	3918298	intron_variant	0.0	0.026780405	8e-07	6.096910013008056		1.2702144	[1.16-1.40]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	12q13.13	12	52915148	NR	KRT8			ENSG00000170421			rs113925811-A	rs113925811	0	113925811	intron_variant	0.0	0.113283674	3e-12	11.522878745280336		1.1950083	[1.14-1.26]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	12q21.33	12	89762600	NR	RNU6-148P - NA	ENSG00000252823			8448.0		rs4842687-A	rs4842687	0	4842687	intron_variant	1.0	0.721672562	3e-06	5.522878745280337		1.0933417	[1.05-1.14]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	13q22.1	13	73421740	NR	LINC00393			ENSG00000224853			rs7336001-G	rs7336001	0	7336001	intron_variant	0.0	0.907376215	2e-06	5.698970004336019		1.1640729	[1.09-1.24]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	14q22.1	14	52920391	NR	FERMT2			ENSG00000073712			rs4901313-G	rs4901313	0	4901313	intron_variant	0.0	0.812484485	1e-07	7.0		1.1266177	[1.08-1.18]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17p13.3	17	715725	NR	VPS53, VPS53			ENSG00000141252, ENSG00000283883			rs684232-C	rs684232	0	684232	intron_variant	0.0	0.355297324	4e-09	8.397940008672037		1.1085898	[1.07-1.15]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17p13.1	17	7899800	NR	CHD3			ENSG00000170004			rs28441558-C	rs28441558	0	28441558	intron_variant	0.0	0.060035581	1e-07	7.0		1.1934913	[1.12-1.27]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17p12	17	12682142	NR	MYOCD, MYOCD-AS1			ENSG00000141052, ENSG00000227274			rs72811270-A	rs72811270	0	72811270	intron_variant	0.0	0.122314123	8e-06	5.096910013008056		1.1195085	[1.07-1.18]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0.0	0.813803076	9e-08	7.045757490560675		1.1311437	[1.08-1.18]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17q12	17	37743574	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263763-A	rs11263763	0	11263763	intron_variant	0.0	0.522688339	5e-33	32.30102999566398		1.2302762	[1.19-1.27]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17q21.32	17	48728343	NR	HOXB13			ENSG00000159184			rs138213197-T	rs138213197	0	138213197	missense_variant	0.0	0.001743436	2e-36	35.69897000433602		4.484751	[3.55-5.66]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	17q24.3	17	71121392	NR	CASC17			ENSG00000260785			rs148511027-G	rs148511027	1	66883347	intron_variant	0.0	0.459755254	4e-20	19.39794000867204		1.1691511	[1.13-1.21]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	19q13.2	19	38247490	NR	SPINT2			ENSG00000167642			rs4802297-G	rs4802297	0	4802297	intron_variant	0.0	0.484588494	1e-11	11.0		1.1218854	[1.09-1.16]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	19q13.33	19	50842312	NR	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		5099.0	12603.0	rs2659051-G	rs2659051	0	2659051	intron_variant	1.0	0.790271854	2e-08	7.698970004336019		1.1417319	[1.09-1.20]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	19q13.33	19	50859459	NR	KLK3			ENSG00000142515			rs76765083-T	rs76765083	0	76765083	intron_variant	0.0	0.926448239	2e-20	19.69897000433602		1.4557381	[1.34-1.58]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	20q13.2	20	53848180	NR	NA - SUMO1P1		ENSG00000241721			27072.0	rs6126986-C	rs6126986	0	6126986	intergenic_variant	1.0	0.49267198	9e-06	5.045757490560675		1.0787308	[1.04-1.12]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	20q13.33	20	63676164	NR	RTEL1-TNFRSF6B, RTEL1			ENSG00000026036, ENSG00000258366			rs3787099-A	rs3787099	0	3787099	intron_variant	0.0	0.921220997	3e-06	5.522878745280337		1.1690993	[1.10-1.25]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	20q13.33	20	63743036	NR	SLC2A4RG			ENSG00000125520			rs1058319-C	rs1058319	0	1058319	3_prime_UTR_variant	0.0	0.863990161	3e-06	5.522878745280337		1.1354545	[1.08-1.20]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	21q22.3	21	41510535	NR	TMPRSS2			ENSG00000184012			rs9978557-C	rs9978557	0	9978557	intron_variant	0.0	0.905108994	5e-09	8.301029995663981		1.1990082	[1.13-1.27]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	0.50244081	2e-13	12.69897000433602		1.1383158	[1.10-1.18]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	Xp22.2	X	9843055	NR	SHROOM2			ENSG00000146950			rs960417-A	rs960417	0	960417	intron_variant	0.0	0.734063666	3e-07	6.522878745280337		1.0747885	[1.05-1.10]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	Xp21.2	X	30878203	NR	TAB3			ENSG00000157625			rs5972255-T	rs5972255	0	5972255	intron_variant	0.0	0.241454521	2e-06	5.698970004336019		1.06779	[1.04-1.10]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	Xp11.22	X	51502425	NR	LINC01496			ENSG00000234766			rs11338635-GA	rs11338635	0	11338635	intron_variant	0.0	0.3676828	1e-09	9.0		1.083639	[1.06-1.11]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		2p15	2	63050708	NR	OTX1			ENSG00000115507			rs58235267-G	rs58235267	0	58235267	intron_variant	0.0	0.447	3e-08	7.522878745280337		1.122	[1.08-1.17]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		2q37.3	2	237502650	NR	MLPH			ENSG00000115648			rs74001374-C	rs74001374	0	74001374	intron_variant	0.0	0.714	4e-09	8.397940008672037		1.147	[1.10-1.20]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		5p15.33	5	1891060	NR	CTD-2194D22.4			ENSG00000249326			rs4975758-G	rs4975758	0	4975758	intron_variant	0.0	0.318	2e-07	6.698970004336019		1.121	[1.07-1.17]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		6p21.1	6	41568849	NR	FOXP4			ENSG00000137166			rs4714485-G	rs4714485	0	4714485	intron_variant	0.0	0.47	8e-07	6.096910013008056		1.106	[1.06-1.15]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		6q14.1	6	75786165	NR	MYO6			ENSG00000196586			rs9443189-A	rs9443189	0	9443189	intron_variant	0.0	0.473	2e-06	5.698970004336019		1.105	[1.06-1.15]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		6q22.1	6	116879271	NR	RFX6			ENSG00000185002			rs339351-C	rs339351	0	339351	intron_variant	0.0	0.741	9e-17	16.045757490560675		1.218	[1.16-1.28]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		6q25.3	6	160160512	NR	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1794.0	10549.0	rs4646284-TG	rs4646284	0	4646284	downstream_gene_variant	1.0	0.365	3e-08	7.522878745280337		1.13	[1.08-1.18]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		8p21.2	8	23672008	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		36501.0	6689.0	rs1160267-G	rs1160267	0	1160267	intergenic_variant	1.0	0.704	1e-12	12.0		1.177	[1.13-1.23]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		8q24.21	8	127015709	NR	PCAT1			ENSG00000253438			rs7463326-G	rs7463326	0	7463326	intron_variant	0.0	0.84	5e-15	14.30102999566398		1.274	[1.20-1.35]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		8q24.21	8	127062570	NR	PCAT1			ENSG00000253438			rs72725854-T	rs72725854	0	72725854	intron_variant	0.0	0.061	4.0000000000000004e-82	81.39794000867204		2.087	[1.94-2.25]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		8q24.21	8	127091724	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0.0	0.341	6e-29	28.22184874961636		1.308	[1.25-1.37]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.614	4e-07	6.3979400086720375		1.112	[1.07-1.16]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		11p15.5	11	2212863	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39725.0	55635.0	rs11043143-T	rs11043143	0	11043143	intergenic_variant	1.0	0.289	2e-06	5.698970004336019		1.11	[1.06-1.16]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		11q13.3	11	69234875	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		75123.0	59276.0	rs11228580-C	rs11228580	0	11228580	intergenic_variant	1.0	0.158	4.0000000000000004e-24	23.39794000867204		1.31	[1.24-1.38]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		12q13.13	12	52915148	NR	KRT8			ENSG00000170421			rs113925811-A	rs113925811	0	113925811	intron_variant	0.0	0.153	5e-09	8.301029995663981		1.174	[1.11-1.24]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		13q34	13	109708437	NR	NA - LINC00676		ENSG00000234854			19845.0	rs75823044-T	rs75823044	0	75823044	intron_variant	1.0	0.021	2e-11	10.69897000433602		1.53	[1.35-1.73]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		17q12	17	37743574	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263763-A	rs11263763	0	11263763	intron_variant	0.0	0.612	2e-06	5.698970004336019		1.109	[1.06-1.16]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		17q21.33	17	49320883	NR	ZNF652			ENSG00000198740			rs565189650-T	rs565189650	0	565189650	intron_variant	0.0	0.087	8e-06	5.096910013008056		1.174	[1.09-1.26]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		22q12.1	22	28695159	NR	CHEK2			ENSG00000183765			rs17886163-C	rs17886163	0	17886163	missense_variant	0.0	0.015	1e-09	9.0		1.594	[1.37-1.85]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	10,368 African ancestry cases, 10,986 African ancestry controls		Xp11.22	X	51502425	NR	LINC01496			ENSG00000234766			rs11338635-GA	rs11338635	0	11338635	intron_variant	0.0	0.349	3e-08	7.522878745280337		1.087	[1.06-1.12]	Affymetrix, Illumina [18877980] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		1q23.1	1	157150123	NR	ETV3 - NA	ENSG00000117036			11649.0		rs80237341-C	rs80237341	0	80237341	intergenic_variant	1.0	0.103	2e-07	6.698970004336019		1.165	[1.10-1.23]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2p24.3	2	15876379	NR	RPLP1P5 - MYCNOS	ENSG00000214657	ENSG00000233718		6136.0	41971.0	rs7602028-C	rs7602028	0	7602028	intergenic_variant	1.0	0.398	6e-07	6.221848749616356		1.103	[1.06-1.15]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	127519892	NR	CASC8 - NA	ENSG00000246228			37753.0		rs10090154-T	rs10090154	0	10090154	intergenic_variant	1.0	0.154	4e-06	5.3979400086720375		1.612	[1.32-1.97]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	127523298	NR	CASC8 - NA	ENSG00000246228			41159.0		rs34265760-T	rs34265760	0	34265760	intergenic_variant	1.0	0.906	8e-09	8.096910013008056		1.215	[1.14-1.30]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.47	1e-18	18.0		1.181	[1.14-1.23]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		10q22.3	10	78477242	NR	LINC00856						rs11817544-C	rs11817544	0	11817544	intron_variant	0.0	0.793	2e-12	11.69897000433602		1.165	[1.12-1.22]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		10q22.3	10	79076241	NR	ZMIZ1			ENSG00000108175			rs12412705-C	rs12412705	0	12412705	intron_variant	0.0	0.343	7e-10	9.154901959985745		1.114	[1.08-1.15]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		10q26.12	10	121074969	NR	NA - RPL19P16		ENSG00000236762			58121.0	rs140783917-C	rs140783917	0	140783917	intergenic_variant	1.0	0.849	4e-14	13.397940008672036		1.218	[1.16-1.28]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		10q26.13	10	121425789	NR	RN7SKP167 - FGFR2	ENSG00000222979	ENSG00000066468		14589.0	52543.0	rs10749415-A	rs10749415	0	10749415	intergenic_variant	1.0	0.978	9e-06	5.045757490560675		1.281	[1.15-1.43]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		11p15.4	11	7526356	NR	PPFIBP2			ENSG00000166387			rs61890184-A	rs61890184	0	61890184	intron_variant	0.0	0.13	8e-07	6.096910013008056		1.149	[1.09-1.21]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		11q12.1	11	59135206	NR	FAM111A-DT			ENSG00000245571			rs1048374-G	rs1048374	0	1048374	non_coding_transcript_exon_variant	0.0	0.177	6e-09	8.221848749616356		1.151	[1.10-1.21]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		12p13.1	12	12725049	NR	CDKN1B - APOLD1	ENSG00000111276	ENSG00000178878		2680.0	868.0	rs77216612-A	rs77216612	0	77216612	upstream_gene_variant	1.0	0.579	2e-08	7.698970004336019		1.103	[1.07-1.14]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		12q13.13	12	52935447	NR	KRT8			ENSG00000170421			rs187809440-T	rs187809440	0	187809440	intron_variant	0.0	0.03	1e-12	12.0		1.355	[1.25-1.47]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		12q21.33	12	89762600	NR	RNU6-148P - NA	ENSG00000252823			8448.0		rs4842687-A	rs4842687	0	4842687	intron_variant	1.0	0.789	2e-06	5.698970004336019		1.12	[1.07-1.17]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		13q22.1	13	73142724	NR	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		29706.0	48804.0	rs7489409-C	rs7489409	0	7489409	intergenic_variant	1.0	0.401	9e-14	13.045757490560677		1.144	[1.10-1.19]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		14q23.2	14	64221208	NR	ESR2, SYNE2			ENSG00000140009, ENSG00000054654			rs79133931-T	rs79133931	0	79133931	intron_variant	0.0	0.088	1e-06	6.0		1.195	[1.11-1.28]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		15q22.31	15	66649755	NR	LINC01169			ENSG00000259471			rs8023793-A	rs8023793	0	8023793	intron_variant	0.0	0.608	1e-09	9.0		1.116	[1.08-1.16]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0.0	0.693	9e-13	12.045757490560677		1.15	[1.11-1.20]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		17q12	17	37743574	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263763-A	rs11263763	0	11263763	intron_variant	0.0	0.713	1e-38	38.0		1.31	[1.26-1.36]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		19q13.33	19	50842312	NR	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		5099.0	12603.0	rs2659051-G	rs2659051	0	2659051	intron_variant	1.0	0.621	3e-13	12.522878745280336		1.144	[1.10-1.19]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		20q13.13	20	50932270	NR	ADNP-AS1			ENSG00000259456			rs73909841-T	rs73909841	0	73909841	intron_variant	0.0	0.925	9e-06	5.045757490560675		1.202	[1.11-1.30]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		20q13.33	20	63743036	NR	SLC2A4RG			ENSG00000125520			rs1058319-C	rs1058319	0	1058319	3_prime_UTR_variant	0.0	0.425	4e-09	8.397940008672037		1.114	[1.07-1.15]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		22q13.1	22	38742327	NR	SUN2			ENSG00000100242			rs138708-G	rs138708	0	138708	missense_variant	0.0	0.867	5e-09	8.301029995663981		1.175	[1.11-1.24]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	2,714 Hispanic cases, 5,239 Hispanic controls		3q26.2	3	170356729	NR	PRKCI - SKIL	ENSG00000163558	ENSG00000136603		50752.0	949.0	rs78416326-G	rs78416326	0	78416326	upstream_gene_variant	1.0	0.765	2e-09	8.698970004336019		1.275	[1.18-1.38]	Affymetrix, Illumina [11334207] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	2,714 Hispanic cases, 5,239 Hispanic controls		8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.603	2e-06	5.698970004336019		1.21	[1.12-1.31]	Affymetrix, Illumina [11334207] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	2,714 Hispanic cases, 5,239 Hispanic controls		10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.349	1e-10	10.0		1.291	[1.19-1.39]	Affymetrix, Illumina [11334207] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	2,714 Hispanic cases, 5,239 Hispanic controls		11q13.3	11	69648505	NR	CCND1			ENSG00000110092			rs3918298-A	rs3918298	0	3918298	intron_variant	0.0	0.041	1e-06	6.0		1.377	[1.21-1.57]	Affymetrix, Illumina [11334207] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p21	2	43624143	NR	Y_RNA - PLEKHH2	ENSG00000264495	ENSG00000152527		3159.0	13117.0	rs28514770-C	rs28514770	0	28514770	intergenic_variant	1.0	NR	3e-09	8.522878745280337		1.047	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p15	2	62525840	NR	TMEM17 - RPL21P37	ENSG00000186889	ENSG00000229503		13946.0	6743.0	rs11125927-G	rs11125927	0	11125927	regulatory_region_variant	1.0	NR	6e-20	19.22184874961636		1.088	[1.07-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p15	2	63050708	NR	OTX1			ENSG00000115507			rs58235267-G	rs58235267	0	58235267	intron_variant	0.0	NR	6.999999999999999e-62	61.15490195998574		1.119	[1.10-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p15	2	63711622	NR	WDPCP			ENSG00000143951			rs139283528-G	rs139283528	0	139283528	intron_variant	0.0	NR	2e-13	12.69897000433602		1.276	[1.20-1.36]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p14	2	66425753	NR	LINC01873 - MEIS1-AS3	ENSG00000232164	ENSG00000226819		33303.0	982.0	rs74702681-T	rs74702681	0	74702681	intergenic_variant	1.0	NR	1e-10	10.0		1.172	[1.12-1.23]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p11.2	2	85540612	NR	MAT2A			ENSG00000168906			rs2028900-C	rs2028900	0	2028900	intron_variant	0.0	NR	3e-38	37.52287874528034		1.089	[1.07-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q13	2	111104416	NR	ACOXL, ACOXL-AS1, MIR4435-2HG			ENSG00000153093, ENSG00000204581, ENSG00000172965			rs2165108-A	rs2165108	0	2165108	intron_variant	0.0	NR	3e-10	9.522878745280336		1.08	[1.05-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q13	2	111135519	NR	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs11691517-T	rs11691517	0	11691517	intron_variant	0.0	NR	1e-11	11.0		1.054	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q14.2	2	120346022	NR	RALB - INHBB	ENSG00000144118	ENSG00000163083		51312.0	114.0	rs111595856-T	rs111595856	0	111595856	regulatory_region_variant	1.0	NR	2e-15	14.69897000433602		1.084	[1.06-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q14.2	2	120615890	NR	NA - Y_RNA		ENSG00000264495			35383.0	rs10206072-G	rs10206072	0	10206072	intergenic_variant	1.0	NR	4e-09	8.397940008672037		1.057	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q24.3	2	168156445	NR	STK39			ENSG00000198648			rs16854905-C	rs16854905	0	16854905	intron_variant	0.0	NR	5e-09	8.301029995663981		1.058	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q31.1	2	172455202	NR	ITGA6			ENSG00000091409			rs77167534-C	rs77167534	0	77167534	intron_variant	0.0	NR	1e-55	55.0		1.235	[1.20-1.27]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q31.1	2	173369819	NR	CDCA7 - JPT1P1	ENSG00000144354	ENSG00000213148		822.0	61530.0	rs34925593-C	rs34925593	0	34925593	intergenic_variant	1.0	NR	2e-14	13.69897000433602		1.054	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q33.1	2	201261892	NR	CASP8			ENSG00000064012			rs1861270-G	rs1861270	0	1861270	intron_variant	0.0	NR	5e-11	10.30102999566398		1.049	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q33.3	2	207253577	NR	MYOSLID - LINC01802	ENSG00000229647	ENSG00000225064		4909.0	6868.0	rs12621900-C	rs12621900	0	12621900	intron_variant	1.0	NR	2e-09	8.698970004336019		1.048	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q37.3	2	237502650	NR	MLPH			ENSG00000115648			rs74001374-C	rs74001374	0	74001374	intron_variant	0.0	NR	3e-11	10.522878745280336		1.131	[1.09-1.17]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q37.3	2	237534583	NR	MLPH			ENSG00000115648			rs2292884-G	rs2292884	0	2292884	missense_variant	0.0	NR	6e-16	15.221848749616356		1.063	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q37.3	2	241195850	NR	ANO7			ENSG00000146205			rs77559646-A	rs77559646	0	77559646	missense_variant	0.0	NR	1e-27	27.0		1.328	[1.26-1.40]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q37.3	2	241200185	NR	ANO7			ENSG00000146205			rs77482050-G	rs77482050	0	77482050	stop_gained	0.0	NR	7e-18	17.154901959985743		1.432	[1.32-1.55]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q37.3	2	241202304	NR	ANO7			ENSG00000146205			rs2074840-C	rs2074840	0	2074840	splice_region_variant	0.0	NR	1e-11	11.0		1.05	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2q37.3	2	241217826	NR	ANO7			ENSG00000146205			rs76832527-A	rs76832527	0	76832527	missense_variant	0.0	NR	7e-28	27.154901959985743		1.108	[1.09-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p24.3	3	18697448	NR	SATB1-AS1			ENSG00000228956			rs6550597-A	rs6550597	0	6550597	intron_variant	0.0	NR	8e-10	9.096910013008056		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p24.3	3	23111571	NR	NA - RPL24P7		ENSG00000215016			22801.0	rs7618603-A	rs7618603	0	7618603	regulatory_region_variant	1.0	NR	4e-12	11.397940008672036		1.06	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p21.31	3	49584286	NR	BSN			ENSG00000164061			rs34680713-A	rs34680713	0	34680713	intron_variant	0.0	NR	2e-10	9.69897000433602		1.061	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		3p13	3	70747545	NR	NA - COX6CP6		ENSG00000240156			3578.0	rs13091518-T	rs13091518	0	13091518	intergenic_variant	1.0	NR	3e-08	7.522878745280337		1.039	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p15.33	5	1293971	NR	TERT			ENSG00000164362			rs2736098-T	rs2736098	0	2736098	synonymous_variant	0.0	NR	3e-18	17.522878745280337		1.072	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p15.33	5	1891060	NR	CTD-2194D22.4			ENSG00000249326			rs4975758-G	rs4975758	0	4975758	intron_variant	0.0	NR	2e-48	47.69897000433602		1.101	[1.09-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p15.2	5	14372254	NR	TRIO			ENSG00000038382			rs71599622-T	rs71599622	0	71599622	intron_variant	0.0	NR	4e-08	7.397940008672037		1.047	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p13.2	5	37833317	NR	GDNF-AS1, GDNF			ENSG00000248587, ENSG00000168621			rs10941370-T	rs10941370	0	10941370	intron_variant	0.0	NR	4e-08	7.397940008672037		1.037	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5p12	5	44368404	NR	FGF10			ENSG00000070193			rs1482675-T	rs1482675	0	1482675	intron_variant	0.0	NR	4e-07	6.3979400086720375		1.036	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5q11.2	5	56792083	NR	NA - MAP3K1		ENSG00000095015			23466.0	rs9292122-A	rs9292122	0	9292122	intergenic_variant	1.0	NR	5e-09	8.301029995663981		1.043	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5q31.1	5	134500518	NR	RNU6-456P - LINC01843	ENSG00000207222	ENSG00000251169		234.0	6034.0	rs10793821-T	rs10793821	0	10793821	upstream_gene_variant	1.0	NR	3e-17	16.522878745280337		1.058	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5q35.1	5	169745129	NR	DOCK2			ENSG00000134516			rs76551843-A	rs76551843	0	76551843	intron_variant	0.0	NR	2e-08	7.698970004336019		1.311	[1.19-1.44]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5q35.2	5	173532027	NR	NA - BOD1		ENSG00000145919			75118.0	rs9686557-C	rs9686557	0	9686557	regulatory_region_variant	1.0	NR	4e-07	6.3979400086720375		1.035	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5q35.3	5	178256904	NR	COL23A1			ENSG00000050767			rs61739424-G	rs61739424	0	61739424	missense_variant	0.0	NR	1e-09	9.0		1.105	[1.07-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		5q35.3	5	178464550	NR	COL23A1			ENSG00000050767			rs2672843-G	rs2672843	0	2672843	intron_variant	0.0	NR	3e-11	10.522878745280336		1.048	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p25.3	6	1670751	NR	GMDS			ENSG00000112699			rs2814811-A	rs2814811	0	2814811	intron_variant	0.0	NR	2e-09	8.698970004336019		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p24.2	6	11217664	NR	NEDD9			ENSG00000111859			rs2018336-T	rs2018336	0	2018336	intron_variant	0.0	NR	4e-13	12.397940008672036		1.064	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p22.3	6	21330458	NR	CDKAL1 - NA	ENSG00000145996			98054.0		rs6927369-C	rs6927369	0	6927369	intergenic_variant	1.0	NR	2e-16	15.69897000433602		1.067	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p22.3	6	21471259	NR	NA - LINC00581		ENSG00000280989			14637.0	rs4269363-G	rs4269363	0	4269363	intergenic_variant	1.0	NR	3e-10	9.522878745280336		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p22.3	6	21878618	NR	CASC15			ENSG00000272168			rs12665509-A	rs12665509	0	12665509	intron_variant	0.0	NR	3e-09	8.522878745280337		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p22.2	6	26649603	NR	ZNF322			ENSG00000181315			rs35159226-C	rs35159226	0	35159226	intron_variant	0.0	NR	4e-08	7.397940008672037		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p21.32	6	32684843	NR	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		16460.0	21281.0	rs9275160-A	rs9275160	0	9275160	regulatory_region_variant	1.0	NR	9e-08	7.045757490560675		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p21.31	6	34825347	NR	UHRF1BP1			ENSG00000065060			rs9469899-A	rs9469899	0	9469899	intron_variant	0.0	NR	8e-11	10.096910013008056		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p21.1	6	41568849	NR	FOXP4			ENSG00000137166			rs4714485-G	rs4714485	0	4714485	intron_variant	0.0	NR	2e-41	40.69897000433602		1.099	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6p21.1	6	43742048	NR	MRPS18A - VEGFA	ENSG00000096080	ENSG00000112715		54257.0	28136.0	rs9472120-C	rs9472120	0	9472120	intergenic_variant	1.0	NR	3e-09	8.522878745280337		1.039	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q14.1	6	75786165	NR	MYO6			ENSG00000196586			rs9443189-A	rs9443189	0	9443189	intron_variant	0.0	NR	3e-17	16.522878745280337		1.075	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q21	6	108974090	NR	ARMC2			ENSG00000118690			rs2038542-C	rs2038542	0	2038542	3_prime_UTR_variant	0.0	NR	6e-13	12.221848749616356		1.067	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q22.1	6	116879271	NR	RFX6			ENSG00000185002			rs339351-C	rs339351	0	339351	intron_variant	0.0	NR	3e-53	52.52287874528034		1.116	[1.10-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q23.2	6	133971580	NR	TBPL1			ENSG00000028839			rs150184171-G	rs150184171	0	150184171	intron_variant	0.0	NR	8e-10	9.096910013008056		1.047	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		11q25	11	134396478	NR	B3GAT1			ENSG00000109956			rs878987-G	rs878987	0	878987	intron_variant	0.0	NR	4e-11	10.397940008672036		1.066	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12p13.1	12	12718165	NR	CDKN1B			ENSG00000111276			rs2066827-T	rs2066827	0	2066827	missense_variant	0.0	NR	3e-10	9.522878745280336		1.055	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12p13.1	12	12725049	NR	CDKN1B - APOLD1	ENSG00000111276	ENSG00000178878		2680.0	868.0	rs77216612-A	rs77216612	0	77216612	upstream_gene_variant	1.0	NR	2e-07	6.698970004336019		1.038	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12p13.1	12	14263984	NR	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758.0	92858.0	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1.0	NR	9e-17	16.045757490560675		1.057	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q13.11	12	48025835	NR	COL2A1 - SENP1	ENSG00000139219	ENSG00000079387		21281.0	17062.0	rs80130819-A	rs80130819	0	80130819	regulatory_region_variant	1.0	NR	4e-12	11.397940008672036		1.095	[1.07-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q13.12	12	49278931	NR	TUBA1C - PRPH	ENSG00000167553	ENSG00000135406		4331.0	14321.0	rs56222401-G	rs56222401	0	56222401	regulatory_region_variant	1.0	NR	6e-24	23.22184874961636		1.078	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q13.13	12	52915148	NR	KRT8			ENSG00000170421			rs113925811-A	rs113925811	0	113925811	intron_variant	0.0	NR	5.0000000000000005e-58	57.30102999566398		1.178	[1.15-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q13.13	12	52935447	NR	KRT8			ENSG00000170421			rs187809440-T	rs187809440	0	187809440	intron_variant	0.0	NR	2e-12	11.69897000433602		1.342	[1.24-1.46]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q14.2	12	64619044	NR	RASSF3			ENSG00000153179			rs7968403-T	rs7968403	0	7968403	intron_variant	0.0	NR	6e-15	14.221848749616356		1.058	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q21.33	12	89762600	NR	RNU6-148P - NA	ENSG00000252823			8448.0		rs4842687-A	rs4842687	0	4842687	intron_variant	1.0	NR	2e-17	16.69897000433602		1.064	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q23.2	12	102052897	NR	WASHC3			ENSG00000120860			rs77121786-G	rs77121786	0	77121786	intron_variant	0.0	NR	1e-08	8.0		1.048	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q24.21	12	114247766	NR	LINC02459 - NA	ENSG00000257476			5996.0		rs1270884-A	rs1270884	0	1270884	intergenic_variant	1.0	NR	6e-25	24.22184874961636		1.072	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		12q24.33	12	132491403	NR	FBRSL1			ENSG00000112787			rs7295014-G	rs7295014	0	7295014	intron_variant	0.0	NR	1e-14	14.0		1.055	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		13q14.3	13	50502304	NR	DLEU1			ENSG00000176124			rs1327653-T	rs1327653	0	1327653	intron_variant	0.0	NR	1e-08	8.0		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		13q22.1	13	73142724	NR	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		29706.0	48804.0	rs7489409-C	rs7489409	0	7489409	intergenic_variant	1.0	NR	4.0000000000000004e-24	23.39794000867204		1.086	[1.07-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		13q22.1	13	73421740	NR	LINC00393			ENSG00000224853			rs7336001-G	rs7336001	0	7336001	intron_variant	0.0	NR	2e-10	9.69897000433602		1.099	[1.07-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		13q34	13	109708437	NR	NA - LINC00676		ENSG00000234854			19845.0	rs75823044-T	rs75823044	0	75823044	intron_variant	1.0	NR	2e-11	10.69897000433602		1.525	[1.35-1.73]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q11.2	14	22836440	NR	MRPL52 - MMP14	ENSG00000172590	ENSG00000157227		1403.0	120.0	rs1004030-T	rs1004030	0	1004030	upstream_gene_variant	1.0	NR	1e-08	8.0		1.039	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q13.3	14	36666989	NR	PAX9			ENSG00000198807			rs6571758-G	rs6571758	0	6571758	intron_variant	0.0	NR	3e-19	18.522878745280337		1.063	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q21.1	14	37675387	NR	TTC6			ENSG00000139865			rs11849126-G	rs11849126	0	11849126	intron_variant	0.0	NR	2e-08	7.698970004336019		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q22.1	14	52920391	NR	FERMT2			ENSG00000073712			rs4901313-G	rs4901313	0	4901313	intron_variant	0.0	NR	1e-19	19.0		1.083	[1.06-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q23.1	14	60639981	NR	SALRNA1			ENSG00000258952			rs8005621-G	rs8005621	0	8005621	non_coding_transcript_exon_variant	0.0	NR	6e-12	11.221848749616356		1.071	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q24.1	14	68457191	NR	RAD51B			ENSG00000182185			rs2093202-A	rs2093202	0	2093202	intron_variant	0.0	NR	2e-09	8.698970004336019		1.041	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q24.1	14	68667547	NR	RAD51B			ENSG00000182185			rs767127-G	rs767127	0	767127	intron_variant	0.0	NR	5e-14	13.30102999566398		1.052	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		14q24.2	14	70289616	NR	ADAM21P1 - COX16	ENSG00000235812	ENSG00000133983		41815.0	35465.0	rs17565772-G	rs17565772	0	17565772	intron_variant	1.0	NR	6e-10	9.221848749616356		1.042	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		15q15.1	15	40672846	NR	KNL1 - RAD51-AS1	ENSG00000137812	ENSG00000245849		8504.0	13337.0	rs11561564-G	rs11561564	0	11561564	intergenic_variant	1.0	NR	1e-12	12.0		1.065	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		15q21.3	15	56093670	NR	RFX7			ENSG00000181827			rs33984059-A	rs33984059	0	33984059	missense_variant	0.0	NR	2e-09	8.698970004336019		1.19	[1.12-1.26]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		15q22.31	15	66543366	NR	ZWILCH			ENSG00000174442			rs74634457-G	rs74634457	0	74634457	intron_variant	0.0	NR	8e-10	9.096910013008056		1.05	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		15q22.31	15	66649755	NR	LINC01169			ENSG00000259471			rs8023793-A	rs8023793	0	8023793	intron_variant	0.0	NR	1e-06	6.0		1.031	[1.02-1.04]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		15q23	15	70376485	NR							rs12913603-A	rs12913603	0	12913603	intergenic_variant	1.0	NR	1e-08	8.0		1.039	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		16q12.2	16	54435419	NR	LINC02140 - NA	ENSG00000261803			64625.0		rs7188897-T	rs7188897	0	7188897	intergenic_variant	1.0	NR	2e-09	8.698970004336019		1.046	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		16q12.2	16	54644393	NR	LINC02183 - NA	ENSG00000283304			85293.0		rs13380763-C	rs13380763	0	13380763	intron_variant	1.0	NR	2e-09	8.698970004336019		1.056	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		16q21	16	57620664	NR	ADGRG1			ENSG00000205336			rs11863709-C	rs11863709	0	11863709	intron_variant	0.0	NR	3e-11	10.522878745280336		1.14	[1.10-1.19]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		16q23.2	16	79813735	NR	LINC01228			ENSG00000261082			rs28709974-C	rs28709974	0	28709974	intron_variant	0.0	NR	5e-09	8.301029995663981		1.09	[1.06-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		16q23.3	16	82132576	NR	MTCYBP28 - MPHOSPH6	ENSG00000260161	ENSG00000135698		10807.0	15222.0	rs8052913-C	rs8052913	0	8052913	intron_variant	1.0	NR	4e-10	9.397940008672036		1.042	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17p13.3	17	715725	NR	VPS53, VPS53			ENSG00000141252, ENSG00000283883			rs684232-C	rs684232	0	684232	intron_variant	0.0	NR	2e-33	32.69897000433602		1.084	[1.07-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17p13.1	17	7668434	NR	TP53			ENSG00000141510			rs78378222-G	rs78378222	0	78378222	3_prime_UTR_variant	0.0	NR	3e-11	10.522878745280336		1.262	[1.18-1.35]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17p13.1	17	7899800	NR	CHD3			ENSG00000170004			rs28441558-C	rs28441558	0	28441558	intron_variant	0.0	NR	2e-21	20.69897000433602		1.165	[1.13-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17p12	17	12682142	NR	MYOCD, MYOCD-AS1			ENSG00000141052, ENSG00000227274			rs72811270-A	rs72811270	0	72811270	intron_variant	0.0	NR	2e-08	7.698970004336019		1.057	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q11.2	17	31765879	NR	GPR160P2 - COPRS	ENSG00000265863	ENSG00000172301		4494.0	85992.0	rs4795646-G	rs4795646	0	4795646	intron_variant	1.0	NR	2e-11	10.69897000433602		1.057	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q12	17	37687414	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs3110641-A	rs3110641	0	3110641	intron_variant	0.0	NR	8e-14	13.096910013008056		1.056	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0.0	NR	9e-35	34.045757490560675		1.108	[1.09-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q12	17	37743574	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263763-A	rs11263763	0	11263763	intron_variant	0.0	NR	1e-183	183.0		1.214	[1.20-1.23]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q21.32	17	48728343	NR	HOXB13			ENSG00000159184			rs138213197-T	rs138213197	0	138213197	missense_variant	0.0	NR	1e-62	62.0		3.976	[3.38-4.68]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q21.33	17	49302943	NR	FLJ40194, ZNF652			ENSG00000177369, ENSG00000198740			rs2960158-T	rs2960158	0	2960158	intron_variant	0.0	NR	1e-08	8.0		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q21.33	17	49320883	NR	ZNF652			ENSG00000198740			rs565189650-T	rs565189650	0	565189650	intron_variant	0.0	NR	2e-14	13.69897000433602		1.107	[1.08-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q22	17	58348666	NR	TSPOAP1-AS1, SUPT4H1			ENSG00000265148, ENSG00000213246			rs12938538-T	rs12938538	0	12938538	intron_variant	0.0	NR	9e-09	8.045757490560675		1.038	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		17q24.3	17	71121392	NR	CASC17			ENSG00000260785			rs148511027-G	rs148511027	1	66883347	intron_variant	0.0	NR	1e-105	105.0		1.163	[1.15-1.18]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		18q21.2	18	54244952	NR	MBD2 - POLI	ENSG00000134046	ENSG00000101751		20283.0	24565.0	rs8089411-C	rs8089411	0	8089411	intergenic_variant	1.0	NR	7e-10	9.154901959985745		1.043	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		18q21.32	18	59078767	NR	OACYLP - SEC11C	ENSG00000224367	ENSG00000166562		9429.0	61099.0	rs35283980-G	rs35283980	0	35283980	intergenic_variant	1.0	NR	1e-08	8.0		1.041	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2p24.1	2	20678345	NR	GDF7			ENSG00000143869			rs9306894-G	rs9306894	0	9306894	3_prime_UTR_variant	0.0	0.515	1e-10	10.0		1.134	[1.09-1.18]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2p21	2	43410859	NR	THADA			ENSG00000115970			rs7591218-A	rs7591218	0	7591218	intron_variant	0.0	0.661	4e-09	8.397940008672037		1.129	[1.08-1.18]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2p15	2	62525840	NR	TMEM17 - RPL21P37	ENSG00000186889	ENSG00000229503		13946.0	6743.0	rs11125927-G	rs11125927	0	11125927	regulatory_region_variant	1.0	0.246	5e-12	11.30102999566398		1.152	[1.11-1.20]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2p15	2	63050708	NR	OTX1			ENSG00000115507			rs58235267-G	rs58235267	0	58235267	intron_variant	0.0	0.691	3e-06	5.522878745280337		1.102	[1.06-1.15]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2p11.2	2	85540612	NR	MAT2A			ENSG00000168906			rs2028900-C	rs2028900	0	2028900	intron_variant	0.0	0.628	5e-06	5.301029995663981		1.093	[1.05-1.14]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2q14.2	2	120346022	NR	RALB - INHBB	ENSG00000144118	ENSG00000163083		51312.0	114.0	rs111595856-T	rs111595856	0	111595856	regulatory_region_variant	1.0	0.192	6e-09	8.221848749616356		1.112	[1.07-1.15]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		2q31.1	2	172455202	NR	ITGA6			ENSG00000091409			rs77167534-C	rs77167534	0	77167534	intron_variant	0.0	0.767	1e-10	10.0		1.167	[1.11-1.22]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		3p12.1	3	87094867	NR	LINC00506			ENSG00000281392			rs143745027-G	rs143745027	0	143745027	non_coding_transcript_exon_variant	0.0	0.131	3e-13	12.522878745280336		1.196	[1.14-1.26]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		3p11.2	3	87126834	NR	LINC00506			ENSG00000281392			rs7628934-C	rs7628934	0	7628934	intron_variant	0.0	0.69	9e-07	6.045757490560675		1.103	[1.06-1.15]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		3q21.3	3	128179658	NR	EEFSEC			ENSG00000132394			rs2811476-C	rs2811476	0	2811476	intron_variant	0.0	0.115	5e-07	6.301029995663981		1.138	[1.08-1.20]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		3q21.3	3	128495151	NR	GATA2-AS1			ENSG00000244300			rs35006112-G	rs35006112	0	35006112	intron_variant	0.0	0.631	4e-11	10.397940008672036		1.134	[1.09-1.18]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		3q26.2	3	170356729	NR	PRKCI - SKIL	ENSG00000163558	ENSG00000136603		50752.0	949.0	rs78416326-G	rs78416326	0	78416326	upstream_gene_variant	1.0	0.781	3e-11	10.522878745280336		1.162	[1.11-1.21]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		5p15.33	5	1279913	NR	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	0.81	7e-15	14.154901959985745		1.164	[1.12-1.21]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		5p15.33	5	1891060	NR	CTD-2194D22.4			ENSG00000249326			rs4975758-G	rs4975758	0	4975758	intron_variant	0.0	0.4	1e-31	31.0		1.226	[1.18-1.27]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		6p22.3	6	21330458	NR	CDKAL1 - NA	ENSG00000145996			98054.0		rs6927369-C	rs6927369	0	6927369	intergenic_variant	1.0	0.348	5e-07	6.301029995663981		1.096	[1.06-1.14]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		6p21.1	6	41568849	NR	FOXP4			ENSG00000137166			rs4714485-G	rs4714485	0	4714485	intron_variant	0.0	0.378	3e-12	11.522878745280336		1.146	[1.10-1.19]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		6q22.1	6	116879271	NR	RFX6			ENSG00000185002			rs339351-C	rs339351	0	339351	intron_variant	0.0	0.64	8.000000000000001e-23	22.096910013008056		1.221	[1.17-1.27]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		6q25.3	6	159729247	NR	SOD2, WTAP			ENSG00000112096, ENSG00000146457			rs963800-C	rs963800	0	963800	intron_variant	0.0	0.599	6e-06	5.221848749616356		1.087	[1.05-1.13]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8p21.2	8	23672008	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		36501.0	6689.0	rs1160267-G	rs1160267	0	1160267	intergenic_variant	1.0	0.337	2e-40	39.69897000433602		1.27	[1.23-1.32]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8p21.2	8	26205649	NR	RNA5SP258 - PPP2R2A	ENSG00000199620	ENSG00000221914		68651.0	85859.0	rs12677206-A	rs12677206	0	12677206	intergenic_variant	1.0	0.243	3e-06	5.522878745280337		1.096	[1.06-1.14]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	126889404	NR	PCAT1			ENSG00000253438			rs6984837-G	rs6984837	0	6984837	intron_variant	0.0	0.198	1e-07	7.0		1.137	[1.08-1.19]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	126909955	NR	PCAT1			ENSG00000253438			rs7011138-A	rs7011138	0	7011138	intron_variant	0.0	0.847	1e-13	13.0		0.822	[0.78-0.87]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	127015709	NR	PCAT1			ENSG00000253438			rs7463326-G	rs7463326	0	7463326	intron_variant	0.0	0.801	3.9999999999999997e-25	24.39794000867204		1.265	[1.21-1.32]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	127091724	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0.0	0.64	9.000000000000001e-29	28.045757490560675		1.708	[1.55-1.88]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	8,611 East Asian ancestry cases, 18,809 East Asian ancestry controls		8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.366	3e-13	12.522878745280336		1.148	[1.11-1.19]	Affymetrix, Illumina [10186136] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1p36.22	1	10504618	NR	PEX14			ENSG00000142655			rs2847344-A	rs2847344	0	2847344	intron_variant	0.0	NR	1e-08	8.0		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1p36.13	1	16050336	NR	CLCNKB			ENSG00000184908			rs10803412-C	rs10803412	0	10803412	intron_variant	0.0	NR	6e-09	8.221848749616356		1.053	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1p34.1	1	45785983	NR	IPP - MAST2	ENSG00000197429	ENSG00000086015		35330.0	1004.0	rs544780844-T	rs544780844	0	544780844	regulatory_region_variant	1.0	NR	2e-10	9.69897000433602		1.065	[1.04-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1p22.3	1	87745033	NR	PKN2-AS1			ENSG00000237505			rs56391074-AT	rs56391074	0	56391074	intron_variant	0.0	NR	5e-10	9.30102999566398		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q21.3	1	150800137	NR	CTSK			ENSG00000143387			rs1811698-C	rs1811698	0	1811698	intron_variant	0.0	NR	3e-14	13.522878745280336		1.077	[1.06-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q21.3	1	150982195	NR	CERS2 - ANXA9	ENSG00000143418	ENSG00000143412		7192.0	54.0	rs607518-A	rs607518	0	607518	upstream_gene_variant	1.0	NR	8e-12	11.096910013008056		1.063	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q21.3	1	153950800	NR	CRTC2			ENSG00000160741			rs10127983-T	rs10127983	0	10127983	intron_variant	0.0	NR	1e-19	19.0		1.066	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q21.3	1	155007875	NR	ZBTB7B			ENSG00000160685			rs56103503-T	rs56103503	0	56103503	intron_variant	0.0	NR	2e-14	13.69897000433602		1.058	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q22	1	155146112	NR	DPM3 - HMGN2P18	ENSG00000179085	ENSG00000223452		5517.0	2432.0	rs147847496-C	rs147847496	0	147847496	intergenic_variant	1.0	NR	5e-11	10.30102999566398		1.165	[1.11-1.22]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q22	1	155720395	NR	DAP3			ENSG00000132676			rs184104770-A	rs184104770	0	184104770	intron_variant	0.0	NR	4e-08	7.397940008672037		1.172	[1.11-1.24]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q23.1	1	157150123	NR	ETV3 - NA	ENSG00000117036			11649.0		rs80237341-C	rs80237341	0	80237341	intergenic_variant	1.0	NR	1e-11	11.0		1.147	[1.10-1.19]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q23.3	1	163325888	NR	NUF2			ENSG00000143228			rs6660538-A	rs6660538	0	6660538	intron_variant	0.0	NR	9e-09	8.045757490560675		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q24.1	1	167166704	NR	GPA33 - LINC01363	ENSG00000143167	ENSG00000231605		225.0	8659.0	rs4075646-T	rs4075646	0	4075646	TF_binding_site_variant	1.0	NR	3e-08	7.522878745280337		1.068	[1.04-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q25.2	1	179927935	NR	TOR1AIP1 - CEP350	ENSG00000143337	ENSG00000135837		7858.0	26838.0	rs507603-A	rs507603	0	507603	intron_variant	1.0	NR	2e-08	7.698970004336019		1.048	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q25.3	1	183063313	NR	LAMC1			ENSG00000135862			rs34295433-CTAAG	rs34295433	0	34295433	intron_variant	0.0	NR	1e-08	8.0		1.041	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q32.1	1	204061235	NR	LINC00303 - SOX13	ENSG00000176754	ENSG00000143842		19970.0	11880.0	rs138638958-TTTTG	rs138638958	0	138638958	intergenic_variant	1.0	NR	2e-10	9.69897000433602		1.045	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q32.1	1	204549714	NR	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0.0	NR	2.0000000000000002e-29	28.69897000433602		1.092	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		1q32.1	1	205770138	NR	RAB29			ENSG00000117280			rs708723-C	rs708723	0	708723	3_prime_UTR_variant	0.0	NR	5e-14	13.30102999566398		1.05	[1.04-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p25.1	2	8458314	NR	LINC00299			ENSG00000236790			rs11686272-T	rs11686272	0	11686272	intron_variant	0.0	NR	7e-09	8.154901959985743		1.042	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p25.1	2	9954397	NR	GRHL1			ENSG00000134317			rs73913932-G	rs73913932	0	73913932	intron_variant	0.0	NR	6e-10	9.221848749616356		1.08	[1.05-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p25.1	2	10641849	NR	NOL10			ENSG00000115761			rs1990613-T	rs1990613	0	1990613	intron_variant	0.0	NR	5e-19	18.30102999566398		1.061	[1.05-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p24.3	2	15876379	NR	RPLP1P5 - MYCNOS	ENSG00000214657	ENSG00000233718		6136.0	41971.0	rs7602028-C	rs7602028	0	7602028	intergenic_variant	1.0	NR	1e-13	13.0		1.058	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p24.1	2	20678345	NR	GDF7			ENSG00000143869			rs9306894-G	rs9306894	0	9306894	3_prime_UTR_variant	0.0	NR	9e-33	32.045757490560675		1.086	[1.07-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p21	2	42837415	NR	CHORDC1P1 - NA	ENSG00000232202			9798.0		rs6738169-C	rs6738169	0	6738169	regulatory_region_variant	1.0	NR	6e-09	8.221848749616356		1.043	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		2p21	2	43410859	NR	THADA			ENSG00000115970			rs7591218-A	rs7591218	0	7591218	intron_variant	0.0	NR	2e-19	18.69897000433602		1.068	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q25.2	6	153126381	NR	RGS17			ENSG00000091844			rs13215045-C	rs13215045	0	13215045	intron_variant	0.0	NR	1.0000000000000001e-24	24.0		1.074	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q25.3	6	159729247	NR	SOD2, WTAP			ENSG00000112096, ENSG00000146457			rs963800-C	rs963800	0	963800	intron_variant	0.0	NR	3e-16	15.522878745280336		1.064	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		6q25.3	6	160160512	NR	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1794.0	10549.0	rs4646284-TG	rs4646284	0	4646284	downstream_gene_variant	1.0	NR	6e-121	120.22184874961636		1.202	[1.18-1.22]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p22.3	7	1888523	NR	MAD1L1			ENSG00000002822			rs4513875-T	rs4513875	0	4513875	intron_variant	0.0	NR	1e-08	8.0		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p21.1	7	20374488	NR	ITGB8			ENSG00000105855			rs11452686-T	rs11452686	0	11452686	intron_variant	0.0	NR	3e-09	8.522878745280337		1.043	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p15.3	7	20959592	NR	LINC01162			ENSG00000232790			rs9655205-C	rs9655205	0	9655205	non_coding_transcript_exon_variant	0.0	NR	6e-28	27.22184874961636		1.091	[1.07-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p15.3	7	21772425	NR	DNAH11			ENSG00000105877			rs35389879-T	rs35389879	0	35389879	intron_variant	0.0	NR	1e-08	8.0		1.042	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p15.2	7	27525243	NR	PSMC1P2 - HIBADH	ENSG00000213781	ENSG00000106049		62274.0	199.0	rs6956484-A	rs6956484	0	6956484	intergenic_variant	1.0	NR	7e-13	12.154901959985745		1.056	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	NR	2e-38	37.69897000433602		1.117	[1.10-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p14.1	7	40837874	NR	SUGCT			ENSG00000175600			rs12701838-A	rs12701838	0	12701838	intron_variant	0.0	NR	2e-14	13.69897000433602		1.065	[1.05-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7p12.3	7	47412320	NR	TNS3			ENSG00000136205			rs834608-A	rs834608	0	834608	intron_variant	0.0	NR	7e-14	13.154901959985745		1.051	[1.04-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7q21.2	7	92948446	NR	CDK6-AS1 - RN7SL7P	ENSG00000237819	ENSG00000266794		31259.0	22556.0	rs6955627-C	rs6955627	0	6955627	intergenic_variant	1.0	NR	4e-08	7.397940008672037		1.056	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		7q21.3	7	98059128	NR	RN7SL478P - LMTK2	ENSG00000277946	ENSG00000164715		60506.0	47734.0	rs4727386-A	rs4727386	0	4727386	intergenic_variant	1.0	NR	5e-42	41.30102999566398		1.1	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p23.1	8	8641293	NR	RN7SL178P - CLDN23	ENSG00000284857	ENSG00000285098		58638.0	60644.0	rs870167-G	rs870167	0	870167	TF_binding_site_variant	1.0	NR	2e-08	7.698970004336019		1.065	[1.04-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p23.1	8	11359946	NR	TDH, TDH			ENSG00000284856, ENSG00000154316			rs2572375-C	rs2572375	0	2572375	intron_variant	0.0	NR	4e-08	7.397940008672037		1.046	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p21.2	8	23613272	NR	RNU4-71P - SINHCAFP3	ENSG00000252067	ENSG00000253488		13134.0	21604.0	rs6557704-A	rs6557704	0	6557704	intergenic_variant	1.0	NR	2e-18	17.69897000433602		1.072	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p21.2	8	23672008	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		36501.0	6689.0	rs1160267-G	rs1160267	0	1160267	intergenic_variant	1.0	NR	9e-123	122.04575749056067		1.168	[1.15-1.18]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p21.2	8	26036686	NR	EBF2			ENSG00000221818			rs141811748-C	rs141811748	1	74273823	intron_variant	0.0	NR	6e-14	13.221848749616356		1.078	[1.06-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p21.2	8	26205649	NR	RNA5SP258 - PPP2R2A	ENSG00000199620	ENSG00000221914		68651.0	85859.0	rs12677206-A	rs12677206	0	12677206	intergenic_variant	1.0	NR	5e-10	9.30102999566398		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8p11.22	8	38787396	NR	TACC1			ENSG00000147526			rs11467-A	rs11467	0	11467	5_prime_UTR_variant	0.0	NR	4e-08	7.397940008672037		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q23.1	8	107910879	NR	RSPO2			ENSG00000147655			rs73700335-G	rs73700335	0	73700335	intron_variant	0.0	NR	4e-08	7.397940008672037		1.054	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	126824681	NR	PCAT1			ENSG00000253438			rs57588856-C	rs57588856	0	57588856	intron_variant	0.0	NR	2e-07	6.698970004336019		1.047	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	126889404	NR	PCAT1			ENSG00000253438			rs6984837-G	rs6984837	0	6984837	intron_variant	0.0	NR	7.000000000000001e-24	23.154901959985743		1.085	[1.07-1.10]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	126909955	NR	PCAT1			ENSG00000253438			rs7011138-A	rs7011138	0	7011138	intron_variant	0.0	NR	2e-08	7.698970004336019		0.94	[0.92-0.96]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		8q24.21	8	127015709	NR	PCAT1			ENSG00000253438			rs7463326-G	rs7463326	0	7463326	intron_variant	0.0	NR	2.0000000000000002e-82	81.69897000433602		1.181	[1.16-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		18q21.33	18	63293961	NR	BCL2			ENSG00000171791			rs533722308-CT	rs533722308	1	397698226	intron_variant	0.0	NR	4e-10	9.397940008672036		1.051	[1.03-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		18q22.3	18	75323558	NR	TSHZ1 - SMIM21	ENSG00000179981	ENSG00000206026		33608.0	85918.0	rs11876000-T	rs11876000	0	11876000	intergenic_variant	1.0	NR	5e-09	8.301029995663981		1.039	[1.03-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		18q23	18	79010820	NR	SALL3 - ATP9B	ENSG00000263310	ENSG00000166377		8143.0	58465.0	rs9959454-A	rs9959454	0	9959454	intergenic_variant	1.0	NR	5e-21	20.30102999566398		1.071	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19p13.11	19	17117744	NR	MYO9B			ENSG00000099331			rs10412482-C	rs10412482	0	10412482	intron_variant	0.0	NR	2e-12	11.69897000433602		1.053	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19q12	19	31677437	NR	RNA5SP471 - NA	ENSG00000252780			21976.0		rs17501397-C	rs17501397	0	17501397	intergenic_variant	1.0	NR	3e-08	7.522878745280337		1.079	[1.05-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19q13.13	19	38057454	NR	SIPA1L3			ENSG00000105738			rs59710626-G	rs59710626	0	59710626	intron_variant	0.0	NR	1e-08	8.0		1.058	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19q13.2	19	38247490	NR	SPINT2			ENSG00000167642			rs4802297-G	rs4802297	0	4802297	intron_variant	0.0	NR	6.9999999999999995e-40	39.15490195998574		1.092	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls					NR							rs11673591-T	rs11673591	0	11673591		1.0	NR	1e-22	22.0		1.076	[1.06-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19q13.33	19	50842312	NR	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		5099.0	12603.0	rs2659051-G	rs2659051	0	2659051	intron_variant	1.0	NR	3e-29	28.522878745280337		1.097	[1.08-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19q13.33	19	50858126	NR	KLK3			ENSG00000142515			rs61752561-G	rs61752561	0	61752561	missense_variant	0.0	NR	5e-12	11.30102999566398		1.152	[1.11-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		19q13.33	19	50859459	NR	KLK3			ENSG00000142515			rs76765083-T	rs76765083	0	76765083	intron_variant	0.0	NR	2e-62	61.69897000433602		1.304	[1.26-1.35]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20p13	20	886681	NR	ANGPT4			ENSG00000101280			rs6039055-A	rs6039055	0	6039055	intron_variant	0.0	NR	2e-06	5.698970004336019		1.037	[1.02-1.05]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q11.21	20	32759707	NR	COMMD7 - DNMT3B	ENSG00000149600	ENSG00000088305		16240.0	2678.0	rs11480453-C	rs11480453	0	11480453	intergenic_variant	1.0	NR	4e-08	7.397940008672037		1.042	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q11.22	20	35419167	NR	UQCC1 - GDF5-AS1	ENSG00000101019	ENSG00000204183		7136.0	13862.0	rs6141551-C	rs6141551	0	6141551	intergenic_variant	1.0	NR	3e-09	8.522878745280337		1.042	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q13.13	20	50932270	NR	ADNP-AS1			ENSG00000259456			rs73909841-T	rs73909841	0	73909841	intron_variant	0.0	NR	5e-16	15.30102999566398		1.106	[1.08-1.13]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q13.2	20	53848180	NR	NA - SUMO1P1		ENSG00000241721			27072.0	rs6126986-C	rs6126986	0	6126986	intergenic_variant	1.0	NR	5e-16	15.30102999566398		1.058	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q13.33	20	62426006	NR	RBBP8NL			ENSG00000130701			rs139135938-TGGCAGTGGCAGC	rs139135938	0	139135938	intron_variant	0.0	NR	7e-09	8.154901959985743		1.044	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q13.33	20	63598636	NR	GMEB2			ENSG00000101216			rs381331-A	rs381331	0	381331	intron_variant	0.0	NR	1e-12	12.0		1.052	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q13.33	20	63676164	NR	RTEL1-TNFRSF6B, RTEL1			ENSG00000026036, ENSG00000258366			rs3787099-A	rs3787099	0	3787099	intron_variant	0.0	NR	6e-15	14.221848749616356		1.108	[1.08-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		20q13.33	20	63743036	NR	SLC2A4RG			ENSG00000125520			rs1058319-C	rs1058319	0	1058319	3_prime_UTR_variant	0.0	NR	1.0000000000000001e-29	29.0		1.117	[1.10-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		21q22.2	21	38924487	NR	RPSAP64 - LINC01700	ENSG00000227721	ENSG00000232837		29235.0	49942.0	rs11701433-C	rs11701433	0	11701433	intron_variant	1.0	NR	1e-08	8.0		1.041	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		21q22.3	21	41494405	NR	TMPRSS2			ENSG00000184012			rs61735792-A	rs61735792	0	61735792	synonymous_variant	0.0	NR	8e-15	14.096910013008056		1.261	[1.19-1.34]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		21q22.3	21	41510535	NR	TMPRSS2			ENSG00000184012			rs9978557-C	rs9978557	0	9978557	intron_variant	0.0	NR	4e-11	10.397940008672036		1.089	[1.06-1.12]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q11.21	22	19762002	NR	TBX1			ENSG00000184058			rs1978060-G	rs1978060	0	1978060	intron_variant	0.0	NR	4e-14	13.397940008672036		1.054	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q12.1	22	28492951	NR	TTC28			ENSG00000100154			rs9625483-A	rs9625483	0	9625483	intron_variant	0.0	NR	7e-10	9.154901959985745		1.151	[1.10-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q12.1	22	28695159	NR	CHEK2			ENSG00000183765			rs17886163-C	rs17886163	0	17886163	missense_variant	0.0	NR	1e-09	9.0		1.594	[1.37-1.85]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q12.1	22	28695869	NR	CHEK2			ENSG00000183765			rs555607708-A	rs555607708	0	555607708	frameshift_variant	0.0	NR	1e-08	8.0		1.477	[1.29-1.69]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q13.1	22	38742327	NR	SUN2			ENSG00000100242			rs138708-G	rs138708	0	138708	missense_variant	0.0	NR	3e-14	13.522878745280336		1.162	[1.12-1.21]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q13.1	22	40103103	NR	TNRC6B			ENSG00000100354			rs34584683-T	rs34584683	0	34584683	intron_variant	0.0	NR	1e-16	16.0		1.071	[1.05-1.09]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q13.2	22	43103735	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14316.0	7015.0	rs6003062-G	rs6003062	0	6003062	regulatory_region_variant	1.0	NR	4.0000000000000004e-23	22.39794000867204		1.166	[1.13-1.20]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	NR	7e-65	64.15490195998575		1.125	[1.11-1.14]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		22q13.31	22	45302268	NR	UPK3A - FAM118A	ENSG00000100373	ENSG00000100376		6394.0	6700.0	rs9615099-T	rs9615099	0	9615099	regulatory_region_variant	1.0	NR	1e-08	8.0		1.043	[1.03-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xp22.2	X	9843055	NR	SHROOM2			ENSG00000146950			rs960417-A	rs960417	0	960417	intron_variant	0.0	NR	1e-17	17.0		1.048	[1.04-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xp22.2	X	11464514	NR	ARHGAP6			ENSG00000047648			rs17321482-C	rs17321482	0	17321482	intron_variant	0.0	NR	1e-12	12.0		1.06	[1.04-1.08]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xp21.2	X	30878203	NR	TAB3			ENSG00000157625			rs5972255-T	rs5972255	0	5972255	intron_variant	0.0	NR	1e-08	8.0		1.032	[1.02-1.04]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xp11.22	X	51502425	NR	LINC01496			ENSG00000234766			rs11338635-GA	rs11338635	0	11338635	intron_variant	0.0	NR	7e-85	84.15490195998575		1.103	[1.09-1.11]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xp11.22	X	52666845	NR	RNA5SP504 - SSXP5	ENSG00000222608	ENSG00000225508		1498.0	5873.0	rs5943724-G	rs5943724	0	5943724	intergenic_variant	1.0	NR	4e-18	17.397940008672037		1.047	[1.04-1.06]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xq12	X	67605515	NR	AR			ENSG00000169083			rs5919393-T	rs5919393	0	5919393	intron_variant	0.0	NR	2e-16	15.69897000433602		1.06	[1.05-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 10,368 African ancestry cases, 8,611 East Asian ancestry cases, 2,714 Hispanic cases, 91,972 European ancestry controls, 10,986 African ancestry controls, 18,809 East Asian ancestry controls, 5,239 Hispanic controls		Xq13.1	X	70920058	NR	TEX11 - SLC7A3	ENSG00000120498	ENSG00000165349		11347.0	5521.0	rs371707439-A	rs371707439	0	371707439	intergenic_variant	1.0	NR	1e-14	14.0		1.054	[1.04-1.07]	Affymetrix, Illumina [29235255] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	1q32.1	1	204549714	NR	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0.0	0.724814157	2e-08	7.698970004336019		1.1148883	[1.07-1.16]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2p21	2	43410859	NR	THADA			ENSG00000115970			rs7591218-A	rs7591218	0	7591218	intron_variant	0.0	0.298921486	6e-06	5.221848749616356		1.0921326	[1.05-1.13]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2p15	2	63050708	NR	OTX1			ENSG00000115507			rs58235267-G	rs58235267	0	58235267	intron_variant	0.0	0.487547337	3e-12	11.522878745280336		1.1305747	[1.09-1.17]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2p11.2	2	85540612	NR	MAT2A			ENSG00000168906			rs2028900-C	rs2028900	0	2028900	intron_variant	0.0	0.549915992	2e-07	6.698970004336019		1.0937226	[1.06-1.13]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2q31.1	2	172455202	NR	ITGA6			ENSG00000091409			rs77167534-C	rs77167534	0	77167534	intron_variant	0.0	0.938325023	1e-11	11.0		1.3034425	[1.21-1.41]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2q37.3	2	241195850	NR	ANO7			ENSG00000146205			rs77559646-A	rs77559646	0	77559646	missense_variant	0.0	0.0199543	4e-06	5.3979400086720375		1.2941197	[1.16-1.44]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2q37.3	2	241202304	NR	ANO7			ENSG00000146205			rs2074840-C	rs2074840	0	2074840	splice_region_variant	0.0	0.303395862	4e-06	5.3979400086720375		1.0890392	[1.05-1.13]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	2q37.3	2	241217826	NR	ANO7			ENSG00000146205			rs76832527-A	rs76832527	0	76832527	missense_variant	0.0	0.188307499	3e-07	6.522878745280337		1.1178178	[1.07-1.17]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	3p11.2	3	87126834	NR	LINC00506			ENSG00000281392			rs7628934-C	rs7628934	0	7628934	intron_variant	0.0	0.499565205	2e-06	5.698970004336019		1.0880475	[1.05-1.13]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	3q13.2	3	113581336	NR	SIDT1			ENSG00000072858			rs2271494-A	rs2271494	0	2271494	intron_variant	0.0	0.582340487	3e-08	7.522878745280337		1.1007563	[1.06-1.14]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	3q21.3	3	128179658	NR	EEFSEC			ENSG00000132394			rs2811476-C	rs2811476	0	2811476	intron_variant	0.0	0.26310582	6e-06	5.221848749616356		1.0890101	[1.05-1.13]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	3q26.2	3	170356729	NR	PRKCI - SKIL	ENSG00000163558	ENSG00000136603		50752.0	949.0	rs78416326-G	rs78416326	0	78416326	upstream_gene_variant	1.0	0.799617928	5e-20	19.30102999566398		1.2318585	[1.18-1.29]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	3q26.31	3	172663987	NR	NCEH1			ENSG00000144959			rs11717887-C	rs11717887	0	11717887	intron_variant	0.0	0.373329354	4e-06	5.3979400086720375		1.0832849	[1.05-1.12]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	4q13.3	4	73576632	NR	RASSF6			ENSG00000169435			rs17804499-G	rs17804499	0	17804499	missense_variant	0.0	0.941437877	2e-07	6.698970004336019		1.2286369	[1.14-1.33]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	4q22.3	4	94623567	NR	PDLIM5			ENSG00000163110			rs6853490-G	rs6853490	0	6853490	intron_variant	0.0	0.422613792	3e-12	11.522878745280336		1.1275649	[1.09-1.17]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	4q24	4	105140377	NR	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-C	rs7679673	0	7679673	intron_variant	1.0	0.625027821	1e-06	6.0		1.1038603	[1.06-1.15]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	5p15.33	5	1279913	NR	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	0.805629024	4e-09	8.397940008672037		1.1475415	[1.10-1.20]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	5p15.33	5	1293971	NR	TERT			ENSG00000164362			rs2736098-T	rs2736098	0	2736098	synonymous_variant	0.0	0.280110751	9e-08	7.045757490560675		1.1079248	[1.07-1.15]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	5p15.33	5	1891060	NR	CTD-2194D22.4			ENSG00000249326			rs4975758-G	rs4975758	0	4975758	intron_variant	0.0	0.462040183	8e-12	11.096910013008056		1.1243056	[1.09-1.16]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	6p21.1	6	41568849	NR	FOXP4			ENSG00000137166			rs4714485-G	rs4714485	0	4714485	intron_variant	0.0	0.276019085	2e-09	8.698970004336019		1.1165469	[1.08-1.16]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	6q21	6	108974090	NR	ARMC2			ENSG00000118690			rs2038542-C	rs2038542	0	2038542	3_prime_UTR_variant	0.0	0.143982008	3e-06	5.522878745280337		1.1147456	[1.06-1.17]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	6q22.1	6	116879271	NR	RFX6			ENSG00000185002			rs339351-C	rs339351	0	339351	intron_variant	0.0	0.695001072	1e-07	7.0		1.104749	[1.07-1.15]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	6q25.3	6	160160512	NR	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1794.0	10549.0	rs4646284-TG	rs4646284	0	4646284	downstream_gene_variant	1.0	0.319856898	9.999999999999999e-27	26.0		1.2171053	[1.17-1.26]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.76672338	1e-08	8.0		1.1367551	[1.09-1.19]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	7q21.3	7	98059128	NR	RN7SL478P - LMTK2	ENSG00000277946	ENSG00000164715		60506.0	47734.0	rs4727386-A	rs4727386	0	4727386	intergenic_variant	1.0	0.466851604	7e-11	10.154901959985745		1.1179241	[1.08-1.16]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8p21.2	8	23672008	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		36501.0	6689.0	rs1160267-G	rs1160267	0	1160267	intergenic_variant	1.0	0.419439506	1e-16	16.0		1.1532314	[1.11-1.19]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8p21.2	8	26036686	NR	EBF2			ENSG00000221818			rs141811748-C	rs141811748	1	74273823	intron_variant	0.0	0.153699978	7e-06	5.154901959985743		1.1080471	[1.06-1.16]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	126889404	NR	PCAT1			ENSG00000253438			rs6984837-G	rs6984837	0	6984837	intron_variant	0.0	0.33391118	1e-06	6.0		1.0965812	[1.06-1.14]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127015709	NR	PCAT1			ENSG00000253438			rs7463326-G	rs7463326	0	7463326	intron_variant	0.0	0.754976862	5e-11	10.30102999566398		1.1732173	[1.12-1.23]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127064901	NR	PCAT1			ENSG00000253438			rs77541621-A	rs77541621	0	77541621	non_coding_transcript_exon_variant	0.0	0.02865675	1e-48	48.0		1.8859878	[1.73-2.05]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127091724	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0.0	0.183733525	1e-19	19.0		1.2214127	[1.17-1.28]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127091872	NR	PRNCR1, CASC19, PCAT1			ENSG00000282961, ENSG00000254166, ENSG00000253438			rs183373024-G	rs183373024	0	183373024	non_coding_transcript_exon_variant	0.0	0.006111072	2.0000000000000002e-29	28.69897000433602		2.4604032	[2.10-2.88]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127330621	NR	PCAT1, CASC8, POU5F1B			ENSG00000253438, ENSG00000246228, ENSG00000212993			rs17464492-A	rs17464492	0	17464492	intron_variant	0.0	0.713512738	4e-17	16.397940008672037		1.1832399	[1.14-1.23]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.51929402	5e-28	27.30102999566398		1.2091146	[1.17-1.25]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127519892	NR	CASC8 - NA	ENSG00000246228			37753.0		rs10090154-T	rs10090154	0	10090154	intergenic_variant	1.0	0.09964465	5e-23	22.30102999566398		1.2957077	[1.23-1.36]	Affymetrix, Illumina [20400945] (imputed)	N
2021-02-03	33398198	Conti DV	2021-01-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/33398198	Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.	Prostate cancer	85,554 European ancestry cases, 91,972 European ancestry controls	6,852 European ancestry cases, 193,117 European ancestry controls	8q24.21	8	127528531	NR	CASC8 - NA	ENSG00000246228			46392.0		rs12549761-C	rs12549761	0	12549761	intergenic_variant	1.0	0.878451631	2e-08	7.698970004336019		1.1715244	[1.11-1.24]	Affymetrix, Illumina [20400945] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		1q32.1	1	205788696	SLC41A1	RAB29 - SLC41A1	ENSG00000117280	ENSG00000133065		13214.0	398.0	rs1775148-C	rs1775148	0	1775148	intergenic_variant	1.0	0.27	4e-08	7.397940008672037		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6q14.1	6	75786165	MYO6	MYO6			ENSG00000196586			rs9443189-G	rs9443189	0	9443189	intron_variant	0.0	0.14	4e-08	7.397940008672037		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		14q23.1	14	60655808	SIX1	SIX1			ENSG00000126778			rs7153648-C	rs7153648	0	7153648	intron_variant	0.0	0.06	2e-09	8.698970004336019		1.11	[1.07-1.14]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		16q22.2	16	71657426	PHLPP2	PHLPP2			ENSG00000040199			rs12051443-A	rs12051443	0	12051443	intron_variant	0.0	0.34	3e-08	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		20q13.13	20	50911385	ADNP	ADNP			ENSG00000101126			rs12480328-T	rs12480328	0	12480328	intron_variant	0.0	0.93	5e-11	10.30102999566398		1.13	[1.10-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		21q22.3	21	41529494	TMPRSS2	TMPRSS2			ENSG00000184012			rs1041449-G	rs1041449	0	1041449	intron_variant	0.0	0.44	3e-08	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		22q11.21	22	19770369	TBX1	TBX1			ENSG00000184058			rs2238776-G	rs2238776	0	2238776	intron_variant	0.0	0.8	2e-08	7.698970004336019		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		1q21.3	1	150685811	GOLPH3L	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0.0	0.22	6e-11	10.221848749616356	(EA)	1.1	[1.07-1.13]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		2p25.1	2	10570604	NOL10	NA - NOL10		ENSG00000115761			150.0	rs9287719-C	rs9287719	0	9287719	intergenic_variant	1.0	0.46	2e-08	7.698970004336019	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		4q13.3	4	72989536	COX18	RNU4ATAC9P - RNU6ATAC5P	ENSG00000252955	ENSG00000210839		24233.0	37212.0	rs10009409-T	rs10009409	0	10009409	intergenic_variant	1.0	0.32	2e-10	9.69897000433602	(EA)	1.09	[1.06-1.12]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6p24.2	6	11218797	NEDD9	NEDD9			ENSG00000111859			rs4713266-C	rs4713266	0	4713266	intron_variant	0.0	0.52	4e-08	7.397940008672037	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6p22.1	6	30105999	TRIM31	TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31			ENSG00000238027, ENSG00000225038, ENSG00000225732, ENSG00000235722, ENSG00000231226, ENSG00000232510, ENSG00000237050, ENSG00000229223, ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130			rs115457135-A	rs115457135	1	7767188	intron_variant	0.0	0.22	2e-08	7.698970004336019	(EA)	1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6p21.32	6	32433162	HLA-DRB6	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25399.0	6716.0	rs115306967-G	rs115306967	1	3129859	intergenic_variant	1.0	0.65	3e-09	8.522878745280337	(EA)	1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		7p12.3	7	47397647	TNS3	TNS3			ENSG00000136205			rs56232506-A	rs56232506	0	56232506	intron_variant	0.0	0.45	2e-09	8.698970004336019	(EA)	1.07	[1.05-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		9p21.3	9	22041999	CDKN2B-AS1	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0.0	0.14	4e-08	7.397940008672037	(EA)	1.1	[1.06-1.13]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		10q11.22	10	45587537	MARCH8	MARCHF8, MARCHF8			ENSG00000165406, ENSG00000278545			rs76934034-T	rs76934034	0	76934034	intron_variant	0.0	0.91	5e-09	8.301029995663981	(EA)	1.14	[1.10-1.18]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		11q23.2	11	113936459	HTR3B	HTR3B			ENSG00000149305			rs11214775-G	rs11214775	0	11214775	intron_variant	0.0	0.71	3e-08	7.522878745280337	(EA)	1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		12q13.11	12	48025835	RP1-228P16.4	COL2A1 - SENP1	ENSG00000139219	ENSG00000079387		21281.0	17062.0	rs80130819-A	rs80130819	0	80130819	regulatory_region_variant	1.0	0.91	4e-08	7.397940008672037	(EA)	1.13	[1.08-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		14q24.2	14	70625539	TTC9	RN7SL77P - TTC9	ENSG00000240837	ENSG00000133985		15160.0	16377.0	rs8014671-G	rs8014671	0	8014671	intron_variant	1.0	0.59	1e-08	8.0	(EA)	1.07	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		Xp11.22	X	52867918	XAGE3	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0.0	0.18	9e-10	9.045757490560677	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		Xq13.1	X	70920000	SLC7A	TEX11 - SLC7A3	ENSG00000120498	ENSG00000165349		11289.0	5579.0	rs6625711-A	rs6625711	0	6625711	intergenic_variant	1.0	0.41	6e-12	11.221848749616356	(EA)	1.07	[1.05-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		Xq13.1	X	71188133	NLGN3, BCYRN1	NLGN3 - GJB1	ENSG00000196338	ENSG00000169562		16932.0	24678.0	rs4844289-G	rs4844289	0	4844289	intron_variant	1.0	0.39	1e-09	9.0	(EA)	1.05	[1.04-1.07]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		20q13.13	20	50911385	ADNP	ADNP			ENSG00000101126			rs12480328-T	rs12480328	0	12480328	intron_variant	0.0	0.93	2e-07	6.698970004336019	(EA)	1.13	[1.08-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		21q22.3	21	41529494	TMPRSS2	TMPRSS2			ENSG00000184012			rs1041449-G	rs1041449	0	1041449	intron_variant	0.0	0.44	3e-07	6.522878745280337	(EA)	1.06	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		22q11.21	22	19770369	TBX1	TBX1			ENSG00000184058			rs2238776-G	rs2238776	0	2238776	intron_variant	0.0	0.8	2e-07	6.698970004336019	(EA)	1.09	[1.06-1.12]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		1p36.22	1	10496040	PEX14	PEX14			ENSG00000142655			rs636291-A	rs636291	0	636291	intron_variant	0.0	0.16	2e-08	7.698970004336019	(EA, early-onset)	1.18	[1.12-1.24]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		1q21.3	1	150685811	GOLPH3L	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0.0	0.22	3e-09	8.522878745280337		1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		2p25.1	2	10570604	NOL10	NA - NOL10		ENSG00000115761			150.0	rs9287719-C	rs9287719	0	9287719	intergenic_variant	1.0	0.46	3e-08	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		4q13.3	4	72989536	COX18	RNU4ATAC9P - RNU6ATAC5P	ENSG00000252955	ENSG00000210839		24233.0	37212.0	rs10009409-T	rs10009409	0	10009409	intergenic_variant	1.0	0.32	2e-10	9.69897000433602		1.08	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6p24.2	6	11218797	NEDD9	NEDD9			ENSG00000111859			rs4713266-C	rs4713266	0	4713266	intron_variant	0.0	0.52	3e-09	8.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6p22.1	6	30105999	TRIM31	TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31			ENSG00000238027, ENSG00000225038, ENSG00000225732, ENSG00000235722, ENSG00000231226, ENSG00000232510, ENSG00000237050, ENSG00000229223, ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130			rs115457135-A	rs115457135	1	7767188	intron_variant	0.0	0.22	1e-07	7.0		1.07	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		6p21.32	6	32433162	HLA-DRB6	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25399.0	6716.0	rs115306967-G	rs115306967	1	3129859	intergenic_variant	1.0	0.65	9e-07	6.045757490560675		1.06	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		7p12.3	7	47397647	TNS3	TNS3			ENSG00000136205			rs56232506-A	rs56232506	0	56232506	intron_variant	0.0	0.45	9e-09	8.045757490560675		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		9p21.3	9	22041999	CDKN2B-AS1	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0.0	0.14	1e-06	6.0		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		10q11.22	10	45587537	MARCH8	MARCHF8, MARCHF8			ENSG00000165406, ENSG00000278545			rs76934034-T	rs76934034	0	76934034	intron_variant	0.0	0.91	1e-08	8.0		1.13	[1.09-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		11q23.2	11	113936459	HTR3B	HTR3B			ENSG00000149305			rs11214775-G	rs11214775	0	11214775	intron_variant	0.0	0.71	5e-08	7.301029995663981		1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		12q13.11	12	48025835	RP1-228P16.4	COL2A1 - SENP1	ENSG00000139219	ENSG00000079387		21281.0	17062.0	rs80130819-A	rs80130819	0	80130819	regulatory_region_variant	1.0	0.91	2e-09	8.698970004336019		1.14	[1.09-1.18]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		14q24.2	14	70625539	TTC9	RN7SL77P - TTC9	ENSG00000240837	ENSG00000133985		15160.0	16377.0	rs8014671-G	rs8014671	0	8014671	intron_variant	1.0	0.59	3e-07	6.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		Xp11.22	X	52867918	XAGE3	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0.0	0.18	3e-11	10.522878745280336		1.07	[1.05-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		Xq13.1	X	70920000	SLC7A	TEX11 - SLC7A3	ENSG00000120498	ENSG00000165349		11289.0	5579.0	rs6625711-A	rs6625711	0	6625711	intergenic_variant	1.0	0.41	6e-07	6.221848749616356		1.04	[1.03-1.06]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls		Xq13.1	X	71188133	NLGN3, BCYRN1	NLGN3 - GJB1	ENSG00000196338	ENSG00000169562		16932.0	24678.0	rs4844289-G	rs4844289	0	4844289	intron_variant	1.0	0.39	9e-08	7.045757490560675		1.04	[1.03-1.06]	Affymetrix, Illumina [up to 16852405] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		2q31.1	2	172446825	CD200R1L x ITAGA6	No mapped genes x ITGA6						rs1002979-? x rs12621278-?	rs1002979 x rs12621278	0		regulatory_region_variant x intron_variant		NR	3e-06	5.522878745280337		1.5873	[1.32-1.92]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		19q13.2	19	38244973	UPF2 x NR	No mapped genes x SPINT2						rs10795917-? x rs8102476-?	rs10795917 x rs8102476	0		intron_variant x intron_variant		NR	7e-07	6.154901959985743		1.24	[1.14-1.36]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		17q12	17	37738049	ANP32D x HNF1B	No mapped genes x HNF1B						rs4489787-? x rs4430796-?	rs4489787 x rs4430796	0		non_coding_transcript_exon_variant x intron_variant		NR	1e-06	6.0		1.47	[1.25-1.72]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11q13.3	11	69167951	DNAH12 x MYEOV	No mapped genes x SMIM38 - MYEOV						rs1916284-? x rs12418451-?	rs1916284 x rs12418451	0		intron_variant x intron_variant		NR	1e-06	6.0		1.2658	[1.15-1.41]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		10q26.13	10	125008303	BAIAP2L1 x CTBP2	No mapped genes x CTBP2						rs9649213-? x rs4962416-?	rs9649213 x rs4962416	0		intron_variant x intron_variant		NR	1e-06	6.0		1.28	[1.16-1.42]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11q13.3	11	69167951	RNASE9 x MYEOV	No mapped genes x SMIM38 - MYEOV						rs1243647-? x rs12418451-?	rs1243647 x rs12418451	0		missense_variant x intron_variant		NR	1e-06	6.0		1.3333	[1.19-1.49]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		4q24	4	105140377	SYK x TET2	No mapped genes x RNU6-351P - TET2						rs290258-? x rs7679673-?	rs290258 x rs7679673	0		intergenic_variant x intron_variant		NR	1e-06	6.0		1.3333	[1.19-1.49]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127472793	C9orf123 x NR	No mapped genes x CASC8						rs12682851-? x rs1447295-?	rs12682851 x rs1447295	0		intergenic_variant x intron_variant		NR	2e-06	5.698970004336019		1.3889	[1.22-1.59]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		17q12	17	37714971	CLVS2 x HNF1B	No mapped genes x HNF1B						rs13192613-? x rs11649743-?	rs13192613 x rs11649743	0		intergenic_variant x intron_variant		NR	3e-06	5.522878745280337		1.37	[1.20-1.56]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		17q24.3	17	71112612	CWC22 x NR	No mapped genes x CASC17						rs16867225-? x rs1859962-?	rs16867225 x rs1859962	0		intergenic_variant x intron_variant		NR	3e-06	5.522878745280337		1.5625	[1.3-1.89]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		19q13.33	19	50861367	LOC63930 x KLK3	No mapped genes x KLK3 - KLK2						rs6089829-? x rs2735839-?	rs6089829 x rs2735839	0		intron_variant x intergenic_variant		NR	3e-06	5.522878745280337		1.3514	[1.19-1.54]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127472793	INHBA x NR	No mapped genes x CASC8						rs7789197-? x rs1447295-?	rs7789197 x rs1447295	0		intergenic_variant x intron_variant		NR	3e-06	5.522878745280337		1.5152	[1.27-1.79]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		3p12.1	3	87061524	CD180 x NR	No mapped genes x PPATP1 - LINC00506						rs7717572-? x rs2660753-?	rs7717572 x rs2660753	0		intron_variant x intergenic_variant		NR	3e-06	5.522878745280337		1.94	[1.47-2.56]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		19q13.2	19	41479716	DNAH5 x PPP1R14A	No mapped genes x PCAT19						rs4463179-? x rs887391-?	rs4463179 x rs887391	0		intergenic_variant x intron_variant		NR	2e-06	5.698970004336019		1.5625	[1.3-1.89]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		3q21.3	3	128319530	MIR656 x EEFSEC	No mapped genes x EEFSEC						rs2400997-? x rs10934853-?	rs2400997 x rs10934853	0		intron_variant x intron_variant		NR	3e-06	5.522878745280337		1.25	[1.14-1.38]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8p21.2	8	23668950	MIR622 x NKX3.1	No mapped genes x SINHCAFP3 - NKX3-1						rs16944141-? x rs1512268-?	rs16944141 x rs1512268	0		intergenic_variant x intergenic_variant		NR	3e-06	5.522878745280337		1.5385	[1.28-1.85]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11q13.3	11	69167951	CEP152 x MYEOV	No mapped genes x SMIM38 - MYEOV						rs784411-? x rs12418451-?	rs784411 x rs12418451	0		intron_variant x intron_variant		NR	1e-07	7.0		1.42	[1.25-1.61]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		3q21.3	3	128319530	MIR4319 x EEFSEC	No mapped genes x EEFSEC						rs998124-? x rs10934853-?	rs998124 x rs10934853	0		intron_variant x intron_variant		NR	5e-06	5.301029995663981		1.33	[1.18-1.51]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11q13.3	11	69227200	PLCL1 x MYEOV	No mapped genes x SMIM38 - MYEOV						rs13398206-? x rs10896449-?	rs13398206 x rs10896449	0		intron_variant x intergenic_variant		NR	4e-06	5.3979400086720375		1.24	[1.13-1.36]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127472793	ABLIM1 x NR	No mapped genes x CASC8						rs10885582-? x rs1447295-?	rs10885582 x rs1447295	0		intron_variant x intron_variant		NR	4e-06	5.3979400086720375		1.3699	[1.20-1.59]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127112671	TMTC2 x NR	No mapped genes x CASC19, PCAT1						rs12317459-? x rs16901979-?	rs12317459 x rs16901979	0		intron_variant x intron_variant		NR	4e-06	5.3979400086720375		2.06	[1.52-2.80]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		10q26.13	10	125008303	ACTBL2 x CTBP2	No mapped genes x CTBP2						rs10940579-? x rs4962416-?	rs10940579 x rs4962416	0		regulatory_region_variant x intron_variant		NR	4e-06	5.3979400086720375		1.32	[1.18-1.49]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		17q24.3	17	71112612	C7orf66 x NR	No mapped genes x CASC17						rs10277209-? x rs1859962-?	rs10277209 x rs1859962	0		intergenic_variant x intron_variant		NR	4e-06	5.3979400086720375		1.36	[1.19-1.55]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		3q21.3	3	128319530	TNC x EEFSEC	No mapped genes x EEFSEC						rs7847271-? x rs10934853-?	rs7847271 x rs10934853	0		intron_variant x intron_variant		NR	4e-06	5.3979400086720375		1.4925	[1.27-1.79]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		22q13.1	22	40056115	CNTN6 x TNRC6B	No mapped genes x TNRC6B						rs6763848-? x rs9623117-?	rs6763848 x rs9623117	0		intergenic_variant x intron_variant		NR	4e-06	5.3979400086720375		1.3	[1.16-1.45]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		2p21	2	43326810	NCRNA00284 x THADA	No mapped genes x THADA						rs9567349-? x rs1465618-?	rs9567349 x rs1465618	0		intergenic_variant x intron_variant		NR	4e-06	5.3979400086720375		1.6393	[1.33-2.04]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127401060	ACTC1 x NR	No mapped genes x CCAT2, POU5F1B, CASC8, PCAT1						rs543686-? x rs6983267-?	rs543686 x rs6983267	0		intron_variant x non_coding_transcript_exon_variant		NR	4e-06	5.3979400086720375		1.24	[1.13-1.35]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127310936	MN1 x NR	No mapped genes x CASC8, PCAT1						rs6005451-? x rs445114-?	rs6005451 x rs445114	0		intergenic_variant x intron_variant		NR	4e-06	5.3979400086720375		1.42	[1.22-1.65]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		4q24	4	105140377	ZNF280B x TET2	No mapped genes x RNU6-351P - TET2						rs5751168-? x rs7679673-?	rs5751168 x rs7679673	0		intron_variant x intron_variant		NR	4e-06	5.3979400086720375		1.44	[1.23-1.67]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		Xp11.22	X	51498820	C18orf34 x NUDT10	No mapped genes x LINC01496						rs6507016-? x rs5945619-?	rs6507016 x rs5945619	0		intron_variant x non_coding_transcript_exon_variant		NR	4e-06	5.3979400086720375		1.2821	[1.15-1.41]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11p15.5	11	2212344	TNRC6B x IGF2, IGF2AS, INS, TH	No mapped genes x MIR4686 - ASCL2						rs4821941-? x rs7127900-?	rs4821941 x rs7127900	0		intron_variant x intergenic_variant		NR	4e-06	5.3979400086720375		1.3	[1.16-1.46]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11p15.5	11	2212344	ACOXL x IGF2, IGF2AS, INS, TH	No mapped genes x MIR4686 - ASCL2						rs3789080-? x rs7127900-?	rs3789080 x rs7127900	0		intron_variant x intergenic_variant		NR	4e-06	5.3979400086720375		1.4085	[1.22-1.64]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		4q24	4	105140377	INSC x TET2	No mapped genes x RNU6-351P - TET2						rs11605083-? x rs7679673-?	rs11605083 x rs7679673	0		intergenic_variant x intron_variant		NR	4e-06	5.3979400086720375		1.28	[1.15-1.43]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		17q12	17	37738049	EPHA10 x HNF1B	No mapped genes x HNF1B						rs731174-? x rs4430796-?	rs731174 x rs4430796	0		intron_variant x intron_variant		NR	5e-06	5.301029995663981		1.27	[1.15-1.40]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		7q21.3	7	98187015	C16orf78 x LMTK2	No mapped genes x LMTK2						rs8057939-? x rs6465657-?	rs8057939 x rs6465657	0		intergenic_variant x intron_variant		NR	5e-06	5.301029995663981		1.37	[1.20-1.57]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		4q22.3	4	94641726	VGLL3 x PDLIM5	No mapped genes x PDLIM5						rs9757252-? x rs17021918-?	rs9757252 x rs17021918	0		intergenic_variant x intron_variant		NR	5e-06	5.301029995663981		1.25	[1.13-1.37]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	126999692	KIF13A x NR	No mapped genes x PCAT1						rs10456809-? x rs10086908-?	rs10456809 x rs10086908	0		intron_variant x intron_variant		NR	5e-06	5.301029995663981		1.25	[1.14-1.38]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		7p15.1	7	27936944	SPATA16 x JAZF1	No mapped genes x JAZF1						rs11720607-? x rs10486567-?	rs11720607 x rs10486567	0		intron_variant x intron_variant		NR	5e-06	5.301029995663981		1.3699	[1.20-1.59]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		6q25.3	6	160412632	BAI3 x NR	No mapped genes x SLC22A3						rs9351730-? x rs9364554-?	rs9351730 x rs9364554	0		intergenic_variant x intron_variant		NR	5e-06	5.301029995663981		1.25	[1.13-1.37]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q21.13 x 9q33.2	8 x 9	78044423 x 121665094	PKIA x DAB2IC	No mapped genes x DAB2IP						rs2219968-? x rs1571801-?	rs2219968 x rs1571801	0		intergenic_variant x intron_variant		NR	6e-07	6.221848749616356		1.3	[1.17-1.43]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		7q21.3	7	98187015	CHL1 x LMTK2	No mapped genes x LMTK2						rs12485321-? x rs6465657-?	rs12485321 x rs6465657	0		intergenic_variant x intron_variant		NR	3e-06	5.522878745280337		1.2346	[1.14-1.35]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11p15.5	11	2212344	TNRC6B x IGF2, IGF2AS, INS, TH	No mapped genes x MIR4686 - ASCL2						rs12628051-? x rs7127900-?	rs12628051 x rs7127900	0		intron_variant x intergenic_variant		NR	3e-06	5.522878745280337		1.3	[1.17-1.46]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		9q33.2	9	121665094	SNX16 x DAB2IC	No mapped genes x DAB2IP						rs13264970-? x rs1571801-?	rs13264970 x rs1571801	0		intron_variant x intron_variant		NR	4e-06	5.3979400086720375		1.2987	[1.16-1.45]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		11p15.5	11	2212344	ANXA13 x IGF2, IGF2AS, INS, TH	No mapped genes x MIR4686 - ASCL2						rs13258681-? x rs7127900-?	rs13258681 x rs7127900	0		intron_variant x intergenic_variant		NR	4e-06	5.3979400086720375		1.32	[1.17-1.48]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8p21.2	8	23668950	LOC285830 x NKX3.1	No mapped genes x SINHCAFP3 - NKX3-1						rs2523395-? x rs1512268-?	rs2523395 x rs1512268	0		intron_variant x intergenic_variant		NR	2e-06	5.698970004336019		1.24	[1.14-1.35]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		4q25 x 8q24.21	4 x 8	113079800 x 126999692	ANK2 x NR	ANK2 x PCAT1						rs7694725-? x rs10086908-?	rs7694725 x rs10086908	0		intron_variant x intron_variant		NR	2e-06	5.698970004336019		1.36	[1.20-1.55]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		8q24.21	8	127472793	NR2F2 x NR	No mapped genes x CASC8						rs11637980-? x rs1447295-?	rs11637980 x rs1447295	0		intergenic_variant x intron_variant		NR	2e-06	5.698970004336019		1.4706	[1.27-1.72]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		10q11.22	10	46046326	TSEN2 x MSMB	No mapped genes x MSMB						rs6766510-? x rs10993994-?	rs6766510 x rs10993994	0		intron_variant x 5_prime_UTR_variant		NR	2e-06	5.698970004336019		1.58	[1.31-1.91]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		19q13.2	19	41479716	EVC x PPP1R14A	No mapped genes x PCAT19						rs735172-? x rs887391-?	rs735172 x rs887391	0		intron_variant x intron_variant		NR	2e-06	5.698970004336019		1.31	[1.17-1.46]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		22q13.2	22	43104206	AMIGO2 x TTLL1, BIK, MCAT, PACSIN2	No mapped genes x TTLL1 - BIK						rs2711721-? x rs5759167-?	rs2711721 x rs5759167	0		intergenic_variant x TF_binding_site_variant		NR	2e-06	5.698970004336019		1.28	[1.16-1.42]	Affymetrix, Illumina [1117531] (imputed)	N
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls		19q13.2	19	38244973	PTPRU x NR	No mapped genes x SPINT2						rs1866967-? x rs8102476-?	rs1866967 x rs8102476	0		intergenic_variant x intron_variant		NR	5e-06	5.301029995663981		1.2195	[1.12-1.33]	Affymetrix, Illumina [1117531] (imputed)	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	3q21.3	3	128319530	intergenic	EEFSEC			ENSG00000132394			rs10934853-A	rs10934853	0	10934853	intron_variant	0.0	0.28	3e-10	9.522878745280336		1.12	[1.08-1.16]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127308101	intergenic	PCAT1, CASC8			ENSG00000253438, ENSG00000246228			rs16902094-G	rs16902094	0	16902094	intron_variant	0.0	0.15	6e-15	14.221848749616356		1.21	[1.15-1.26]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	17q12	17	37738049	intergenic	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0.0	0.52	8e-06	5.096910013008056		1.19	[1.10-1.28]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127472793	intergenic	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	0.11	2e-19	18.69897000433602		1.58	[1.43-1.74]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127112671	intergenic	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0.0	0.04	3e-14	13.522878745280336		1.8	[1.55-2.09]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127310936	intergenic	CASC8, PCAT1			ENSG00000246228, ENSG00000253438			rs445114-T	rs445114	0	445114	intron_variant	0.0	0.64	5e-10	9.30102999566398		1.14	[1.10-1.19]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	19q13.2	19	38244973	intergenic	SPINT2			ENSG00000167642			rs8102476-C	rs8102476	0	8102476	intron_variant	0.0	0.54	2e-11	10.69897000433602		1.12	[1.08-1.15]	Illumina [310520]	N
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	11q13.3	11	69211113	intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		51361.0	83038.0	rs11228565-A	rs11228565	0	11228565	regulatory_region_variant	1.0	0.20	7e-12	11.154901959985745		1.23	[1.16-1.31]	Illumina [310520]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	7p15.3	7	20954872	NR	LINC01162			ENSG00000232790			rs12155172-?	rs12155172	0	12155172	intron_variant	0.0	0.20	9e-06	5.045757490560675		1.05	[1.00-1.10]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2q31.1	2	172446825	ITGA6	ITGA6			ENSG00000091409			rs12621278-?	rs12621278	0	12621278	intron_variant	0.0	0.94	9.000000000000001e-23	22.045757490560675		1.33	[1.25-1.43]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	3p11.2	3	87124174	NR	LINC00506			ENSG00000281392			rs17181170-?	rs17181170	0	17181170	intron_variant	0.0	NR	3e-08	7.522878745280337				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	8q24.21	8	127506309	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		24170.0	180034.0	rs4242384-?	rs4242384	0	4242384	intergenic_variant	1.0	NR	2.0000000000000002e-24	23.69897000433602				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	11q13.3	11	69228491	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		66051.0	65660.0	rs7130881-?	rs7130881	0	7130881	intergenic_variant	1.0	NR	8e-13	12.096910013008056				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	6q25.3	6	160160342	NR	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1624.0	10719.0	rs651164-?	rs651164	0	651164	regulatory_region_variant	1.0	NR	2e-09	8.698970004336019				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2p21	2	43326810	THADA	THADA			ENSG00000115970			rs1465618-?	rs1465618	0	1465618	intron_variant	0.0	0.23	2e-08	7.698970004336019		1.08	[1.03-1.12]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q22.3	4	94641726	PDLIM5	PDLIM5			ENSG00000163110			rs17021918-?	rs17021918	0	17021918	intron_variant	0.0	0.65	4e-15	14.397940008672036		1.11	[1.08-1.15]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q24	4	105140377	TET2	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-?	rs7679673	0	7679673	intron_variant	1.0	0.55	3e-14	13.522878745280336		1.1	[1.06-1.14]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	8p21.2	8	23668950	NKX3.1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-?	rs1512268	0	1512268	intergenic_variant	1.0	0.45	3e-30	29.522878745280337		1.18	[1.14-1.22]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	11p15.5	11	2212344	IGF2, INS, TH, IGF2AS	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206.0	56154.0	rs7127900-?	rs7127900	0	7127900	intergenic_variant	1.0	0.20	3e-33	32.52287874528034		1.22	[1.17-1.27]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-?	rs5759167	0	5759167	TF_binding_site_variant	1.0	0.53	6e-29	28.22184874961636		1.16	[1.14-1.20]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	Xp11.22	X	51467205	NR	EZHIP - NUDT11	ENSG00000187690	ENSG00000196368		58362.0	22806.0	rs1327301-?	rs1327301	0	1327301	intergenic_variant	1.0	NR	2e-10	9.69897000433602				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q22.3	4	94593458	PDLIM5	PDLIM5			ENSG00000163110			rs12500426-?	rs12500426	0	12500426	intron_variant	0.0	0.46	1e-11	11.0		1.08	[1.05-1.12]	Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2p15	2	63074029	EHBP1	OTX1 - RPL27P5	ENSG00000115507	ENSG00000232403		16193.0	34089.0	rs6545977-?	rs6545977	0	6545977	regulatory_region_variant	1.0	NR	5e-07	6.301029995663981				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	7q21.3	7	98187015	NR	LMTK2			ENSG00000164715			rs6465657-?	rs6465657	0	6465657	intron_variant	0.0	NR	2e-08	7.698970004336019				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	10q11.22	10	46070851	NR	RPL23AP61 - AGAP7P	ENSG00000280012	ENSG00000264204		7136.0	38770.0	rs3123078-?	rs3123078	0	3123078	regulatory_region_variant	1.0	NR	1e-19	19.0				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-?	rs7501939	0	7501939	intron_variant	0.0	NR	3e-18	17.522878745280337				Illumina [541129]	N
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-?	rs1859962	0	1859962	intron_variant	0.0	NR	2e-16	15.69897000433602				Illumina [541129]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls		13q33.1	13	103275657	intergenic	SLC10A2 - LINC01309	ENSG00000125255	ENSG00000234551		209240.0	145168.0	rs1529276-?	rs1529276	0	1529276	intergenic_variant	1.0	NR	2e-06	5.698970004336019				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls		6p12.2	6	51801833	PKHD1	PKHD1			ENSG00000170927			rs10498792-?	rs10498792	0	10498792	intron_variant	0.0	NR	3e-06	5.522878745280337				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls		5q14.3	5	83689920	HAPLN1	HAPLN1			ENSG00000145681			rs4466137-?	rs4466137	0	4466137	intron_variant	0.0	NR	3e-06	5.522878745280337				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls		3q24	3	145456001	intergenic	NA - LARP7P4		ENSG00000244024			67537.0	rs345013-?	rs345013	0	345013	intergenic_variant	1.0	NR	5e-06	5.301029995663981				Affymetrix [70897]	N
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls		3p22.2	3	37954986	CTDSPL	CTDSPL			ENSG00000144677			rs9311171-?	rs9311171	0	9311171	splice_region_variant	0.0	NR	2e-06	5.698970004336019				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		2p16.1	2	59272212	intergenic	LINC01793			ENSG00000222030			rs10490113-?	rs10490113	0	10490113	intron_variant	0.0	NR	5e-06	5.301029995663981				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		15q21.1	15	48608389	FBN1	FBN1			ENSG00000166147			rs1876206-?	rs1876206	0	1876206	intron_variant	0.0	NR	6e-06	5.221848749616356				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		12q21.1	12	73596057	intergenic	NA - RNU6-1012P		ENSG00000252415			83131.0	rs1154865-?	rs1154865	0	1154865	intergenic_variant	1.0	NR	7e-07	6.154901959985743				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		18q21.2	18	55997051	intergenic	LINC01416			ENSG00000260930			rs1978503-?	rs1978503	0	1978503	non_coding_transcript_exon_variant	0.0	NR	1e-06	6.0				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		7q11.22	7	67594280	intergenic	NA - MTATP6P21		ENSG00000226392			33551.0	rs10263639-?	rs10263639	0	10263639	intergenic_variant	1.0	NR	3e-06	5.522878745280337				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		17q21.33	17	50196930	COL1A1	COL1A1			ENSG00000108821			rs2075555-?	rs2075555	0	2075555	intron_variant	0.0	NR	8e-08	7.096910013008056				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		21q21.3	21	29805194	GRIK1	GRIK1			ENSG00000171189			rs458685-?	rs458685	0	458685	intron_variant	0.0	NR	6e-06	5.221848749616356				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		5q34	5	164462274	intergenic	LINC02143			ENSG00000253236			rs6556756-?	rs6556756	0	6556756	intron_variant	0.0	NR	5e-07	6.301029995663981				Affymetrix [70897]	N
2008-09-10	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Breast cancer	58 cases, 665 controls		13q32.1	13	95222702	ABCC4	ABCC4			ENSG00000125257			rs1926657-?	rs1926657	0	1926657	intron_variant	0.0	NR	2e-06	5.698970004336019				Affymetrix [70897]	N
2008-06-16	18264098	Gudmundsson J	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264098	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	Prostate cancer	1,854 European ancestry cases, 21,372 European ancestry controls	8,239 European ancestry cases, 7,590 European ancestry controls	Xp11.22	X	51486831	LOC340602, NUDT10, NUDT11	EZHIP - NUDT11	ENSG00000187690	ENSG00000196368		77988.0	3180.0	rs5945572-A	rs5945572	0	5945572	intergenic_variant	1.0	0.35	4e-13	12.397940008672036		1.23	[1.16-1.30]	Illumina [310520]	N
2008-06-16	18264098	Gudmundsson J	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264098	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	Prostate cancer	1,854 European ancestry cases, 21,372 European ancestry controls	8,239 European ancestry cases, 7,590 European ancestry controls	2p15	2	62904596	EHBP1	EHBP1			ENSG00000115504			rs721048-A	rs721048	0	721048	intron_variant	0.0	0.19	8e-09	8.096910013008056		1.15	[1.10-1.21]	Illumina [310520]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	8q24.21	8	127505328	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		23189.0	181015.0	rs4242382-A	rs4242382	0	4242382	intergenic_variant	1.0	0.12	3e-19	18.522878745280337		1.66	[1.47-1.87]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.40	7e-13	12.154901959985745		1.16	[1.04-1.29]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	10q26.13	10	125008303	CTBP2	CTBP2			ENSG00000175029			rs4962416-C	rs4962416	0	4962416	intron_variant	0.0	0.27	2e-07	6.698970004336019		1.17	[1.05-1.30]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	11q13.3	11	69227200	intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67448.0	66951.0	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1.0	0.52	2e-09	8.698970004336019		1.1	[0.98-1.23]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	7p15.1	7	27936944	JAZF1	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	0.77	2e-06	5.698970004336019		1.12	[1.02-1.25]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	8q24.21	8	127401060	intergenic	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.53	7e-12	11.154901959985745		1.28	[1.15-1.45]	Illumina [527869]	N
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	17q12	17	37738049	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0.0	0.54	1e-09	9.0		1.18	[1.04-1.32]	Illumina [527869]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		12q23.3	12	108373556	CMKLR1	CMKLR1 - LINC01498	ENSG00000174600	ENSG00000247213		34239.0	60574.0	rs10861905-?	rs10861905	0	10861905	regulatory_region_variant	1.0	0.01	8e-07	6.096910013008056		33.95	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2q14.3	2	122533446	TSN							rs1527243-?	rs1527243	0	1527243	intron_variant	1.0	0.43	1e-06	6.0		6.67	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2p22.1	2	39720581	TMEM178	TMEM178A - THUMPD2	ENSG00000152154	ENSG00000138050		2618.0	15479.0	rs2716734-?	rs2716734	0	2716734	regulatory_region_variant	1.0	0.14	2e-06	5.698970004336019		5.97	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		1p36.13	1	17967993	IGSF21	NA - LINC01654		ENSG00000261781			97664.0	rs16861326-?	rs16861326	0	16861326	intergenic_variant	1.0	0.02	2e-06	5.698970004336019		17.85	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		9q22.32	9	94978992	C9orf3	AOPEP			ENSG00000148120			rs3802458-?	rs3802458	0	3802458	intron_variant	0.0	0.04	4e-06	5.3979400086720375		10.53	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		5q23.2	5	125030274	ZNF608	LINC02240			ENSG00000260192			rs6862844-?	rs6862844	0	6862844	intron_variant	0.0	0.09	4e-06	5.3979400086720375		6.72	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2q14.2	2	120943713	GLI2	GLI2			ENSG00000074047			rs11122834-?	rs11122834	0	11122834	intron_variant	0.0	0.29	5e-06	5.301029995663981		4.93	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		Xp21.3	X	25835497	MAGEB18							rs5944185-?	rs5944185	0	5944185	intergenic_variant	1.0	0.16	7e-06	5.154901959985743		10.5	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		20p11.21	20	24077771	GGTLC1	LINC01721			ENSG00000230133			rs6049375-?	rs6049375	0	6049375	intron_variant	0.0	0.28	8e-06	5.096910013008056		4.84	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		Xp11.4	X	37995474	SYTL5	H2AL1RP		ENSG00000147041			11079.0	rs872690-?	rs872690	0	872690	intron_variant	0.0	0.03	9e-06	5.045757490560675		11.78	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		Xq11.2	X	65147139	KIAA1166							rs7064929-?	rs7064929	0	7064929	intergenic_variant	1.0	0.17	7e-07	6.154901959985743		13.65	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2p22.2	2	38050689	FAM82A1	RMDN2, RMDN2-AS1			ENSG00000115841, ENSG00000235848			rs6741148-?	rs6741148	0	6741148	intron_variant	0.0	0.33	4e-06	5.3979400086720375		5.2	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2p21	2	47012873	TTC7A	TTC7A			ENSG00000068724			rs10194115-?	rs10194115	0	10194115	intron_variant	0.0	0.07	5e-07	6.301029995663981		9.0	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2p16.3	2	48974189	FSHR	FSHR			ENSG00000170820			rs2268363-?	rs2268363	0	2268363	intron_variant	0.0	0.18	5e-08	7.301029995663981		7.03	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		1p13.1	1	116927159	PTGFRN	PTGFRN			ENSG00000134247			rs2806864-?	rs2806864	0	2806864	intron_variant	0.0	0.15	6e-07	6.221848749616356		6.42	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		9p13.3	9	33283584	CHMP5	CHMP5 - NFX1	ENSG00000086065	ENSG00000086102		1514.0	6928.0	rs12336160-?	rs12336160	0	12336160	downstream_gene_variant	1.0	0.09	1e-06	6.0		7.26	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls					LRP1B							rs10210358-?	rs10210358	0	10210358	intron_variant	1.0	0.31	2e-06	5.698970004336019		5.34	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		Xp22.11	X	22873960	DDX53							rs5925696-?	rs5925696	0	5925696	intron_variant	1.0	0.26	3e-06	5.522878745280337		12.52	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		1p36.21	1	15465931	ELA2A	CELA2B, CELA2A			ENSG00000215704, ENSG00000142615			rs2901964-?	rs2901964	0	2901964	non_coding_transcript_exon_variant	0.0	0.37	5e-06	5.301029995663981		5.26	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2q11.2	2	96835063	CNNM3	CNNM3, ANKRD23			ENSG00000168763, ENSG00000163126			rs9948-?	rs9948	0	9948	3_prime_UTR_variant	0.0	0.31	6e-06	5.221848749616356		4.9	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		Xq12	X	66386851	HEPH	MTFR1P1 - NA	ENSG00000231356			25075.0		rs5965182-?	rs5965182	0	5965182	intergenic_variant	1.0	0.12	6e-06	5.221848749616356		11.73	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		2p24.1	2	21354871	APOB	NA - NUTF2P8		ENSG00000270654			7421.0	rs219553-?	rs219553	0	219553	intron_variant	1.0	0.42	7e-06	5.154901959985743		5.56	[NR]	Affymetrix [512497]	N
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls		Xp21.3	X	28214936	WDR42B							rs5971305-?	rs5971305	0	5971305	intergenic_variant	1.0	0.02	8e-06	5.096910013008056		33.69	[NR]	Affymetrix [512497]	N
2012-01-11	22130093	Nam RK	2011-12-01	Cancer Biol Ther	www.ncbi.nlm.nih.gov/pubmed/22130093	New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.	Prostate cancer	316 cases, 229 controls	55 Asian ancestry cases, 134 Asian ancestry controls, 1,382 European ancestry cases, 1,428 European ancestry controls, 184 Black cases, 127 Black controls, 42 cases, 87 controls	10q26.12	10	121273005	intergenic	LINC01153 - NA	ENSG00000227143			87039.0		rs11199874-?	rs11199874	0	11199874	intergenic_variant	1.0	NR	3e-10	9.522878745280336				Affymetrix [443816]	N
2012-01-11	22130093	Nam RK	2011-12-01	Cancer Biol Ther	www.ncbi.nlm.nih.gov/pubmed/22130093	New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.	Prostate cancer	316 cases, 229 controls	55 Asian ancestry cases, 134 Asian ancestry controls, 1,382 European ancestry cases, 1,428 European ancestry controls, 184 Black cases, 127 Black controls, 42 cases, 87 controls	15q21.1	15	46347610	intergenic	MTND5P40 - NA	ENSG00000259593			6011.0		rs4775302-?	rs4775302	0	4775302	intron_variant	1.0	NR	4e-08	7.397940008672037				Affymetrix [443816]	N
2008-06-16	17401363	Yeager M	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401363	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,124 European ancestry cases, 3,142 European ancestry controls	8q24.21	8	127472793	intergenic	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	0.11	2e-14	13.69897000433602		1.43	[1.29-1.59]	Illumina [538548]	N
2008-06-16	17401363	Yeager M	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401363	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,124 European ancestry cases, 3,142 European ancestry controls	8q24.21	8	127401060	intergenic	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.50	9e-13	12.045757490560677		1.26	[1.13-1.41]	Illumina [538548]	N
2008-06-16	17603485	Gudmundsson J	2007-07-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17603485	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	Prostate cancer	1,501 European ancestry cases, 11,290 European ancestry controls	1,992 European ancestry cases, 3,058 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	0.46	3e-10	9.522878745280336		1.2	[1.14-1.27]	Illumina [310520]	N
2008-06-16	17603485	Gudmundsson J	2007-07-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17603485	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	Prostate cancer	1,501 European ancestry cases, 11,290 European ancestry controls	1,992 European ancestry cases, 3,058 European ancestry controls	17q12	17	37738049	TCF2	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0.0	0.49	1e-11	11.0		1.22	[1.15-1.30]	Illumina [310520]	N
2013-05-09	23376709	Kerns SL	2013-01-31	J Urol	www.ncbi.nlm.nih.gov/pubmed/23376709	A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.	Urinary symptoms in response to radiotherapy in prostate cancer	346 European, African, Hispanic and Asian ancestry individuals	377 European, African, Hispanic and Asian ancestry individuals	9p21.2	9	27488094	IFNK, MOB3B	MOB3B			ENSG00000120162			rs17779457-?	rs17779457	0	17779457	intron_variant	0.0	0.25	7e-07	6.154901959985743	(at 2-3 yrs)	2.4	[1.1-3.6] unit increase	Affymetrix [613496]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8q24.21	8	127527115	intergenic	CASC8 - NA	ENSG00000246228			44976.0		rs7837688-?	rs7837688	0	7837688	intergenic_variant	1.0	NR	9.999999999999999e-26	25.0				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8q24.21	8	127091692	intergenic	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0.0	NR	2.0000000000000002e-29	28.69897000433602				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	2p24.1	2	20688505	C2orf43	LDAH			ENSG00000118961			rs13385191-G	rs13385191	0	13385191	intron_variant	0.0	0.44	8e-08	7.096910013008056		1.15	[1.10-1.21]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	6q22.1	6	116888889	GPRC6A, RFX6	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0.0	0.37	2e-12	11.69897000433602		1.22	[1.15-1.28]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	13q22.1	13	73154002	intergenic	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		40984.0	37526.0	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1.0	0.38	3e-09	8.522878745280337		1.18	[1.12-1.24]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	3p11.2	3	87103019	intergenic	LINC00506			ENSG00000281392			rs9284813-?	rs9284813	0	9284813	intron_variant	0.0	NR	5e-09	8.301029995663981				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8p21.2	8	23668950	NKX3.1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-?	rs1512268	0	1512268	intergenic_variant	1.0	NR	4e-11	10.397940008672036				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-?	rs10993994	0	10993994	5_prime_UTR_variant	0.0	NR	3e-08	7.522878745280337				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	17q12	17	37741165	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-?	rs7501939	0	7501939	intron_variant	0.0	NR	1e-12	12.0				Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	5p15.33	5	1895715	intergenic	CTD-2194D22.4			ENSG00000249326			rs12653946-T	rs12653946	0	12653946	intron_variant	0.0	0.44	4e-18	17.397940008672037		1.26	[1.20-1.33]	Illumina [510687]	N
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	6p21.1	6	41568689	FOXP4	FOXP4			ENSG00000137166			rs1983891-T	rs1983891	0	1983891	intron_variant	0.0	0.41	8e-08	7.096910013008056		1.15	[1.09-1.21]	Illumina [510687]	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	19q13.2	19	41479679	ATP5SL, CEACAM21	PCAT19			ENSG00000267107			rs11672691-G	rs11672691	0	11672691	non_coding_transcript_exon_variant	0.0	NR	1e-08	8.0	(Aggressive)	1.11	[1.02-1.20]	Illumina [~ 2600000] (imputed)	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	19q13.2	19	41479679	ATP5SL, CEACAM21	PCAT19			ENSG00000267107			rs11672691-G	rs11672691	0	11672691	non_coding_transcript_exon_variant	0.0	NR	2e-12	11.69897000433602	(All)	1.08	[1.04-1.12]	Illumina [~ 2600000] (imputed)	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	22q13.1	22	40040969	TNRC6B	FAM83F			ENSG00000133477			rs11704416-C	rs11704416	0	11704416	3_prime_UTR_variant	0.0	NR	4e-06	5.3979400086720375	(Aggressive)	1.05	[0.96-1.15]	Illumina [~ 2600000] (imputed)	N
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	22q13.1	22	40040969	TNRC6B	FAM83F			ENSG00000133477			rs11704416-C	rs11704416	0	11704416	3_prime_UTR_variant	0.0	NR	4e-07	6.3979400086720375	(All)	1.06	[1.02-1.10]	Illumina [~ 2600000] (imputed)	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	7q21.3	7	98187015	LMTK2	LMTK2			ENSG00000164715			rs6465657-C	rs6465657	0	6465657	intron_variant	0.0	0.46	1e-09	9.0		1.12	[1.05-1.20]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	0.40	9.000000000000001e-29	28.045757490560675		1.25	[1.17-1.34]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	19q13.33	19	50861367	KLK3	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603.0	201.0	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1.0	0.85	2e-18	17.69897000433602		1.2	[1.10-1.33]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127081052	intergenic	PRNCR1, PCAT1, CASC19			ENSG00000282961, ENSG00000253438, ENSG00000254166			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0.0	0.18	1e-07	7.0		1.37	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	0.46	1e-06	6.0		1.26	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	3p12.1	3	87061524	intergenic	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786.0	27605.0	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1.0	0.11	3e-08	7.522878745280337		1.18	[1.06-1.31]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	6q25.3	6	160412632	SLC22A3	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0.0	0.29	6e-10	9.221848749616356		1.17	[1.08-1.26]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	11q13.3	11	69227030	intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67278.0	67121.0	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1.0	0.51	2e-12	11.69897000433602		1.19	[1.11-1.27]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127401060	intergenic	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	0.49	9e-13	12.045757490560677		1.42	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127506309	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		24170.0	180034.0	rs4242384-C	rs4242384	0	4242384	intergenic_variant	1.0	0.09	3e-16	15.522878745280336		1.88	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	17q12	17	37741165	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0.0	0.57	9e-12	11.045757490560677		1.41	[NR]	Illumina [541129]	N
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	Xp11.22	X	51498820	NUDT10, NUDT11	LINC01496			ENSG00000234766			rs5945619-C	rs5945619	0	5945619	non_coding_transcript_exon_variant	0.0	0.36	2e-09	8.698970004336019		1.19	[1.07-1.31]	Illumina [541129]	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	10q24.32	10	102654464	CNNM2, CUEDC2, CYP17A1, FBXL15, LOC100505761, MIR146B, PSD, SFXN2, SUFU, TMEM180, ARL3, ACTR1A, AS3MT, TRIM8, C10orf32, C10orf32-AS3MT, WBP1L, C10orf95	TRIM8			ENSG00000171206			rs3850699-A	rs3850699	0	3850699	non_coding_transcript_exon_variant	0.0	0.71	5e-10	9.30102999566398		1.1	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	11q22.2	11	102530930	MMP8, BIRC2, MMP10, MMP20, MMP27, MMP7, YAP1, BIRC3, TMEM123	MMP7 - MMP20	ENSG00000137673	ENSG00000137674		180.0	45902.0	rs11568818-A	rs11568818	0	11568818	upstream_gene_variant	1.0	0.56	2e-11	10.69897000433602		1.1	[1.06-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	17p13.3	17	715725	DBIL5P, FAM57A, GEMIN4, GLOD4, NXN, RNMTL1, VPS53	VPS53, VPS53			ENSG00000141252, ENSG00000283883			rs684232-G	rs684232	0	684232	intron_variant	0.0	0.36	5e-15	14.30102999566398		1.1	[1.07-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	20q13.33	20	62440555	GTPBP5, HRH3, MIR1-1, MIR133A2, MIR4758, OSBPL2, RPS21, LAMA5, ADRM1, C20orf15, C20orf151, C20orf166, C20orf166-AS1, CABLES2, GATA5	RBBP8NL - GATA5	ENSG00000130701	ENSG00000130700		13016.0	22942.0	rs2427345-G	rs2427345	0	2427345	intron_variant	1.0	0.63	4e-08	7.397940008672037		1.06	[1.03-1.1]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	2p25.1	2	9977740	C2orf48, CYS1, GRHL1, KLF11, MIR4261, RRM2, TAF1B	GRHL1			ENSG00000134317			rs11902236-A	rs11902236	0	11902236	intron_variant	0.0	0.27	3e-08	7.522878745280337		1.07	[1.03-1.10]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	2q37.3	2	241443449	BOK-AS1, DTYMK, FARP2, HDLBP, SEP2, STK25, THAP4, ANO7, ATG4B, BOK	FARP2			ENSG00000006607			rs3771570-A	rs3771570	0	3771570	3_prime_UTR_variant	0.0	0.15	5e-09	8.301029995663981		1.12	[1.08-1.17]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	3q13.2	3	113556777	WDR52-AS1, ATP6V1A, BOC, KIAA2018, MIR4446, NAA50, SIDT1, SPICE1, WDR52, WDR52-AS	SIDT1			ENSG00000072858			rs7611694-A	rs7611694	0	7611694	intron_variant	0.0	0.59	4e-13	12.397940008672036		1.1	[1.08-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	4q13.3	4	73483441	COX18, AFM, RASSF6, ALB, AFP, ANKRD17, LOC72804, LOC728040	AFM			ENSG00000079557			rs1894292-G	rs1894292	0	1894292	intron_variant	0.0	0.52	5e-13	12.30102999566398		1.1	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	5q35.2	5	173512423	BOD1, FAM44B, LOC285593, STC2	NA - BOD1		ENSG00000145919			94722.0	rs6869841-A	rs6869841	0	6869841	intergenic_variant	1.0	0.21	5e-08	7.301029995663981		1.07	[1.04-1.11]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6q21	6	108963986	LACE1, LINC0022, LINC00222, ARMC2, SESN1, CEP57L1, FOXO3	ARMC2			ENSG00000118690			rs2273669-G	rs2273669	0	2273669	intron_variant	0.0	0.15	8e-09	8.096910013008056		1.07	[1.03-1.11]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6q25.2	6	153119944	RGS17, FBXO5, MTRF1L	RGS17			ENSG00000091844			rs1933488-A	rs1933488	0	1933488	intron_variant	0.0	0.59	4e-18	17.397940008672037		1.12	[1.09-1.15]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	7p15.3	7	20954872	SP8, ABCB5, RPL23P8	LINC01162			ENSG00000232790			rs12155172-A	rs12155172	0	12155172	intron_variant	0.0	0.23	5e-13	12.30102999566398		1.11	[1.07-1.15]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	8p21.2	8	26034626	EBF2	EBF2			ENSG00000221818			rs11135910-A	rs11135910	0	11135910	intron_variant	0.0	0.16	8e-11	10.096910013008056		1.11	[1.07-1.16]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	12q24.21	12	114247766	TBX5, LOC255480	LINC02459 - NA	ENSG00000257476			5996.0		rs1270884-A	rs1270884	0	1270884	intergenic_variant	1.0	0.49	7e-11	10.154901959985745		1.07	[1.04-1.10]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	14q22.1	14	52905612	DDHD1, ERO1L, TXNDC16, FERMT2, GNPNAT1, GPR137C, PSMC6, STYX	FERMT2			ENSG00000073712			rs8008270-G	rs8008270	0	8008270	intron_variant	0.0	0.82	2e-14	13.69897000433602		1.12	[1.08-1.16]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	14q24.1	14	68660027	RAD51B, ZFP36L1, ACTN1	RAD51B			ENSG00000182185			rs7141529-G	rs7141529	0	7141529	intron_variant	0.0	0.5	3e-10	9.522878745280336		1.09	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	17q21.32	17	49267824	NGFR, PHB, PHOSPHO1, HOXB13, PRAC, SPOP, ZNF652, ABI3, B4GALNT2, FLJ40194, GNGT2, IGF2BP1	FLJ40194			ENSG00000177369			rs11650494-A	rs11650494	0	11650494	intron_variant	0.0	0.08	2e-09	8.698970004336019		1.15	[1.09-1.22]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	18q23	18	79013973	SALL3, ATP9B	SALL3 - ATP9B	ENSG00000263310	ENSG00000166377		11296.0	55312.0	rs7241993-G	rs7241993	0	7241993	intergenic_variant	1.0	0.7	2e-09	8.698970004336019		1.09	[1.05-1.12]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	1q21.3	1	154861707	ADAM15, ADAR, CKS1B, DCST1, DCST2, EFNA3, EFNA4, LOC10050, FLAD1, KCNN3, LENEP, LOC100505666, MIR4258, PBXIP1, DPM3, PYGO2, EFNA1, SHC1, SLC50A1, ZBTB7B, PMVK	KCNN3			ENSG00000143603			rs1218582-G	rs1218582	0	1218582	intron_variant	0.0	0.45	2e-08	7.698970004336019		1.06	[1.03-1.09]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	1q32.1	1	204549714	LRRN2, PIK3C2B, LOC127841, MDM4, PPP1R15B, PLEKHA6	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0.0	0.75	2e-11	10.69897000433602		1.1	[1.05-1.14]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6p21.32	6	32224554	CYP21A2, DOM3Z, FKBPL, HLA-DRB6, HCG23, LOC10029, ATF6B, LOC100293534, AGER, LOC100507547, MIR1236, PPT2, PPT2-EGF, HLA-DRA, PPT2-EGFL8, RNF5, RNF5P1, CFB, RDBP, TNXA, TNXB, HLA-DQB1, NOTCH4, SKIV2L, STK19, GPSM3, PBX2, LOC10050, EGFL8, AGPAT1, C2, C4A, PRRT1, BTNL2, C4B, HLA-DRB5, C6orf10, HLA-DRB1, CYP21A1P, HLA-DQA1	NOTCH4 - TSBP1-AS1	ENSG00000238196	ENSG00000225914		487.0	30086.0	rs3096702-A	rs3096702	0	3096702	intergenic_variant	1.0	0.4	5e-09	8.301029995663981		1.07	[1.04-1.10]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	20q13.33	20	63731211	STMN3, ZBTB46, ZGPAT, ABHD16B, ARFRP1, C20orf195, DNAJC5, EEF1A2, GMEB2, LIME1, LOC100505815, MIR1914, MIR647, MIR941-1, MIR941-2, MIR941-3, MIR941-4, PPDPF, PRIC285, PRPF6, PTK6, RTEL1, RTEL1-TN, RTEL1-TNFRSF6B, SAMD10, SRMS, TNFRSF6B, TPD52L2, UCKL1, SLC2A4RG, UCKL1-AS1, ZNF512B	ZGPAT			ENSG00000197114			rs6062509-A	rs6062509	0	6062509	intron_variant	0.0	0.7	4e-16	15.397940008672036		1.12	[1.09-1.16]	Illumina [~ 2600000] (imputed)	N
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	Xp22.2	X	9846095	GPR143, LOC100288814, SHROOM2, TBL1X, WWC3	SHROOM2			ENSG00000146950			rs2405942-A	rs2405942	0	2405942	intron_variant	0.0	0.79	2e-10	9.69897000433602		1.14	[1.09-1.2]	Illumina [~ 2600000] (imputed)	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	11q13.3	11	69228491	intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		66051.0	65660.0	rs7130881-G	rs7130881	0	7130881	intergenic_variant	1.0	NR	9e-09	8.045757490560675		1.31	[1.20-1.44]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	17q12	17	37741165	TCF2	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0.0	NR	2e-06	5.698970004336019		1.19	[1.11-1.28]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	NR	3e-11	10.522878745280336		1.27	[1.18-1.37]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127081052	intergenic	PRNCR1, PCAT1, CASC19			ENSG00000282961, ENSG00000253438, ENSG00000254166			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0.0	NR	4e-10	9.397940008672036		1.31	[1.20-1.42]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	2q37.3	2	237534583	MLPH	MLPH			ENSG00000115648			rs2292884-G	rs2292884	0	2292884	missense_variant	0.0	0.25	4e-08	7.397940008672037		1.14	[1.09-1.19]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	3p11.2	3	87192347	intergenic	LINC00506 - MIR4795	ENSG00000281392	ENSG00000264119		33984.0	33842.0	rs7629490-T	rs7629490	0	7629490	intergenic_variant	1.0	NR	1e-07	7.0	(conditioned on rs2660753)	1.06	[1.04-1.09]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	6q25.3	6	160160342	SLC22A1	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1624.0	10719.0	rs651164-G	rs651164	0	651164	regulatory_region_variant	1.0	NR	2e-10	9.69897000433602	(conditioned on rs9364554)	1.15	[1.10-1.20]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127082911	intergenic	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs13252298-A	rs13252298	0	13252298	non_coding_transcript_exon_variant	0.0	NR	4e-06	5.3979400086720375	(conditioned on 5 SNPs)	1.12	[1.05-1.18]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	22q13.2	22	43122269	BIK	BIK			ENSG00000100290			rs742134-G	rs742134	0	742134	intron_variant	0.0	NR	6e-06	5.221848749616356	(conditioned on rs5759167)	1.16	[1.01-1.23]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127310936	intergenic	CASC8, PCAT1			ENSG00000246228, ENSG00000253438			rs445114-T	rs445114	0	445114	intron_variant	0.0	NR	5e-07	6.301029995663981		1.22	[1.12-1.32]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127401060	intergenic	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	NR	9e-06	5.045757490560675		1.2	[1.11-1.32]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127506309	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		24170.0	180034.0	rs4242384-C	rs4242384	0	4242384	intergenic_variant	1.0	NR	3e-16	15.522878745280336		1.56	[1.40-1.73]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	NR	5e-06	5.301029995663981		1.18	[1.10-1.27]	Illumina [571243]	N
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	12q13.13	12	52880120	KRT8, EIF4B, TENC1	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028.0	5309.0	rs902774-A	rs902774	0	902774	regulatory_region_variant	1.0	0.17	5e-09	8.301029995663981		1.17	[1.11-1.24]	Illumina [571243]	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		1q32.1	1	204591549	AL512306.3	RNA5SP74 - LRRN2	ENSG00000200408	ENSG00000170382		29028.0	25621.0	rs6679717-?	rs6679717	0	6679717	regulatory_region_variant	1.0	NR	3e-13	12.522878745280336				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2p25.1	2	9954397	GRHL1	GRHL1			ENSG00000134317			rs73913932-?	rs73913932	0	73913932	intron_variant	0.0	NR	4e-08	7.397940008672037				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2p24.1	2	20682080	C2orf43	GDF7 - LDAH	ENSG00000143869	ENSG00000118961		2837.0	1934.0	rs2289081-?	rs2289081	0	2289081	regulatory_region_variant	1.0	NR	2e-09	8.698970004336019				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2p23.3	2	27604225	ZNF512	ZNF512			ENSG00000243943			rs12464616-?	rs12464616	0	12464616	intron_variant	0.0	NR	1e-08	8.0				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2p21	2	43570571	THADA	THADA			ENSG00000115970			rs11904510-?	rs11904510	0	11904510	intron_variant	0.0	NR	8e-17	16.096910013008056				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2p14	2	65049318	CEP68	LINC02576, LINC02245			ENSG00000232613, ENSG00000237638			rs1009358-?	rs1009358	0	1009358	intron_variant	0.0	NR	8e-09	8.096910013008056				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2q13	2	111138666	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs17041869-?	rs17041869	0	17041869	intron_variant	0.0	NR	1e-12	12.0				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		2q36.3	2	226310267	AC068138.1							rs2673148-?	rs2673148	0	2673148	intergenic_variant	1.0	NR	2e-08	7.698970004336019				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		3p25.2	3	12234993	PPARG	SYN2 - GSTM5P1	ENSG00000157152	ENSG00000236062		42961.0	22808.0	rs11709119-?	rs11709119	0	11709119	regulatory_region_variant	1.0	NR	5e-10	9.30102999566398				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		3p24.3	3	23242812	UBE2E2	UBE2E2			ENSG00000182247			rs114460169-?	rs114460169	0	114460169	intron_variant	0.0	NR	2e-09	8.698970004336019				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		3q13.2	3	113590302	SIDT1	SIDT1			ENSG00000072858			rs6808932-?	rs6808932	0	6808932	intron_variant	0.0	NR	2e-12	11.69897000433602				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		3q21.3	3	128321052	EEFSEC	EEFSEC			ENSG00000132394			rs11708733-?	rs11708733	0	11708733	intron_variant	0.0	NR	2e-08	7.698970004336019				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		3q23	3	141421524	ZBTB38	ZBTB38			ENSG00000177311			rs6763927-T	rs6763927	0	6763927	intron_variant	0.0	0.44	3e-09	8.522878745280337				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		3q25.1	3	152292353	MBNL1	MBNL1			ENSG00000152601			rs76360965-?	rs76360965	0	76360965	intron_variant	0.0	NR	2e-12	11.69897000433602				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		5q11.2	5	52762839	ITGA1	NA - ITGA1		ENSG00000213949			25077.0	rs4530726-?	rs4530726	0	4530726	intron_variant	1.0	NR	4e-08	7.397940008672037				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		5q31.1	5	134513226	AC005355.2	LINC01843 - RN7SL541P	ENSG00000251169	ENSG00000240250		3997.0	4584.0	rs10900829-?	rs10900829	0	10900829	intergenic_variant	1.0	NR	5e-10	9.30102999566398				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		6p22.3	6	20843920	CDKAL1	CDKAL1			ENSG00000145996			rs9356756-?	rs9356756	0	9356756	intron_variant	0.0	NR	4e-08	7.397940008672037				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		6q22.1	6	116943827	RFX6	RFX6 - NA	ENSG00000185002			11666.0		rs1741652-?	rs1741652	0	1741652	intergenic_variant	1.0	NR	4e-08	7.397940008672037				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		6q25.2	6	153073593	RGS17	RGS17			ENSG00000091844			rs4385321-A	rs4385321	0	4385321	intron_variant	0.0	0.35	1e-15	15.0				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		6q25.3	6	160262349	SLC22A2	SLC22A2			ENSG00000112499			rs316025-?	rs316025	0	316025	intron_variant	0.0	NR	1e-12	12.0				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		7p15.3	7	20972525	LINC01162	LINC01162			ENSG00000232790			rs6944344-?	rs6944344	0	6944344	intron_variant	0.0	NR	4e-08	7.397940008672037				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		7p15.1	7	27988813	JAZF1	JAZF1			ENSG00000153814			rs38514-?	rs38514	0	38514	intron_variant	0.0	NR	8e-10	9.096910013008056				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		7q21.3	7	98124762	LMTK2	LMTK2			ENSG00000164715			rs73404162-?	rs73404162	0	73404162	intron_variant	0.0	NR	8e-09	8.096910013008056				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		8q22.1	8	94727414	DPY19L4	DPY19L4			ENSG00000156162			rs67763258-?	rs67763258	0	67763258	intron_variant	0.0	NR	2e-08	7.698970004336019				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		8q24.21	8	127379167	CASC8	PCAT1, CASC8, POU5F1B			ENSG00000253438, ENSG00000246228, ENSG00000212993			rs62516032-?	rs62516032	0	62516032	intron_variant	0.0	NR	7e-11	10.154901959985745				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		9p22.1	9	19064131	HAUS6	HAUS6			ENSG00000147874			rs13287517-C	rs13287517	0	13287517	intron_variant	0.0	0.39	1e-14	14.0				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		9p21.3	9	22003224	CDKN2A/B	CDKN2B-AS1, CDKN2B			ENSG00000240498, ENSG00000147883			rs3217992-?	rs3217992	0	3217992	3_prime_UTR_variant	0.0	NR	8e-09	8.096910013008056				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		9p13.3	9	34025642	UBAP2	UBAP2			ENSG00000137073			rs1758632-C	rs1758632	0	1758632	intron_variant	0.0	0.38	1e-12	12.0				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		10p14	10	12166308	NUDT5	NUDT5, SEC61A2			ENSG00000165609, ENSG00000065665			rs1053403-?	rs1053403	0	1053403	3_prime_UTR_variant	0.0	NR	3e-08	7.522878745280337				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		10q26.12	10	121279383	LINC01153	LINC01153 - NA	ENSG00000227143			93417.0		rs12413648-?	rs12413648	0	12413648	intergenic_variant	1.0	NR	9e-10	9.045757490560677				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		11p11.2	11	47440142	RAPSN	RAPSN			ENSG00000165917			rs7103835-A	rs7103835	0	7103835	intron_variant	0.0	0.31	3e-10	9.522878745280336				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		11q13.3	11	69127285	RP11-554A11.7	TPCN2			ENSG00000162341			rs12284087-?	rs12284087	0	12284087	intron_variant	0.0	NR	4e-10	9.397940008672036				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		11q13.5	11	76546171	C11orf30	EMSY			ENSG00000158636			rs3753051-?	rs3753051	0	3753051	synonymous_variant	0.0	NR	3e-09	8.522878745280337				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		11q23.2	11	113936459	HTR3A/B	HTR3B			ENSG00000149305			rs11214775-?	rs11214775	0	11214775	intron_variant	0.0	NR	3e-11	10.522878745280336				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		14q12	14	32833676	AKAP6	AKAP6			ENSG00000151320			rs17522122-T	rs17522122	0	17522122	3_prime_UTR_variant	0.0	0.48	4e-09	8.397940008672037				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		15q15.1	15	40588918	KNL1	Metazoa_SRP - KNL1	ENSG00000276525	ENSG00000137812		3167.0	5102.0	rs10400825-G	rs10400825	0	10400825	regulatory_region_variant	1.0	0.15	3e-09	8.522878745280337				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		15q26.1	15	89885916	AP3S2	ARPIN-AP3S2, AP3S2			ENSG00000250021, ENSG00000157823			rs12912009-?	rs12912009	0	12912009	intron_variant	0.0	NR	3e-09	8.522878745280337				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		17p11.2	17	17821475	SREBF1	SREBF1			ENSG00000072310			rs11656665-?	rs11656665	0	11656665	intron_variant	0.0	NR	8e-10	9.096910013008056				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		17q21.32	17	47808390	OSBPL7	OSBPL7			ENSG00000006025			rs9911983-?	rs9911983	0	9911983	synonymous_variant	0.0	NR	5e-08	7.301029995663981				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		17q21.32	17	48959662	GIP	GIP			ENSG00000159224			rs11079847-?	rs11079847	0	11079847	intron_variant	0.0	NR	3e-09	8.522878745280337				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		18q23	18	76850295	ZNF236	ZNF236			ENSG00000130856			rs7236466-G	rs7236466	0	7236466	intron_variant	0.0	0.38	2e-08	7.698970004336019				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		20q13.33	20	63706054	ARFRP1	ARFRP1			ENSG00000101246			rs6011040-?	rs6011040	0	6011040	intron_variant	0.0	NR	2e-13	12.69897000433602				Illumina [5041948] (imputed)	N
2021-03-22	33290408	Ray D	2020-12-08	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/33290408	A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer.	Type 2 diabetes or prostate cancer (pleiotropy)	62,892 European ancestry T2D cases, 79,194 European ancestry PrCa cases, 659,536 European ancestry controls		22q13.1	22	40083807	TNRC6B	TNRC6B			ENSG00000100354			rs9607685-?	rs9607685	0	9607685	intron_variant	0.0	NR	4e-08	7.397940008672037				Illumina [5041948] (imputed)	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127392827	CASC8	CASC8, POU5F1B, PCAT1			ENSG00000246228, ENSG00000212993, ENSG00000253438			rs16902147-C	rs16902147	0	16902147	intron_variant	0.0	0.04	1e-11	11.0		1.86	[1.56-2.23] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127141075	PRNCR1, CASC19	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs79012498-G	rs79012498	0	79012498	intron_variant	0.0	0.044	2e-11	10.69897000433602		1.81	[1.53-2.15] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		17q21.32	17	49267824	RP1-62O9.3, ZNF652	FLJ40194			ENSG00000177369			rs11650494-A	rs11650494	0	11650494	intron_variant	0.0	0.04	3e-09	8.522878745280337		1.96	[1.46-2.12] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127395816	CASC8	PCAT1, CASC8, POU5F1B			ENSG00000253438, ENSG00000246228, ENSG00000212993			rs58809953-A	rs58809953	0	58809953	intron_variant	0.0	0.04	3e-09	8.522878745280337		1.71	[1.43-2.04] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		17q21.32	17	47852993	SP6	SP6			ENSG00000189120			rs2074187-A	rs2074187	0	2074187	intron_variant	0.0	0.042	4e-08	7.397940008672037		1.66	[1.38-1.98] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127522409	CASC8, CASC11	CASC8 - NA	ENSG00000246228			40270.0		rs9656816-G	rs9656816	0	9656816	intergenic_variant	1.0	0.12	2e-10	9.69897000433602		1.43	[1.28-1.60] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		11q13.3	11	69224818	RP11-554A11.8, MYEOV	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		65066.0	69333.0	rs12795301-A	rs12795301	0	12795301	intergenic_variant	1.0	0.098	3e-08	7.522878745280337		1.42	[1.25-1.61] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8p21.2	8	23665338	RP11-583M2.2, NKX3-1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		29831.0	13359.0	rs995432-G	rs995432	0	995432	intergenic_variant	1.0	0.45	8e-16	15.096910013008056		1.38	[1.28-1.50] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127467718	CASC8	CASC8			ENSG00000246228			rs4871798-A	rs4871798	0	4871798	intron_variant	0.0	0.23	3e-10	9.522878745280336		1.33	[1.22-1.46] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127484531	CASC8	CASC8 - NA	ENSG00000246228			2392.0		rs6985504-A	rs6985504	0	6985504	intergenic_variant	1.0	0.3	1e-08	8.0		1.27	[1.17-1.38] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127460075	CASC8	CASC8			ENSG00000246228			rs1447293-G	rs1447293	0	1447293	intron_variant	0.0	0.44	6e-09	8.221848749616356		1.26	[1.16-1.36] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		17q21.32	17	48703135	LINC02086	LINC02086			ENSG00000244649			rs4793976-G	rs4793976	0	4793976	intron_variant	0.0	0.33	1e-08	8.0		1.26	[1.17-1.37] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		17q12	17	37746322	HNF1B	HNF1B - YWHAEP7	ENSG00000275410	ENSG00000282630		1263.0	81983.0	rs3760511-C	rs3760511	0	3760511	regulatory_region_variant	1.0	0.43	7e-09	8.154901959985743		1.26	[1.16-1.36] unit increase	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		17q24.3	17	71122495	CASC17	CASC17			ENSG00000260785			rs4793529-G	rs4793529	0	4793529	intron_variant	0.0	0.53	2e-08	7.698970004336019		0.8	[0.74-0.87] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127429290	CASC8	CASC8			ENSG00000246228			rs4871790-C	rs4871790	0	4871790	intron_variant	0.0	0.5	2e-08	7.698970004336019		0.8	[0.74-0.87] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127329435	CASC8	CASC8, POU5F1B, PCAT1			ENSG00000246228, ENSG00000212993, ENSG00000253438			rs587948-C	rs587948	0	587948	intron_variant	0.0	0.39	3e-08	7.522878745280337		0.8	[0.74-0.87] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		19q13.33	19	50865818	KLK2	KLK2			ENSG00000167751			rs2739459-G	rs2739459	0	2739459	intron_variant	0.0	0.48	2e-08	7.698970004336019		0.79	[0.73-0.86] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		7p15.1	7	27949784	JAZF1	JAZF1			ENSG00000153814			rs757138-C	rs757138	0	757138	intron_variant	0.0	0.31	1e-08	8.0		0.78	[0.72-0.85] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		19q13.33	19	50857562	KLK3	KLK3			ENSG00000142515			rs266876-G	rs266876	0	266876	non_coding_transcript_exon_variant	0.0	0.23	3e-08	7.522878745280337		0.76	[0.69-0.84] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		8q24.21	8	127395198	CASC8	POU5F1B, PCAT1, CASC8			ENSG00000212993, ENSG00000253438, ENSG00000246228			rs10505477-G	rs10505477	0	10505477	intron_variant	0.0	0.53	6e-14	13.221848749616356		0.74	[0.69-0.80] unit decrease	Illumina [185478]	N
2021-06-09	34012061	Sipeky C	2021-05-19	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/34012061	Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.	Prostate cancer	2,738 Finnish ancestry cases, 2,400 Finnish ancestry controls		19q13.33	19	50842312	AC011523.2	KLK15 - KLK3	ENSG00000174562	ENSG00000142515		5099.0	12603.0	rs2659051-G	rs2659051	0	2659051	intron_variant	1.0	0.16	6e-09	8.221848749616356		0.72	[0.64-0.80] unit decrease	Illumina [185478]	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		6p24.2	6	11218797	NR	NEDD9			ENSG00000111859			rs4713266-C	rs4713266	0	4713266	intron_variant	0.0	NR	1e-05	5.0		1.06	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		6q21	6	108963986	NR	ARMC2			ENSG00000118690			rs2273669-G	rs2273669	0	2273669	intron_variant	0.0	NR	9e-07	6.045757490560675		1.1	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		6q22.1	6	116888889	NR	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0.0	NR	4e-10	9.397940008672036		1.1	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		6q25.3	6	160160342	NR	SLC22A1 - SLC22A2	ENSG00000175003	ENSG00000112499		1624.0	10719.0	rs651164-G	rs651164	0	651164	regulatory_region_variant	1.0	NR	2e-08	7.698970004336019		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		6q25.3	6	160412632	NR	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0.0	NR	4e-12	11.397940008672036		1.11	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0.0	NR	2e-19	18.69897000433602		1.17	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		7q21.3	7	98187015	NR	LMTK2			ENSG00000164715			rs6465657-C	rs6465657	0	6465657	intron_variant	0.0	NR	1e-14	14.0		1.12	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443.0	9747.0	rs1512268-A	rs1512268	0	1512268	intergenic_variant	1.0	NR	2e-21	20.69897000433602		1.15	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		8q24.21	8	127081052	NR	PRNCR1, PCAT1, CASC19			ENSG00000282961, ENSG00000253438, ENSG00000254166			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0.0	NR	4e-41	40.39794000867204		1.25	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		8q24.21	8	127401060	NR	CASC8, CCAT2, POU5F1B, PCAT1			ENSG00000246228, ENSG00000280997, ENSG00000212993, ENSG00000253438			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0.0	NR	1e-52	52.0		1.24	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		10q11.22	10	46046326	NR	MSMB			ENSG00000263639			rs10993994-T	rs10993994	0	10993994	5_prime_UTR_variant	0.0	NR	2e-52	51.69897000433602		1.24	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		11p15.5	11	2212344	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206.0	56154.0	rs7127900-A	rs7127900	0	7127900	intergenic_variant	1.0	NR	4.0000000000000004e-24	23.39794000867204		1.19	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		11q13.3	11	69227200	NR	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67448.0	66951.0	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1.0	NR	4e-33	32.39794000867204		1.19	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		11q22.2	11	102530930	NR	MMP7 - MMP20	ENSG00000137673	ENSG00000137674		180.0	45902.0	rs11568818-A	rs11568818	0	11568818	upstream_gene_variant	1.0	NR	6e-06	5.221848749616356		1.07	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		12q13.12	12	49282227	NR	TUBA1C - TROAP-AS1	ENSG00000167553	ENSG00000258334		7627.0	10404.0	rs10875943-C	rs10875943	0	10875943	intergenic_variant	1.0	NR	8e-10	9.096910013008056		1.1	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028.0	5309.0	rs902774-A	rs902774	0	902774	regulatory_region_variant	1.0	NR	2e-10	9.69897000433602		1.13	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		14q22.1	14	52905612	NR	FERMT2			ENSG00000073712			rs8008270-G	rs8008270	0	8008270	intron_variant	0.0	NR	9e-09	8.045757490560675		1.11	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		17p13.3	17	715725	NR	VPS53, VPS53			ENSG00000141252, ENSG00000283883			rs684232-G	rs684232	0	684232	intron_variant	0.0	NR	4e-08	7.397940008672037		1.08	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		17p13.1	17	7899800	NR	CHD3			ENSG00000170004			rs28441558-C	rs28441558	0	28441558	intron_variant	0.0	NR	1e-08	8.0		1.18	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0.0	NR	9e-41	40.04575749056068		1.22	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		17q21.32	17	48728343	NR	HOXB13			ENSG00000159184			rs138213197-T	rs138213197	0	138213197	missense_variant	0.0	NR	3e-43	42.52287874528034		4.46	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0.0	NR	9.000000000000001e-23	22.045757490560675		1.15	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		19q13.2	19	38244973	NR	SPINT2			ENSG00000167642			rs8102476-C	rs8102476	0	8102476	intron_variant	0.0	NR	8e-11	10.096910013008056		1.1	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603.0	201.0	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1.0	NR	1e-21	21.0		1.25	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		22q13.2	22	43104206	NR	TTLL1 - BIK	ENSG00000100271	ENSG00000100290		14787.0	6544.0	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1.0	NR	3.9999999999999997e-25	24.39794000867204		1.16	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		Xp22.2	X	9846095	NR	SHROOM2			ENSG00000146950			rs2405942-A	rs2405942	0	2405942	intron_variant	0.0	NR	2e-06	5.698970004336019		1.06	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		8p12	8	29356070	DUSP4, KIF13B	DUSP4 - NA	ENSG00000120875			5386.0		rs557046152-G	rs557046152	1	78795568	intron_variant	1.0	NR	5e-09	8.301029995663981		1.79	1.47-2.17	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		4q31.21	4	140700216	TBC1D9	TBC1D9			ENSG00000109436			rs555778703-G	rs555778703	0	555778703	intron_variant	0.0	NR	2e-08	7.698970004336019		1.82	1.48-2.24	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3p21.31	3	49612440	BSN	BSN			ENSG00000164061			rs62262671-G	rs62262671	0	62262671	intron_variant	0.0	NR	4e-08	7.397940008672037		1.12	1.07-1.16	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		16p13.3	16	4964068	NR	SEC14L5			ENSG00000103184			rs80242938-G	rs80242938	0	80242938	intron_variant	0.0	NR	4e-09	8.397940008672037		11.7	5.16-26.6	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		8q12.1	8	56135791	NR	MOS - PLAG1	ENSG00000172680	ENSG00000181690		21809.0	25118.0	rs149892036-T	rs149892036	0	149892036	intergenic_variant	1.0	NR	4e-08	7.397940008672037		2.14	1.63-2.81	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3q26.33	3	182870860	NR	ATP11B			ENSG00000058063			rs139191981-A	rs139191981	0	139191981	intron_variant	0.0	NR	5e-08	7.301029995663981		5.43	2.95-9.97	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0.0	NR	7e-07	6.154901959985743		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		1q32.1	1	204549714	NR	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0.0	NR	1e-07	7.0		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		2p21	2	43326810	NR	THADA			ENSG00000115970			rs1465618-A	rs1465618	0	1465618	intron_variant	0.0	NR	6e-09	8.221848749616356		1.1	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		2p15	2	62950976	NR	EHBP1			ENSG00000115504			rs2430386-T	rs2430386	0	2430386	intron_variant	0.0	NR	1e-13	13.0		1.11	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0.0	NR	2e-09	8.698970004336019		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		2q31.1	2	172446825	NR	ITGA6			ENSG00000091409			rs12621278-A	rs12621278	0	12621278	intron_variant	0.0	NR	2e-14	13.69897000433602		1.28	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3p12.1	3	87061524	NR	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786.0	27605.0	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1.0	NR	5e-07	6.301029995663981		1.12	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3q13.2	3	113556777	NR	SIDT1			ENSG00000072858			rs7611694-A	rs7611694	0	7611694	intron_variant	0.0	NR	1e-08	8.0		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3q21.3	3	128319530	NR	EEFSEC			ENSG00000132394			rs10934853-A	rs10934853	0	10934853	intron_variant	0.0	NR	5e-08	7.301029995663981		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3q26.2	3	170281428	NR	PRKCI			ENSG00000163558			rs71277158-T	rs71277158	0	71277158	non_coding_transcript_exon_variant	0.0	NR	4e-11	10.397940008672036		1.14	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		3q26.2	3	170412314	NR	SKIL - CLDN11	ENSG00000136603	ENSG00000013297		15479.0	6554.0	rs10936632-A	rs10936632	0	10936632	intron_variant	1.0	NR	8e-06	5.096910013008056		1.07	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		4q22.3	4	94593458	NR	PDLIM5			ENSG00000163110			rs12500426-A	rs12500426	0	12500426	intron_variant	0.0	NR	6e-09	8.221848749616356		1.09	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		4q24	4	105140377	NR	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-C	rs7679673	0	7679673	intron_variant	1.0	NR	4e-18	17.397940008672037		1.14	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		5p15.33	5	1279913	NR	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0.0	NR	1e-15	15.0		1.16	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		5p15.33	5	1895715	NR	CTD-2194D22.4			ENSG00000249326			rs12653946-T	rs12653946	0	12653946	intron_variant	0.0	NR	6e-11	10.221848749616356		1.1	NR	Affymetrix [at least 232408] (imputed)	N
2021-06-23	33293427	Emami NC	2020-12-08	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/33293427	A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility.	Prostate cancer	14,113 European ancestry cases, 194,140 European ancestry controls		5q31.1	5	134500518	NR	RNU6-456P - LINC01843	ENSG00000207222	ENSG00000251169		234.0	6034.0	rs10793821-T	rs10793821	0	10793821	upstream_gene_variant	1.0	NR	1e-07	7.0		1.08	NR	Affymetrix [at least 232408] (imputed)	N
2021-04-21	31748686	Oh JJ	2019-11-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31748686	An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer.	Prostate cancer	985 Korean ancestry cases and 6,273 Korean ancestry controls		16q23.2	16	80633162	CDYL2	CDYL2			ENSG00000166446			rs148821008-T	rs148821008	0	148821008	missense_variant	0.0	5.59E-4	5e-07	6.301029995663981				Illumina [71270]	N
2021-04-21	31748686	Oh JJ	2019-11-20	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/31748686	An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer.	Prostate cancer	985 Korean ancestry cases and 6,273 Korean ancestry controls		7p22.3	7	1091775	GPER1	C7orf50, GPER1			ENSG00000146540, ENSG00000164850			rs11544331-T	rs11544331	0	11544331	missense_variant	0.0	0.0285	1e-15	15.0				Illumina [71270]	N
2021-12-01	34737426	Jiang L	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737426	A generalized linear mixed model association tool for biobank-scale data.	Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)	3,221 European ancestry cases, 205,547 European ancestry controls		17q21.32	17	48728343		HOXB13			ENSG00000159184			rs138213197-T	rs138213197	0	138213197	missense_variant	0.0	0.001661	6e-23	22.22184874961636		4.0	[3.21-4.79] unit increase	NR [11842647] (imputed)	N
2021-12-01	34737426	Jiang L	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737426	A generalized linear mixed model association tool for biobank-scale data.	Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)	3,221 European ancestry cases, 205,547 European ancestry controls		8q24.21	8	127179427		PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs188140481-A	rs188140481	0	188140481	non_coding_transcript_exon_variant	0.0	0.005168	2e-15	14.69897000433602		1.63	[1.23-2.03] unit increase	NR [11842647] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	18q21.31	18	57982931		LINC01897 - HMGN1P30	ENSG00000267209	ENSG00000235028		18497.0	35863.0	rs77112978-G	rs77112978	0	77112978	regulatory_region_variant	1.0	0.048	3e-08	7.522878745280337		1.47	[1.28-1.68]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	18q21.32	18	60912659		HMGN1P31 - CDH20	ENSG00000267513	ENSG00000101542		117743.0	420771.0	rs55850837-A	rs55850837	0	55850837	intergenic_variant	1.0	0.05	4e-08	7.397940008672037		1.45	[1.27-1.65]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	19p13.11	19	18062031		IL12RB1			ENSG00000096996			rs17878533-A	rs17878533	0	17878533	intron_variant	0.0	0.651	5e-07	6.301029995663981		1.2	[1.12-1.28]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	20q13.33	20	62458650		RBBP8NL - GATA5	ENSG00000130701	ENSG00000130700		31111.0	4847.0	rs74874116-T	rs74874116	0	74874116	downstream_gene_variant	1.0	0.028	3e-07	6.522878745280337		1.74	[1.41-2.15]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	2q14.2	2	120533314		LINC01101 - Y_RNA	ENSG00000280409	ENSG00000264495		67096.0	117959.0	rs1404610-G	rs1404610	0	1404610	intergenic_variant	1.0	0.012	5e-10	9.30102999566398		3.74	[2.47-5.67]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	3p12.3	3	75472204		ENPP7P2, LINC02018			ENSG00000239959, ENSG00000272690			rs116419656-G	rs116419656	0	116419656	intron_variant	0.0	0.01	2e-08	7.698970004336019		3.45	[2.24-5.32]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	8q24.3	8	144167882		MROH1			ENSG00000179832			rs113658888-T	rs113658888	0	113658888	intron_variant	0.0	0.011	9e-08	7.045757490560675		2.11	[1.6-2.77]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	9q34.2	9	133826997		VAV2			ENSG00000160293			rs115861550-T	rs115861550	0	115861550	intron_variant	0.0	0.01	4e-06	5.3979400086720375		2.05	[1.51-2.79]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	10q26.3	10	129839530		EBF3			ENSG00000108001			rs3750827-A	rs3750827	0	3750827	intron_variant	0.0	0.011	8e-10	9.096910013008056		2.24	[1.73-2.89]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	13q34	13	113122057		F7 - F10	ENSG00000057593	ENSG00000126218		1372.0	742.0	rs563064-A	rs563064	0	563064	upstream_gene_variant	1.0	0.01	5e-08	7.301029995663981		2.98	[2.01-4.41]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	17q25.1	17	75631738		RECQL5			ENSG00000108469			rs820198-T	rs820198	0	820198	intron_variant	0.0	0.01	6e-06	5.221848749616356		2.97	[1.86-4.75]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	17q25.3	17	82048551		RFNG			ENSG00000169733			rs12452625-A	rs12452625	0	12452625	3_prime_UTR_variant	0.0	0.011	7e-08	7.154901959985743		2.14	[1.62-2.82]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	19p13.3	19	611321		HCN2			ENSG00000099822			rs59027729-A	rs59027729	0	59027729	intron_variant	0.0	0.014	4e-08	7.397940008672037		1.9	[1.51-2.39]	Illumina [9962324] (imputed)	N
2022-03-28	34993496	Jiang Y	2021-11-19	HGG Adv	www.ncbi.nlm.nih.gov/pubmed/34993496	Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment.	Conversion from active surveillance to active treatment in prostate cancer	1,609 European ancestry cases, 3,613 European ancestry controls	77 European ancestry cases, 348 European ancestry controls, 123 African ancestry cases, 273 African ancestry controls, 88 Asian ancestry cases, 149 Asian ancestry controls, 21 Latin American cases, 60 Latin American controls	19q13.42	19	53869214		MYADM			ENSG00000179820			rs116837676-A	rs116837676	0	116837676	intron_variant	0.0	0.011	7e-08	7.154901959985743		2.42	[1.76-3.34]	Illumina [9962324] (imputed)	N
2023-01-12	33951180	George DJ	2021-05-05	Cancer	www.ncbi.nlm.nih.gov/pubmed/33951180	A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.	Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer	83 European or Black individuals		2q36.3	2	228111733		SPHKAP			ENSG00000153820			rs80275835-?	rs80275835	0	80275835	intron_variant	0.0	NR	1e-07	7.0				Illumina [934674]	N
2023-01-12	33951180	George DJ	2021-05-05	Cancer	www.ncbi.nlm.nih.gov/pubmed/33951180	A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.	Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer	83 European or Black individuals		2q36.3	2	227388580		SCYGR1 - MIR5703	ENSG00000284629	ENSG00000284092		631.0	83552.0	rs75639111-?	rs75639111	0	75639111	upstream_gene_variant	1.0	NR	3e-07	6.522878745280337				Illumina [934674]	N
2023-01-12	33951180	George DJ	2021-05-05	Cancer	www.ncbi.nlm.nih.gov/pubmed/33951180	A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.	Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer	83 European or Black individuals		2q36.3	2	227642674		C2orf83			ENSG00000042304			rs6733782-?	rs6733782	0	6733782	intron_variant	0.0	NR	4e-07	6.3979400086720375				Illumina [934674]	N
2023-01-12	33951180	George DJ	2021-05-05	Cancer	www.ncbi.nlm.nih.gov/pubmed/33951180	A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.	Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer	83 European or Black individuals		18q21.1	18	49792133		ACAA2			ENSG00000167315			rs10502901-?	rs10502901	0	10502901	intron_variant	0.0	NR	5e-07	6.301029995663981				Illumina [934674]	N
2023-01-12	33951180	George DJ	2021-05-05	Cancer	www.ncbi.nlm.nih.gov/pubmed/33951180	A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.	Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer	83 European or Black individuals		2q36.3	2	227346754		MFF			ENSG00000168958			rs10177414-?	rs10177414	0	10177414	non_coding_transcript_exon_variant	0.0	NR	6e-07	6.221848749616356				Illumina [934674]	N
2023-01-12	33951180	George DJ	2021-05-05	Cancer	www.ncbi.nlm.nih.gov/pubmed/33951180	A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.	Time to prostate-specific antigen progression in metastatic castration-resistant prostate cancer	83 European or Black individuals		2q37.1	2	232913187		NGEF			ENSG00000066248			rs73102745-?	rs73102745	0	73102745	intron_variant	0.0	NR	9e-07	6.045757490560675				Illumina [934674]	N
2022-12-05	32424261	Lee MJ	2020-05-18	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/32424261	Association between metformin medication, genetic variation and prostate cancer risk.	Prostate cancer x metformin use interaction (complex model)	2,608 European ancestry individuals, 322 Asian ancestry individuals, 551 individuals		8p21.2	8	27145181		MIR548H4 - STMN4	ENSG00000221616	ENSG00000015592		96218.0	90127.0	rs115071742-?	rs115071742	0	115071742	intergenic_variant	1.0	NR	4e-08	7.397940008672037		15.8	[5.9-42.2]	Illumina [6504155] (imputed)	N
2022-12-05	32424261	Lee MJ	2020-05-18	Prostate Cancer Prostatic Dis	www.ncbi.nlm.nih.gov/pubmed/32424261	Association between metformin medication, genetic variation and prostate cancer risk.	High grade prostate cancer x metformin use interaction (simple model)	2,608 European ancestry individuals, 322 Asian ancestry individuals, 551 individuals		16q13	16	56940948		HERPUD1			ENSG00000051108			rs149137006-?	rs149137006	0	149137006	non_coding_transcript_exon_variant	0.0	NR	5e-08	7.301029995663981		3.92	[2.4-6.4]	Illumina [6504155] (imputed)	N
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8	127472793	intergenic	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0.0	0.09	6e-18	17.221848749616356		1.6	[1.43-1.77]	Illumina [316515]	N
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8	127112671	intergenic	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0.0	0.03	1e-12	12.0	(EA)	1.79	[1.53-2.11]	Illumina [316515]	N
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8;8	127081032;127081052	intergenic	No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; CASC19; PCAT1; PRNCR1; No mapped genes; No mapped genes; No mapped genes; CASC19; PRNCR1; PCAT1						rs1456305-T; rs1551510-G; rs1456314-G; rs1456306-C; rs7816535-G; rs1378897-G; rs17831626-T; rs1016342-C; rs6994316-A; rs1031588-G; rs6470494-T; rs6993569-G; rs7825414-G; rs1016343-T	rs1456305; rs1551510; rs1456314; rs1456306; rs7816535; rs1378897; rs17831626; rs1016342; rs6994316; rs1031588; rs6470494; rs6993569; rs7825414; rs1016343	0		intron_variant; non_coding_transcript_exon_variant; intron_variant; intron_variant; intron_variant; intron_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant; intron_variant; intron_variant; non_coding_transcript_exon_variant		0.022	3e-15	14.522878745280336	(EA)	2.1	[1.75-2.53]	Illumina [316515]	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		1p36.11	1	24456821		NIPAL3			ENSG00000001461			rs2235558-?	rs2235558	0	2235558	intron_variant	0.0	NR	2e-08	7.698970004336019		0.039	unit increase	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		2q31.3	2	180404497		CWC22 - SCHLAP1	ENSG00000163510	ENSG00000281131		397200.0	287607.0	rs4893909-?	rs4893909	0	4893909	intergenic_variant	1.0	NR	3e-09	8.522878745280337		0.043	unit increase	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		5q13.3	5	74096841		LINC02122			ENSG00000248474			rs4704108-?	rs4704108	0	4704108	intron_variant	0.0	NR	2e-09	8.698970004336019		0.045	unit decrease	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		8q21.13	8	80223726		TPD52			ENSG00000076554			rs35055448-?	rs35055448	0	35055448	intron_variant	0.0	NR	5e-08	7.301029995663981		0.041	unit decrease	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		10p15.1	10	5684858		TASOR2			ENSG00000108021			rs11259192-?	rs11259192	0	11259192	5_prime_UTR_variant	0.0	NR	3e-09	8.522878745280337		0.062	unit increase	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		15q13.3	15	33057362		FMN1			ENSG00000248905			rs11857866-?	rs11857866	0	11857866	intron_variant	0.0	NR	2e-09	8.698970004336019		0.043	unit increase	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		16q22.3	16	72968522		ZFHX3			ENSG00000140836			rs8052683-?	rs8052683	0	8052683	intron_variant	0.0	NR	2e-07	6.698970004336019		0.038	unit decrease	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		20p11.21	20	25419344		GINS1			ENSG00000101003			rs11087515-?	rs11087515	0	11087515	intron_variant	0.0	NR	4e-08	7.397940008672037		0.039	unit increase	Affymetrix, Illumina [6873681] (imputed)	N
2023-09-05	37612283	Ito S	2023-08-23	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/37612283	Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.	Prostate cancer	8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls, 85,554 European ancestry cases, 91,972 European ancestry controls, 10,368 African ancestry cases, 10,986 African ancestry controls, 2,714 Hispanic cases, 5,239 Hispanic controls		21q22.11	21	34162803		LINC00310			ENSG00000227456			rs10154043-?	rs10154043	0	10154043	intron_variant	0.0	NR	1e-08	8.0		0.038	unit decrease	Affymetrix, Illumina [6873681] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2p25.3	2	630070		LINC01875 - TMEM18	ENSG00000225942	ENSG00000151353		83403.0	33807.0	rs66906321-T	rs66906321	0	66906321	intergenic_variant	1.0	NR	1e-08	8.0	(random effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2q24.2	2	160772472		RBMS1 - RN7SL423P	ENSG00000153250	ENSG00000244372		278665.0	105075.0	rs146071273-A	rs146071273	0	146071273	intergenic_variant	1.0	NR	8e-09	8.096910013008056	(fixed effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2q32.1	2	187377642		CALCRL			ENSG00000064989			rs62172372-A	rs62172372	0	62172372	intron_variant	0.0	NR	1e-08	8.0	(fixed effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2q37.1	2	232651825		EFHD1			ENSG00000115468			rs34755199-A	rs34755199	0	34755199	intron_variant	0.0	NR	9e-09	8.045757490560675	(2-sided ASSET)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		6p24.3	6	7231610		RREB1			ENSG00000124782			rs9379084-A	rs9379084	0	9379084	missense_variant	0.0	NR	9e-09	8.045757490560675	(random effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		15q15.3	15	43896656		FRMD5			ENSG00000171877			rs533143-T	rs533143	0	533143	intron_variant	0.0	NR	4e-10	9.397940008672036				NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		18q21.31	18	57650664		ATP8B1			ENSG00000081923			rs8097764-A	rs8097764	0	8097764	intron_variant	0.0	NR	1e-08	8.0	(random effect)			NR [NR] (imputed)	N
